US20080103590A1 - Method and apparatus for reducing mitral regurgitation - Google Patents
Method and apparatus for reducing mitral regurgitation Download PDFInfo
- Publication number
- US20080103590A1 US20080103590A1 US11/818,991 US81899107A US2008103590A1 US 20080103590 A1 US20080103590 A1 US 20080103590A1 US 81899107 A US81899107 A US 81899107A US 2008103590 A1 US2008103590 A1 US 2008103590A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- coronary sinus
- accordance
- assembly
- anchoring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 72
- 206010027727 Mitral valve incompetence Diseases 0.000 title claims abstract description 62
- 210000003748 coronary sinus Anatomy 0.000 claims abstract description 205
- 210000004115 mitral valve Anatomy 0.000 claims abstract description 88
- 238000004873 anchoring Methods 0.000 claims description 61
- 238000003780 insertion Methods 0.000 claims description 16
- 230000037431 insertion Effects 0.000 claims description 16
- 239000006260 foam Substances 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 13
- 210000003462 vein Anatomy 0.000 claims description 12
- 238000005452 bending Methods 0.000 claims description 11
- 230000004913 activation Effects 0.000 claims description 9
- 238000013459 approach Methods 0.000 claims description 8
- 230000017531 blood circulation Effects 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 7
- 239000000853 adhesive Substances 0.000 claims description 5
- 230000001070 adhesive effect Effects 0.000 claims description 5
- 238000009958 sewing Methods 0.000 claims description 5
- 238000009877 rendering Methods 0.000 claims description 4
- 230000000472 traumatic effect Effects 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 2
- 238000002788 crimping Methods 0.000 claims description 2
- 238000004891 communication Methods 0.000 claims 4
- 238000007789 sealing Methods 0.000 claims 4
- 230000002792 vascular Effects 0.000 description 16
- 229910001000 nickel titanium Inorganic materials 0.000 description 11
- 210000001631 vena cava inferior Anatomy 0.000 description 11
- 238000010276 construction Methods 0.000 description 10
- 230000007246 mechanism Effects 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 206010019280 Heart failures Diseases 0.000 description 9
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 9
- 230000008901 benefit Effects 0.000 description 9
- 238000013461 design Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000033001 locomotion Effects 0.000 description 9
- 210000005245 right atrium Anatomy 0.000 description 9
- 229910052751 metal Inorganic materials 0.000 description 8
- 239000002184 metal Substances 0.000 description 8
- 238000011065 in-situ storage Methods 0.000 description 7
- 210000004731 jugular vein Anatomy 0.000 description 7
- 210000001321 subclavian vein Anatomy 0.000 description 7
- 230000000747 cardiac effect Effects 0.000 description 6
- 210000002620 vena cava superior Anatomy 0.000 description 6
- 206010000891 acute myocardial infarction Diseases 0.000 description 5
- 210000003484 anatomy Anatomy 0.000 description 5
- 238000002592 echocardiography Methods 0.000 description 5
- 239000003292 glue Substances 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 238000002594 fluoroscopy Methods 0.000 description 4
- 208000005907 mitral valve insufficiency Diseases 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 0 CCC[C@@](C[C@@](C1(C)C#C*=C1)C=C=O)CC1CC1 Chemical compound CCC[C@@](C[C@@](C1(C)C#C*=C1)C=C=O)CC1CC1 0.000 description 3
- 206010067171 Regurgitation Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000037237 body shape Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 210000003191 femoral vein Anatomy 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000005240 left ventricle Anatomy 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- 208000005189 Embolism Diseases 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 206010007625 cardiogenic shock Diseases 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000005003 heart tissue Anatomy 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 210000005246 left atrium Anatomy 0.000 description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 2
- 238000004513 sizing Methods 0.000 description 2
- 239000003351 stiffener Substances 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- GDOPTJXRTPNYNR-UHFFFAOYSA-N CC1CCCC1 Chemical compound CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 206010038669 Respiratory arrest Diseases 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000002512 anti-withdrawal effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000011316 hemodynamic instability Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002608 intravascular ultrasound Methods 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000003540 papillary muscle Anatomy 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2451—Inserts in the coronary sinus for correcting the valve shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3478—Endoscopic needles, e.g. for infusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3468—Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00392—Transmyocardial revascularisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0004—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
- A61F2250/0007—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting length
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/006—Additional features; Implant or prostheses properties not otherwise provided for modular
- A61F2250/0063—Nested prosthetic parts
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/902—Method of implanting
- Y10S623/904—Heart
Definitions
- This invention relates to surgical methods and apparatus in general, and more particularly to surgical methods and apparatus for improving mitral valve function.
- Mitral valve repair is the procedure of choice to correct mitral regurgitation of all etiologies. With the use of current surgical techniques, between 70% and 95% of regurgitant mitral valves can be repaired. The advantages of mitral valve repair over mitral valve replacement are well documented. These include better preservation of cardiac function and reduced risk of anticoagulant-related hemorrhage, thromboembolism and endocarditis.
- mitral valve surgery requires an extremely invasive approach that includes a chest wall incision, cardiopulmonary bypass, cardiac and pulmonary arrest, and an incision on the heart itself to gain access to the mitral valve.
- a procedure is associated with high morbidity and mortality. Due to the risks associated with this procedure, many of the sickest patients are denied the potential benefits of surgical correction of mitral regurgitation. In addition, patients with moderate, symptomatic mitral regurgitation are denied early intervention and undergo surgical correction only after the development of cardiac dysfunction.
- Mitral regurgitation is a common occurrence in patients with heart failure and a source of important morbidity and mortality in these patients. Mitral regurgitation in patients with heart failure is caused by changes in the geometric configurations of the left ventricle, papillary muscles and mitral annulus. These geometric alterations result in incomplete coaptation of the mitral leaflets during systole. In this situation, mitral regurgitation is corrected by plicating the mitral valve annulus, either by sutures alone or by sutures in combination with a support ring, so as to reduce the circumference of the distended annulus and restore the original geometry of the mitral valve annulus.
- mitral valve annulus be reduced in radius by surgically opening the left atrium and then fixing sutures, or more commonly sutures in combination with a support ring, to the internal surface of the annulus; this structure is used to pull the annulus back into a smaller radius, thereby reducing mitral regurgitation by improving leaflet coaptation.
- This method of mitral valve repair effectively reduces mitral regurgitation in heart failure patients. This, in turn, reduces symptoms of heart failure, improves quality of life and increases longevity.
- annuloplasty effectively reduces mitral regurgitation in heart failure patients. This, in turn, reduces symptoms of heart failure, improves quality of life and increases longevity.
- the invasive nature of mitral valve surgery and the attendant risks render most heart failure patients poor surgical candidates.
- a less invasive means to increase leaflet coaptation and thereby reduce mitral regurgitation in heart failure patients would make this therapy available to a much greater percentage of patients.
- Mitral regurgitation also occurs in approximately 20% of patients suffering acute myocardial infarction.
- mitral regurgitation is the primary cause of cardiogenic shock in approximately 10% of patients who develop severe hemodynamic instability in the setting of acute myocardial infarction.
- Patients with mitral regurgitation and cardiogenic shock have about a 50% hospital mortality. Elimination of mitral regurgitation in these patients would be of significant benefit.
- patients with acute mitral regurgitation complicating acute myocardial infarction are particularly high-risk surgical candidates, and are therefore not good candidates for a traditional annuloplasty procedure.
- a minimally invasive means to effect a temporary reduction or elimination of mitral regurgitation in these critically ill patients would afford them the time to recover from the myocardial infarction or other acute life-threatening events and make them better candidates for medical, interventional or surgical therapy.
- one object of the present invention is to provide improved methods and apparatus for reducing mitral regurgitation.
- Another object of the present invention is to provide methods and apparatus for reducing mitral regurgitation which is minimally invasive.
- Another object of the present invention is to provide methods and apparatus for reducing mitral regurgitation which can be deployed either permanently (e.g., for patients suffering from heart failure) or temporarily (e.g., for patients suffering from mitral regurgitation with acute myocardial infarction).
- a feature of the present invention is the provision of a novel method for reducing mitral regurgitation.
- the method comprises the steps of inserting a flexible guiding catheter into a coronary sinus of a patient in a vicinity of a posterior leaflet of a mitral valve, anchoring a distal end of the catheter in the coronary sinus, moving an elongated body through the catheter and into a position within the catheter and in the vicinity of the posterior leaflet, the body being adapted to straighten a natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
- a further method for reducing mitral regurgitation comprises the steps of advancing a guidewire into a coronary sinus of a patient, advancing a catheter around the guidewire and into the coronary sinus, providing a push rod having an elongated substantially rigid body fixed to a distal portion thereof, advancing the push rod through the catheter until the body is in a vicinity of a posterior leaflet of a mitral valve of the patient, detaching a proximal portion of the catheter from a distal portion of the catheter, and detaching a proximal portion of the push rod from a distal portion of the push rod, and removing the proximal portions of the catheter and the push rod from the patient.
- a further method for reducing mitral regurgitation comprises the steps of advancing a flexible strand into a coronary sinus, anchoring at least a distal end of the strand in the coronary sinus proximate an anterior interventricular vein, interconnecting a proximal end of the strand and a cinch activation structure, and operating the cinch activation structure to pull the strand taut, whereby to cause the strand to approach a straight configuration and a mid-portion of the strand to engage a posterior wall of a mitral valve annulus, which pushes a posterior mitral valve leaflet anteriorly to improve coaptation.
- a novel assembly for reducing mitral regurgitation comprising a flexible guiding catheter for insertion into a coronary sinus of a patient in a vicinity of a posterior leaflet of a mitral valve, structure for anchoring a distal end of the catheter in the coronary sinus, an elongated body for moving through the catheter and into a position within the catheter and in the vicinity of the posterior leaflet, the body being adapted to straighten a natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, to move the posterior leaflet anteriorly and thereby improve leaflet coaptation.
- the assembly comprises a flexible catheter having as a part thereof an elongated substantially rigid portion, the catheter being adapted for insertion into a coronary sinus of a patient and adapted to be moved to a position placing the rigid portion in a vicinity of a posterior leaflet of a mitral valve, the rigid portion being adapted to straighten a natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, to move the posterior leaflet anteriorly and thereby improve leaflet coaptation.
- the assembly comprises a flexible guide wire for insertion into a coronary sinus of a patient, a flexible guiding catheter for disposition around the guide wire and adapted for insertion into the coronary sinus, an elongated substantially rigid body fixed to a distal end of a push rod and adapted to advance in the catheter to a vicinity of a posterior leaflet of a mitral valve of the patient, a detachable joint by which the push rod may be separated, and a break-away joint by which the catheter may be separated into distal and proximal portions, whereby after the body is in the vicinity of the posterior leaflet, the push rod and the catheter proximal portions may be removed from the site and withdrawn from the patient.
- the assembly comprises a flexible strand adapted to advance into and through a coronary sinus, an anchor at a distal end of the strand for securing the distal end in a fixed position in the coronary sinus, and a cinch activation structure connected to a proximal portion of the strand and operable by an operator to pull the strand taut, whereby to cause the strand to approach a straight configuration with a mid-portion of the strand adapted to engage a posterior wall of a mitral valve annulus to urge a posterior mitral valve leaflet anteriorly to improve coaptation.
- an elongated body for introduction into a coronary sinus.
- the body comprises an elastomeric sleeve substantially closed at both ends thereof, the sleeve defining two internal chambers in axial alignment with each other, the chambers being separated by a wall having a aperture therein.
- a rod is slidably disposed in the aperture and enters into the two chambers, the rod having a distal flexible portion, a middle rigid portion and a proximal flexible portion.
- a pull wire extends from the proximal end of the rod and through a proximal end of the sleeve.
- the rod is positionable such that one of the flexible portions of the rod is disposed in the aperture in the chamber wall, rendering the body flexible.
- the rod is further positionable by manipulation of the pull wire to cause the rod rigid portion to be disposed in the aperture in the chamber wall, rendering the wall rigid.
- the body may be rendered flexible so as to be moved to the coronary sinus and may be rendered rigid so as to effect a change in coronary leaflet coaptation.
- a method for reducing mitral regurgitation comprising inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus having a distal end, a proximal end and an intermediate portion, the apparatus being configured so that when the apparatus is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends will apply a posteriorly-directed force to the walls of the coronary sinus and the intermediate portion will apply an anteriorly-directed force to the walls of the coronary sinus, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
- an apparatus for reducing mitral regurgitation comprising a body having a distal end, a proximal end and an intermediate portion, the body being configured so that when the body is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends will apply a posteriorly-directed force to the walls of the coronary sinus, and the intermediate portion will apply an anteriorly-directed force to the walls of the coronary sinus, whereby to move the posterior annulus of the mitral valve anteriorly and thereby improve leaflet coaptation.
- the present invention may be practiced in a minimally invasive manner, either permanently or temporarily, so as to reduce mitral regurgitation.
- FIG. 1 is a schematic view of portions of the human vascular system
- FIG. 2 is a schematic view of portions of the human heart
- FIG. 3 is a schematic view of a preferred system formed in accordance with the present invention.
- FIGS. 4-7 are a series of views illustrating use of the system of FIG. 3 to reduce mitral regurgitation
- FIG. 8 shows an alternative form of delivery catheter
- FIG. 9 shows an alternative form of flexible push rod
- FIG. 9A shows an alternative form of the present invention
- FIG. 9B is a diagrammatic side elevational partly sectioned view of a further flexible push rod
- FIGS. 9C and 9D are similar to FIG. 9B and showing alternative embodiments of flexible push rod
- FIG. 9E is a generally side elevational view of a flexible support catheter
- FIG. 9F is a generally side elevational view of an alternative flexible delivery catheter
- FIGS. 10 and 11 show alternative constructions for the straight, substantially rigid elongated body
- FIGS. 11A-11N and 11 P- 11 S illustrate other aspects of the present invention.
- FIG. 11T is a diagrammatic illustration of forces engaging upon an operative portion of the inventive assemblies
- FIGS. 11U and 11V are graphs illustrating comparative strains and stresses
- FIG. 12 shows another alternative system formed in accordance with the present invention.
- FIG. 13 shows the components of FIG. 12 assembled for use
- FIGS. 14-16 illustrate another aspect of the present invention
- FIGS. 16A-16D illustrate other aspects of the present invention.
- FIGS. 17-20 illustrate still other aspects of the present invention.
- FIGS. 21-24 illustrate other aspects of the present invention.
- FIG. 24A is a diagrammatic illustration of another feature of the invention.
- FIGS. 24B-24H and 24 J- 24 O illustrate alternative features of the invention
- FIGS. 25-27 illustrate another form of the present invention
- FIGS. 28-32 illustrate the embodiment of FIGS. 25-27 in use
- FIGS. 32A-32E illustrate other aspects of the present invention.
- FIGS. 33 and 34 illustrate another form of the present invention
- FIGS. 35-37 illustrate the embodiment of FIGS. 33 and 34 in use
- FIGS. 37A-37C illustrate another aspect of the present invention
- FIGS. 37D and 37E illustrate another aspect of the present invention
- FIGS. 37F-37I illustrate another aspect of the present invention
- FIGS. 37J and 37K illustrate yet another aspect of the present invention
- FIGS. 37L and 37M are sectional views of a further embodiment of the substantially rigid elongated body; illustrate yet another aspect of the present invention
- FIG. 38 illustrates another form of the present invention
- FIGS. 39 and 40 illustrate the embodiment of FIG. 38 in use
- FIGS. 41 and 42 illustrate yet another form of the present invention
- FIGS. 43 and 44 illustrate still another aspect of the present invention.
- FIGS. 45-75 are diagrammatic views illustrating alternative methods and apparatus for anchoring components in place
- FIGS. 76 and 77 illustrate another alternative method and apparatus for reducing mitral regurgitation
- FIG. 78 illustrates another form of the present invention.
- the coronary sinus is the largest vein in the human heart. During a large portion of its course in the atrioventricular groove, the coronary sinus typically extends adjacent to the left atrium of the heart for a distance of approximately 5 to 10 centimeters. Significantly, for a portion of its length, e.g., typically approximately 7-9 cm, the coronary sinus extends substantially adjacent to the posterior perimeter of the mitral annulus.
- the present invention takes advantage of this anatomic relationship.
- the natural curvature of the coronary sinus may be modified in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly so as to improve leaflet coaptation and, as a result, reduce mitral regurgitation.
- the novel apparatus comprises a straight, substantially rigid elongated body, the length of the straight, substantially rigid elongated body being sized so that when the straight, substantially rigid body is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the straight, substantially rigid elongated body causes at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
- the straight, substantially rigid elongated body is introduced into the patient's vascular system via the jugular vein or via the left subclavian vein, passed down the superior vena cava, passed through the right atrium and then passed into the coronary sinus, where it is deployed.
- the straight, substantially rigid elongated body may be introduced into the coronary sinus through a small incision in the heart, or through some other incision into the patient's vascular system.
- the straight, substantially rigid elongated body is guided into position by (i) passing it through a pre-positioned catheter, and/or (ii) passing it over a pre-positioned guidewire, and/or (iii) passing it guide-free (e.g., on the end of a steerable delivery tool) to the surgical site.
- the novel apparatus may be left in position permanently (e.g., in the case of patients suffering from mitral regurgitation associated with heart failure) or the novel apparatus may be left in position only temporarily (e.g., in the case of patients suffering from mitral regurgitation associated with acute myocardial infarction).
- Visualization of the procedure may be obtained by fluoroscopy, echocardiography, intravascular ultrasound, angioscopy, real-time magnetic resonance imaging, etc.
- the efficacy of the procedure may be determined through echocardiography, although other imaging modalities may also be suitable.
- cardiovascular system 3 generally comprises the heart 6 , the superior vena cava 9 ( FIG. 1 ), the right subclavian vein 12 , the left subclavian vein 15 , the jugular vein 18 , and the inferior vena cava 21 .
- Superior vena cava 9 and inferior vena cava 21 communicate with the heart's right atrium 24 ( FIGS. 1 and 2 ).
- a coronary ostium 27 leads to a coronary sinus 30 .
- the vascular structure leads to a vertically-descending anterior interventricular vein (“AIV”) 32 .
- AIV anterior interventricular vein
- coronary sinus 30 generally extends substantially adjacent to a posterior perimeter of an annulus 33 of a mitral valve 36 .
- Mitral valve 36 comprises a posterior leaflet 39 and an anterior leaflet 42 .
- posterior leaflet 39 and anterior leaflet 42 will generally fail to properly coapt at systole, thereby leaving an intervening gap 45 which will permit regurgitation.
- system 100 which comprises one preferred embodiment of the present invention. More particularly, system 100 generally comprises a guidewire 103 , a delivery catheter 106 and a push rod 109 .
- Guidewire 103 comprises a flexible body 112 having a distal end 115 and a proximal end 118 .
- the distal end 115 of guidewire 103 preferably includes a spring tip 121 for allowing the distal end of guidewire 103 to atraumatically traverse vascular structures, i.e., while the guidewire 103 is being passed through the vascular system of a patient.
- Delivery catheter 106 comprises a flexible body 124 having a distal end 127 and a proximal end 130 , preferably with an adjustable valve 133 attached.
- a central lumen 136 extends from distal end 127 to proximal end 130 .
- a balloon 139 may be positioned about the exterior of flexible body 124 , just proximal to distal end 127 , with an inflation lumen 142 extending between balloon 139 and an inflation fitting 145 .
- Alternative means for securing the delivery catheter 106 within a vascular structure are discussed hereinafter.
- Push rod 109 comprises a flexible body 148 having a distal end 151 and a proximal end 154 .
- a straight, substantially rigid elongated body 157 which may have a variety of different lengths, is formed on flexible body 148 , proximal to distal end 151 .
- a removable proximal stiffener, or handle, 160 may be placed between straight, substantially rigid elongated body 157 and proximal end 154 to facilitate gripping flexible body 148 , e.g., for advancement or retraction purposes.
- System 100 may be used as follows to reduce mitral regurgitation.
- distal end 115 of guidewire 103 is passed down the jugular vein 18 (or the left subclavian vein 15 ) of a patient, down superior vena cava 9 , through right atrium 24 of the heart 6 , and into the coronary sinus 30 ( FIG. 4 ).
- the guidewire will tend to assume the natural curved shape of the coronary sinus, due to the flexible nature of the guidewire.
- the guidewire's atraumatic spring tip 121 helps ensure minimal damage to vascular structures as guidewire 103 is maneuvered into position.
- distal end 127 of delivery catheter 106 is placed over proximal end 118 of guidewire 103 and passed down the guidewire until the distal end 127 of the delivery catheter 106 is positioned in coronary sinus 30 ( FIG. 5 ).
- the delivery catheter will tend to assume the natural curved shape of the coronary sinus, due to the flexible nature of the delivery catheter.
- balloon 139 may be inflated so as to secure distal end 127 of delivery catheter 106 in position within coronary sinus 30 .
- a selected one of several anchor structures described hereinbelow may be provided and at this point activated so as to secure the catheter distal end 127 in place.
- push rod 109 is passed down the central lumen 136 of delivery catheter 106 .
- the push rod's straight, substantially rigid elongated body 157 is passed down central lumen 136 of delivery catheter 106 , it forces the delivery catheter 106 to assume a straight configuration at the point where the straight, substantially rigid elongated body 157 currently resides ( FIG. 7 ).
- balloon 139 holds the distal end 127 of the delivery catheter 106 in position within coronary sinus 30 .
- Push rod 109 is pushed down delivery catheter 106 , utilizing proximal handle 160 as needed, until the straight, substantially rigid elongated body 157 is located adjacent to the posterior annulus 33 of mitral valve 36 ( FIG. 7 ).
- the presence of the straight, substantially rigid elongated body 157 in delivery catheter 106 causes at least a portion of coronary sinus 30 to assume a substantially straight configuration at this point, so that the posterior annulus 33 of mitral valve 36 is forced anteriorly.
- This causes the mitral valve's posterior leaflet 39 to move anteriorly so as to improve mitral valve leaflet coaptation and thereby reduce (or completely eliminate) mitral valve regurgitation.
- the posterior annulus 33 may be shifted anteriorly so as to achieve, or to attempt to achieve to the extent anatomically possible, leaflet-to-leaflet engagement or leaflet-to-annulus engagement (e.g., where a leaflet may be tethered due to left ventricular distortion). Both of these types of engagement, or targeted engagement, are intended to be encompassed by the terms “improved leaflet coaptation” and/or “increased leaflet coaptation” and the like.
- standard visualization means e.g. echocardiography or fluoroscopy
- the exact position of the straight, substantially rigid elongated body 157 is adjusted so as to reduce (or completely eliminate) regurgitation in mitral valve 36 .
- the straight, substantially rigid elongated body 157 is preferably sized to be somewhat less than the length of the coronary sinus between coronary ostium 27 and AIV 32 . However, in some circumstances it may be desirable to size the straight, substantially rigid elongated body 157 so that it will extend out of the coronary sinus 30 and into the right atrium 24 .
- the system provides a degree of tactile feedback to the user during deployment. More particularly, substantial resistance will typically be encountered as the straight, substantially rigid elongated body 157 is pushed out of right atrium 24 and into coronary sinus 30 ; then resistance will typically drop as body 157 is moved through the coronary sinus; and then resistance will typically increase significantly again as the distal end 151 of push rod 109 , and/or the leading distal tip of body 157 , comes to the far end 31 of the coronary sinus.
- the straight, substantially rigid elongated body 157 is locked in position, e.g., by closing adjustable valve 133 ( FIG. 3 ), and balloon 139 may be deflated.
- System 100 is left in this position until it is no longer needed. In some cases, this may mean that system 100 is left in position for a period of a few hours, days or weeks; in other cases system 100 may be substantially permanent. If and when system 100 is to be removed, push rod 109 is removed from delivery catheter 106 , and then delivery catheter 106 is removed from the patient.
- the straight, substantially rigid elongated body 157 is essentially force-fit into the normally curved portion of the coronary sinus adjacent to the mitral valve's posterior leaflet 39 .
- the straight, substantially rigid elongated body will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet 39 of the mitral valve 36 .
- the straight, substantially rigid elongated body 157 will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet 39 of the mitral valve 36 , whereby to drive the posterior annulus of the mitral valve anteriorly, so as to improve leaflet coaptation and thereby reduce mitral regurgitation.
- push rod 109 is preferably provided as part of a kit having a plurality of different push rods 109 , each with a differently-sized elongated body 157 , whereby a physician may select and deploy the appropriately-sized elongated body 157 for a specific patient's anatomy. Furthermore, if upon deployment it should be discovered (e.g., under echocardiography or fluoroscopy) that a different size of elongated body 157 is needed, the first push rod 109 may be replaced by a second push rod having the desired size of elongated body 157 .
- the left ventricle may be remodeled so as to help alleviate congestive heart failure.
- the distal and proximal ends of straight, substantially rigid elongated body 157 apply a posteriorly-directed force on the walls of coronary sinus 30 (e.g., as shown with arrows P in FIG. 7 ) while the intermediate portion of straight, substantially rigid elongated body 157 applies an anteriorly-directed force on the walls of coronary sinus 30 (e.g., as shown with arrows A in FIG. 7 ).
- proximal end 130 of delivery catheter 106 may be fixed to the patient's outer skin, using standard patient care methods such as adhesive tape, pursestring sutures, skin staples, etc.
- proximal end 130 of delivery catheter 106 may include a sewing cuff whereby the delivery catheter may be secured to the patient's tissue by suturing. See, for example, FIG. 8 , where a sewing cuff 166 is shown attached to the proximal end 130 of delivery catheter 106 .
- an element 169 may be provided proximal to adjustable valve 133 , whereby flexible push rod 109 may be made fast to delivery catheter 106 .
- element 169 may comprise a crimpable element to secure flexible push rod 109 to delivery catheter 106 , which is in turn secured to the patient, e.g., with sewing cuff 166 .
- the proximal end of the assembly may be embedded under the skin of the patient, e.g., in the case of a permanent implant.
- the distal end of delivery catheter 106 can be secured in position within the coronary sinus prior to pushing push rod 109 into the delivery catheter. Such an arrangement will keep the delivery catheter in place as the push rod makes the turn within the right atrium and enters the coronary sinus.
- the push rod may drive the delivery catheter down the inferior vena cava 21 ( FIG. 1 ).
- the delivery catheter can be stabilized against diversion down the inferior vena cava 21 when the straight, substantially rigid elongate body 157 encounters initial resistance to making the turn into the coronary sinus.
- the balloon 139 is one way of accomplishing such anchoring. However, it is also possible to utilize other types of securing mechanisms to anchor the distal end 127 of delivery catheter 106 in position within coronary sinus 30 , e.g., spring clips, ribs, etc. If desired, the distal end 151 of push rod 109 may itself be provided with a distal anchor, e.g., such as the distal anchor 172 shown in FIG. 9 . Such a distal anchor on push rod 109 can help hold the straight, substantially rigid elongated body 157 in proper position within coronary sinus 30 .
- a distal anchor on push rod 109 can help hold the straight, substantially rigid elongated body 157 in proper position within coronary sinus 30 .
- FIG. 9A there is shown a support catheter 173 which is formed out of a more rigid material than delivery catheter 106 .
- Support catheter 173 is constructed so that its distal end 174 can be positioned in coronary ostium 27 and then its sidewall 174 A can support delivery catheter 106 adjacent to inferior vena cava 21 when push rod 109 is passed down delivery catheter 106 , whereby to prevent delivery catheter 106 from diverting down inferior vena cava 21 .
- FIG. 9A also shows an introducer catheter 174 B at the entrance to jugular vein 18 .
- Push rod 112 A which comprises an alternative form of push rod.
- Push rod 112 A comprises a flexible body 148 A having a distal end 151 A and a proximal end 154 A.
- flexible body 148 A is formed out of a superelastic shape memory alloy, such as Nitinol.
- a straight, substantially rigid member 157 A is formed on flexible body 148 A, proximal to distal end 151 A.
- Substantially rigid member 157 A can have a variety of different lengths so as to accommodate different patient anatomies.
- a tube 158 A is positioned concentrically over flexible body 148 A and extends for at least part of the distance between substantially rigid member 157 A and a locking collar 159 A secured to proximal end 154 A of flexible body 148 A.
- Tube 158 A serves as a stiffener or reinforcer for flexible body 148 A, whereby flexible body 148 A can have the flexibility required (particularly at its distal end 151 A) to traverse tortuous vascular passages, yet have the column strength, particularly at its proximal end 154 A, to advance flexible body 148 A by pushing.
- tube 158 A can be sized so as to have a diameter just slightly smaller than the internal diameter of delivery catheter 106 , whereby to further support flexible body 148 A.
- tube 158 A preferably comprises a PEEK tube.
- flexible body 148 A can also be necked down, e.g., as shown at 220 A, so as to further increase the flexibility of flexible body 148 A distal to tube 158 A.
- Flexible push rod 112 A preferably is a device with a series of changes in stiffness and flexibility that allow the device to be bending flexible and have column strength sufficient to pass through a tortuous path, such as the vascular system of a patient, yet have specific areas of stiffness to reduce mitral valve regurgitation by pushing the posterior annulus anteriorly and thus closing the gap between the anterior and posterior leaflets of the mitral valve.
- One preferred embodiment of this device is a single rod of superelastic material, such as Nitinol, that has a plurality of changes in diameter that allow for appropriate bending flexibility. At the same time, the largest diameter section has a bending stiffness sufficient to push the posterior annulus anteriorly. The longest portions of the rod may have serrations that provide bending flexibility along with column strength.
- a support catheter 162 preferably with a pre-formed tip 164 , which could be advanced over guidewire 103 , whereby pre-formed tip 164 of support catheter 162 would engage the opening of the coronary sinus 30 .
- the distalmost portion of the pre-formed tip 164 is sufficiently flexible to execute extreme bends, and may be of reduced diameter, so as to facilitate deployment into the coronary sinus.
- the region proximal to the distalmost portion is preferably substantially more rigid, e.g., with a rigidity similar to the sidewall 174 A of support catheter 173 , so as to prevent diversion down inferior vena cava 21 .
- guidewire 103 Upon successful engagement and advancement of the support catheter tip 164 a short distance into the coronary sinus, guidewire 103 is removed. Then delivery catheter 106 is advanced toward and into the coronary sinus through the central lumen 165 of support catheter 162 . Then, push rod 109 would be advanced within central lumen 136 of the delivery catheter 106 into the coronary sinus and into position as described herein.
- the structure of the delivery catheter 106 may be modified so as to add a region 163 ( FIG. 9F ) of increased stiffness proximal to the distal tip 127 of delivery catheter 106 .
- a region 163 FIG. 9F
- the distal tip of delivery catheter 106 will be sufficiently flexible for placement into the coronary sinus, yet the body of delivery catheter will be rigid enough to prevent diversion down the inferior vena cava during the delivery of push rod 109 .
- delivery catheter 106 includes an intermediate region of increased stiffness, it should not be necessary to utilize a support catheter 173 or a support catheter 162 to prevent diversion down the inferior vena cava.
- the straight, substantially rigid elongated body 157 (or 157 A) distorts the natural configuration of the coronary sinus so that it assumes a substantially straight configuration. While this action induces the desired valve remodeling, it can also induce a significant stress on the walls of the coronary sinus, particularly at the distal and proximal ends of the straight, substantially rigid elongated body 157 (or 157 A), where stress will be concentrated. To this end, the construction of the straight, substantially rigid elongated body 157 (or 157 A) may be modified somewhat so as to better distribute this stress.
- the distal and proximal ends of straight, substantially rigid elongated body 157 may include relatively flexible portions 175 to help better distribute the stress exerted on the walls of the coronary sinus. Additionally, and/or alternatively, any taper applied to the distal and proximal ends of straight, substantially rigid elongated body 157 may be elongated, e.g., such as shown at 178 in FIG. 11 , so as to better distribute the stress imposed on the walls of the coronary sinus.
- push rod 109 is described as being inserted to the surgical site through the delivery catheter 106 and remaining within delivery catheter 106 while at the surgical site and, when push rod 109 is to be removed, removing push rod 109 and then delivery catheter 106 . However, if desired, once push rod 109 has been deployed at the surgical site, delivery catheter 106 may then be removed, leaving just push rod 109 at the surgical site. See, for example, FIG. 11A .
- push rod 109 It is also possible to advance push rod 109 directly to the surgical site without passing it through a delivery catheter; in this case push rod 109 would be advanced on its own through the intervening vascular structure until it is deployed in coronary sinus 30 .
- the body 157 may be provided with extended strain relief tapers 200 and a non-traumatic distal tip 202 in a body having a cross-section of a circular configuration ( FIG. 11C ), which provides the advantage of rotational symmetry.
- FIGS. 11D and 11E there is shown a similar body 157 with extended strain relief tapers 200 and non-traumatic tip 202 , but of a generally “square” configuration with rounded corners, in cross-section, which provides four stable orientations.
- FIGS. 11F and 11G there is shown a similar body 157 which is generally rectangular in cross-section.
- the rectangular configuration offers increased flexibility in two stable orientations.
- the body 157 may be hollow and of a metal construction.
- Tubular hollow cross-sections can provide additional flexure.
- FIGS. 11L-11N and lip there are shown embodiments in which an elastomeric outer body 204 is molded over a metal tube 206 ( FIGS. 11L and 11P ) or over a metal rod 208 ( FIG. 11N ).
- the tubes 206 may be empty ( FIG. 11P ) or filled with an appropriate metal or other material 207 ( FIG. 11L ).
- FIGS. 11L-11N and 11 P may be molded with barbs 210 (shown in FIG. 11P ) which are engageable with the interior of the delivery catheter 106 and/or the walls of the coronary sinus 30 so as to help stabilize the longitudinal position of body 157 .
- FIGS. 11R and 11S there are illustrated stepped strain relief segments 212
- FIG. 11Q there is shown an embodiment in which there are provided a series of metal and/or plastic strain relief segments 213 .
- the body 157 must negotiate two difficult turns and several less tortuous ones.
- the two difficult ones are (1) a small radius 80 to 120 degree turn as the device begins to enter the coronary ostium, and (2) the 160 to 200 degree turn around the coronary sinus.
- Two problems must be overcome in order to successfully place the body 157 in the coronary sinus.
- the forces required to advance it into its correct position can cause the delivery catheter 106 to prolapse down the inferior vena cava (in the case of a jugular or subclavian approach) or up into the right atrium or superior vena cava (in the case of a femoral vein approach). Once the delivery catheter has prolapsed, further advancement of the body 157 is generally very difficult.
- Several features of the body 157 and introducer systems disclosed above and hereinbelow may be incorporated to solve these introduction problems.
- the body 157 must be able to resist bending moments in order to appropriately deform the mitral annulus. Note that, for the body described above, this requirement directly conflicts with the ability to negotiate the sharp turn into the coronary ostium. For a non-articulating (i.e., passive) body, a balance must generally be struck between flexibility (for introduction) and stiffness (for in-situ functionality).
- the force loading and strain reliefs for the body 157 are shown in FIG. 11T .
- a high, distributed center load 140 is imparted by the mitral annulus and smaller (approximately half) loads 141 on either strain relief 200 are imparted by the coronary sinus.
- the stress-strain curves for stainless steel and nickel titanium are shown in FIG. 11U .
- Stress is defined as force per unit area, and strain is defined as elongation per unit length.
- a pure tensile case will be described first.
- the slightly more complicated condition of bending will be described next.
- the stress distribution in not uniform throughout the body, but is distributed.
- the outer fibers of the body 157 are at higher strain levels than those close to the neutral axis. This outer fiber strain limits the amount of bend that the body can tolerate. Sharper bends mean higher strains.
- a body 157 After a body 157 has been loaded beyond its proportional limit, it will retain some residual strain when it is unloaded. This residual strain will manifest itself as a permanent elongation in the case of a tensile strain, or as a residual bend in the case of a bending strain. A residual bend in the body will have a very specific detrimental effect on the performance of the body. Due to the lubricity of the vessels, a round body with a residual bend will self-align to the minimum energy condition where the bend of the body coincides with the bend of the coronary sinus. As a result, the amount of bend in the body directly subtracts from the deflection of the mitral annulus. Larger residual strains will result in larger residual bends, and larger “lost” deflection.
- stainless steel can be stretched to approximately 1% and return with a residual strain of 0.5%, while nickel titanium can be stretched to approximately 6% and return with the same residual strain. This means that nickel titanium can bend around much sharper bends, and return with an equivalent residual strain.
- the body 157 preferably is placed with a percutaneous procedure.
- a body fabricated from non-superelastic material such as stainless steel
- This residual curvature will detrimentally affect the performance of the body, subtracting from the resultant deflection of the mitral annulus.
- the use of a body fabricated from a superelastic material will negotiate these sharp curves without acquiring this detrimental residual curvature.
- the stress in the stainless steel continues to rise between 0 and 1% (although at a slower rate above 0.4%). With the nickel titanium, however, the stress reaches a plateau level at a strain of about 2%. Between 2% and 6% strain, the stress remains almost constant at about 80 ksi.
- the stress plateau has the very desirable effect of putting an upper limit on the forces that are required to bend the device and strain reliefs.
- the plateau feature of the nickel titanium allows placing an upper limit on the amount of stress put on the tissue that is causing the body or strain reliefs to bend. With careful design, this intrinsic feature of nickel titanium results in two specific benefits:
- the straight, substantially rigid, elongated body 157 be of nickel titanium, or an alloy thereof.
- bodies 157 featuring a combination of elastomeric material and metal e.g., such as those shown in FIGS. 11L-11N and 11 P
- a preferred metal is, similarly, nickel titanium or an alloy thereof.
- system 181 which comprises another preferred embodiment of the present invention. More particularly, system 181 generally comprises the guidewire 103 , a straight, substantially rigid elongated body 184 and a push cannula 187 .
- Guidewire 103 is as previously described.
- Straight, substantially rigid elongated body 184 which may have a variety of different lengths, comprises a distal end 188 and a proximal end 190 .
- a central lumen 193 extends between distal end 188 and proximal end 190 . Central lumen 193 accommodates guidewire 103 .
- Push cannula 187 comprises a distal end 194 and a proximal end 196 .
- a central lumen 199 extends between distal end 194 and proximal end 196 .
- Central lumen 199 accommodates guidewire 103 .
- elongated body 184 and push cannula 187 may be mounted on guidewire 103 , and push cannula 187 may be used to push elongated body 184 down guidewire 103 ( FIG. 13 ).
- System 181 may be used as follows to reduce mitral regurgitation.
- distal end 115 of guidewire 103 is passed down jugular vein 18 (or the left subclavian vein 15 ) of a patient, down superior vena cava 9 , through right atrium 24 of the heart, and into coronary sinus 30 ( FIG. 14 ).
- the guidewire tends to assume the natural curved shape of the coronary sinus, due to the flexible nature of the guidewire.
- the guidewire's atraumatic spring tip 121 helps minimize damage to vascular structures as the guidewire is advanced into position.
- distal end 188 of straight, substantially rigid elongated body 184 is placed over proximal end 118 of guidewire 103 and passed a short distance down the guidewire. Then the distal end 194 of push cannula 187 is placed over proximal end 118 of guidewire 103 , and then push cannula 187 is advanced down the guidewire. As push cannula 187 is advanced down the guidewire, its distal end 194 pushes the straight, substantially rigid elongated body 184 ahead of it ( FIG. 15 ).
- the straight, substantially rigid elongated body 184 As the straight, substantially rigid elongated body 184 is passed down the coronary sinus 30 , it forces the coronary sinus to assume a straight configuration at the point where the straight, substantially rigid elongated body 184 currently resides.
- Push cannula 187 is pushed down guidewire 103 as needed, until the straight, substantially rigid elongated body 184 is located adjacent to the posterior annulus of the mitral valve ( FIG. 16 ).
- the presence of the straight, substantially rigid elongated body 184 in the coronary sinus 30 causes the coronary sinus to assume a substantially straight configuration at this point, so that the posterior annulus of the mitral valve is forced anteriorly.
- the posterior mitral valve leaflet to also move anteriorly so as to improve leaflet coaptation and thereby reduce, or eliminate, mitral valve regurgitation.
- standard visualization means e.g. echocardiography or fluoroscopy
- the exact position of the straight, substantially rigid elongated body 184 may be adjusted so as to reduce, or eliminate regurgitation in the mitral valve.
- the push cannula 187 may be provided with a releasably attachable interface (e.g., a grasper) so that it may releasably secure the proximal end 190 of the straight, substantially rigid elongated body 184 .
- a releasably attachable interface e.g., a grasper
- Such a feature will permit the straight, substantially rigid elongated body 184 to be pulled backward within the coronary sinus, either for positioning or removal purposes.
- elongated body 184 is to be left within the body for a substantial period of time, it is possible to leave the apparatus in the position shown in FIG. 16 , i.e., with elongated body 184 fit over guidewire 103 and at the end of push cannula 187 .
- guidewire 103 and/or push cannula 187 may be removed, leaving just elongated body 184 deployed at the surgical site ( FIG. 16A ).
- the straight, substantially rigid elongated body 184 may include relatively flexible portions 175 and/or elongated relatively flexible portions 178 at its distal and proximal ends so as to better distribute the loads on the coronary sinus.
- straight inflexible body 184 is an integral part of flexible delivery catheter 106 ( FIG. 16C ). The catheter 106 remains in place after the positioning of the body 184 , as shown in FIG. 16D ).
- the flexible delivery catheter 106 serves as a strain relief means.
- This strain relief means minimizes trauma to the walls of the coronary sinus by spreading the loads at the proximal and distal ends of the body 184 over a greater length of the coronary sinus walls.
- Elongated body 157 and/or elongated body 184 may have any of a variety of non-straight shapes along its length.
- the elongated body may be wavy, spiraled, or curved along all or a portion of its length.
- elongated body 157 and/or 184 may have a curved configuration so as to invert the natural curvature of the coronary sinus, i.e., so that it is bowed towards the anterior annulus.
- the elongated body may have a compound shape along its length, e.g., it may have a sort of “w” shape, with the center of the “w” being directed towards the anterior annulus. See, for example, FIG.
- FIG. 17 which shows a push rod 109 having an elongated body 157 with a “w” type of shape
- FIG. 18 which shows an elongated body 184 with a “w” type of shape.
- FIGS. 19 and 20 show a “w” shaped elongated body 184 being advanced down guidewire 103 ( FIG. 19 ) to a position adjacent to mitral valve 36 ( FIG. 20 ), whereby to reduce mitral regurgitation.
- Any of the aforementioned elongated body shapes, or other alternative shapes, may effect the anterior displacement of the posterior annulus that results in reduction of the mitral valve regurgitation.
- delivery catheter 106 is preferably sized so as to have a diameter less than the diameter of coronary sinus 30 , so that blood may flow about the perimeter of delivery catheter 106 when delivery catheter 106 is disposed in coronary sinus 30 .
- delivery catheter 106 may be provided with one or more longitudinally-extending surface grooves SG so as to facilitate blood flow past the perimeter of delivery catheter 106 .
- elongated body 184 is preferably sized so as to have a diameter less that the diameter of coronary sinus 30 , so that blood may flow about the perimeter of elongated body 184 when elongated body 184 is disposed in coronary sinus 30 .
- elongated body 184 may be provided with one or more longitudinally-extending surface grooves SG so as to facilitate blood flow past the perimeter of elongated body 184 .
- mitral regurgitation reduction assembly There are at least three possible configurations for the mitral regurgitation reduction assembly, namely, (i) a non-drop-off body, (ii) a drop-off body with a detachable short length of a delivery catheter and, (iii) a drop-off body without the short delivery catheter segment.
- the drop-off body 184 without a short section of delivery catheter is easily appreciated.
- it may comprise the system shown in FIG. 12 .
- the push rod 109 is provided with a detachable joint 230 ( FIG. 24A ) near the proximal end of the body 184 .
- the delivery catheter 106 is introduced into place in the coronary sinus, as described above, the body is advanced into place, and the delivery catheter 106 and push rod 187 are withdrawn, leaving only the body 184 in place, as shown in FIG. 16A .
- FIGS. 24A-24D The drop-off design that leaves a short section of the delivery catheter 106 in place is shown in FIGS. 24A-24D .
- This design requires an annular locking mechanism between the body and the delivery catheter 106 . Embodiments of annular locking mechanism are described hereinbelow.
- the drop-off embodiment requires a break-away joint 232 in the delivery catheter 106 , as well as the breakaway joint 230 in the push rod 12 A.
- the delivery catheter 106 remains indwelling and extends from the body 157 (or 184 ) all the way to the puncture site 234 .
- the non-drop-off prosthetic bodies (active or passive) are identical to their diagnostic counterparts, with the additional needs for a long term, reliable anchor and proximal termination of the delivery catheter 106 and push rod 109 .
- the delivery catheter 106 (and push rod 109 in the case of body 157 ) are snipped and terminated near the perforation site 234 .
- This site will be the neck, chest or thigh in the case of a jugular, subclavian or femoral vein approach, respectively.
- Crimping and/or adhesive bonding in the annular space between the push rod and the delivery catheter provides reliable fixation of these two components.
- the proximal end of the assembly is capped and terminated in a manner similar to the techniques used to implant subcutaneous pacing leads.
- the fixation of the delivery catheter 106 to the push rod/body assembly assures that there can be no relative motion between these components, and therefore the body 157 , 184 cannot migrate within the delivery catheter 106 .
- An additional feature of prosthetic designs that leave an indwelling delivery catheter is the ability to close the proximal end of the catheter. It is desirable to close off this relatively large lumen to avoid clot formation within the lumen, and the concomitant risk of embolus.
- a cap 236 designed to permit this closure is shown in FIG. 24H . The cap 236 can close the delivery catheter 106 at any point along its length, from the proximal end of a non-drop-off prosthetic device to the proximal end of the drop-off prosthetic device.
- FIGS. 24J-24O A second embodiment of a delivery catheter cap is shown in FIGS. 24J-24O .
- This device is constructed of a short length of malleable metal 238 surrounded by a woven mesh collar 240 fixed to a mesh tab 242 .
- the delivery catheter 106 and push rod are sectioned as before.
- the cap is then slid over the end of the delivery catheter 106 , the collar 240 of the crimp is crushed onto the delivery catheter ( FIG. 24M ), securely locking the delivery catheter and push rod together.
- the woven mesh tab 242 is then folded over the mesh collar 240 and delivery catheter 106 ( FIG. 24N ) and pressed against the mesh collar 240 and catheter 162 .
- elongated bodies 157 and 184 are shown completely formed prior to their deployment in the patient. However, it is also possible to form elongated body 157 and/or elongated body 184 in situ from a plurality of smaller elements.
- push rod 109 for use with guidewire 103 and delivery catheter 106 .
- push rod 109 comprises flexible body 148 and a plurality of substantially rigid elongated elements 157 A, 157 B, 157 C, etc. which collectively form the complete elongated body 157 .
- the distalmost elongated element 157 A is fixed to flexible body 148 while the remaining elongated elements 157 B, 157 C, 157 D, etc. are free to slide on flexible body 148 .
- elongated elements 157 A, 157 B, 157 C, etc. preferably include connectors C for permitting one elongated element to be secured to a neighboring elongated body.
- the connectors C shown in FIG. 25 comprise male and female screw type connectors; however, other types of connectors may also be used.
- elongated body 157 By assembling the elongated body 157 in situ using a plurality of elongated elements 157 A, 157 B, 157 C, etc., it is possible to create an elongated body 157 which is perfectly sized to the needs of the patient.
- the push rod 109 shown in FIGS. 25-27 may be used as follows. First, guidewire 103 is passed down to the coronary sinus 30 ( FIG. 28 ). Then delivery catheter 106 is passed down guidewire 103 and into the coronary sinus ( FIGS. 28 and 29 ). Then the guidewire 103 is withdrawn from the surgical site and replaced by the push rod's flexible body 148 with elongated element 157 A attached ( FIG. 30 ). Next, a plurality of elongated elements 157 B, 157 C, 157 D, etc. are slid down flexible body 148 ( FIG. 31 ) and secured to elongated element 157 A (and any preceding elongated element). As many elongated elements 157 A, 157 B, 157 C, etc. are used as is necessary to effect the desired leaflet coaptation ( FIG. 32 ).
- elongated body 157 is formed by a plurality of elongated elements 157 A, 157 B, 157 C, etc. which collectively form the complete elongated body 157 .
- the distalmost elongated element 157 A is fixed to flexible body 148 while the remaining elongated elements 157 A, 157 B, 157 C, etc. are free to slide on flexible body 148 .
- elongated body 157 may be formed in situ by moving elongated elements 157 A, 157 B, 157 C, etc.
- elongated element 157 A acting as a distal stop, and then keeping elongated elements 157 A, 157 B, 157 C, etc. biased distally with a holding mechanism, e.g., a crimp CR.
- a holding mechanism e.g., a crimp CR.
- elongated elements 157 A, 157 B, 157 C, etc. are shown configured so as to form a substantially straight elongated body 157 .
- elongated elements 157 A, 157 B, 157 C, etc. could have alternative configurations so as to form other body shapes.
- elongated elements 157 A, 157 B, 157 C, etc. are shown forming a curved elongated body 157
- FIG. 32E elongated elements 157 A, 157 B, 157 C, etc. are shown forming a composite curved-and-straight elongated body 157 .
- elongated elements 157 A, 157 B, 157 C, etc. may be established either by (1) forming elongated elements 157 A, 157 B, 157 C, etc. so that they have only one possible way of being assembled together, or (2) by forming elongated elements 157 A, 157 B, 157 C, etc. so that they have multiple ways of being assembled together.
- one possible way to vary the final configuration of elongated body 157 is by individually rotating various ones of elongated elements 157 A, 157 B, 157 C, etc., e.g., such as is shown in FIGS. 32D and 32E .
- FIGS. 33 and 34 there is shown an alternative form of elongated body 184 which comprises a plurality of substantially rigid elongated elements 184 A, 184 B, 184 C, etc. which collectively form the complete elongated body 184 .
- elongated elements 184 A, 184 B, 184 C, etc. preferably include connectors C for permitting one elongated element to be secured to a neighboring elongated element.
- the connectors C shown in FIGS. 25 and 33 comprise male and female screw type connectors; however, other types of connectors may also be used.
- the elongated body 184 shown in FIGS. 33 and 34 may be used as follows. First, guidewire 103 is passed down coronary sinus 30 ( FIG. 35 ). Then push cannula 187 is used to push a plurality of elongated elements 184 A, 184 B, 184 C, etc. down guidewire 103 and into the coronary sinus ( FIGS. 36 and 37 ). As many elongated elements 184 A, 184 B, 184 C, etc. are used as is necessary to effect the desired leaflet coaptation ( FIG. 37 ).
- FIGS. 37A-37C there is shown another form of elongated body 184 . More particularly, with this form of elongated body, the elongated body 184 is formed by a plurality of elongated elements 184 A, 184 B, 184 C, etc. which collectively form the complete elongated body 184 . Preferably, all of the elongated elements 184 A, 184 B, 184 C, etc. are free to slide on guidewire 103 . With this version of the invention, elongated body 184 may be formed in situ by moving elongated elements 184 A, 184 B, 184 C, etc. distally and then drawing them tightly together, e.g., such as by using a cinching system such as that shown in FIG. 37C and comprising a distal member DM and a crimp CR.
- a cinching system such as that shown in FIG. 37C and comprising a distal member DM and a crimp CR
- elongated elements 184 A, 184 B, 184 C, etc. are shown configured so as to form a substantially straight elongated body 184 .
- elongated elements 184 A, 184 B, 184 C, etc. could have alternative configurations so as to form other body shapes.
- FIG. 37D elongated elements 184 A, 184 B, 184 C, etc. are shown forming a curved elongated body 184
- FIG. 37E elongated elements 184 A, 184 B, 184 C, etc.
- elongated body 184 is shown forming a composite curved-and-straight elongated body 184 . It will be appreciated that still other shapes may be formed by elongated elements 184 A, 184 B, 184 C, etc. In this respect it will be appreciated that the shapes of elongated body 184 may be established either by (1) forming elongated elements 184 A, 184 B, 184 C, etc. so that they have only one possible way of being assembled together, or (2) by forming elongated elements 184 A, 184 B, 184 C, etc. so that they have multiple ways of being assembled together.
- one possible way to vary the final configuration of elongated body 184 is by individually rotating various ones of elongated elements 184 A, 184 B, 184 C, etc., e.g., such as is shown in FIGS. 37D and 37E .
- FIGS. 37F-37I there is shown another form of push rod 109 having an elongated body 157 formed by a plurality of elongated elements 157 A, 157 B, 157 C, etc.
- Each of the elongated elements 157 A, 157 B, 157 C, etc. is attached to flexible body 148 and is separated from adjacent elongated elements by a gap G.
- gaps G By orienting gaps G radially away from mitral valve 36 ( FIG. 37H ), push rod 109 will be able to curve as required so as to follow the natural curvature of the coronary sinus, e.g., during insertion of push rod 109 into coronary sinus 30 .
- gaps G will be closed and push rod 109 will be straightened, whereby to apply an anteriorly-directed force to the posterior annulus of mitral valve 36 and reduce mitral regurgitation.
- an internal member IM has a plurality of slots SI and an external member EM has a plurality of slots SE.
- Internal member IM is concentrically received within external member EM.
- internal member IM and external member EM may be curved as required so as to follow the natural curvature of the coronary sinus, e.g. during insertion of the members into the coronary sinus.
- internal member IM and external member EM will be straightened, whereby to apply an anteriorly-directed force to the posterior annulus of the mitral valve and reduce mitral regurgitation.
- FIGS. 37L and 37M there is shown a body assembly comprising two rigid tubes 262 , 264 with an internal rod 266 comprised of three sections.
- the first and third sections 268 , 270 of the internal rod 266 are made from a generally flexible material, while the middle section 272 is made from inflexible material.
- the assembly can flex at the central point ( FIG. 37L ).
- the rigid rod portion 272 is pulled into place to span the gap between the outer tubes, generating a rigid, straight assembly ( FIG. 37M ).
- the rod is pulled by a pull wire 274 until the flexible segment 268 spans the gap, and the body 157 can once again flex in the middle.
- elongated body 157 of push rod 109 ( FIG. 3 ) with an inflatable construction. More particularly, and looking next at FIG. 38 , there is shown a push rod 109 having an inflatable elongated body 157 in the form of a balloon B.
- the push rod's flexible body 148 includes an inflation lumen L which communicates with the interior of balloon B, whereby fluid may be supplied to the interior of the balloon so as to inflate the balloon.
- the balloon B is constructed so that it has a flexible configuration when it is in a deflated condition and an elongated, straight configuration when it is in an inflated condition.
- the push rod 109 of FIG. 38 may be used as follows. First, guidewire 103 is advanced into the coronary sinus 30 ( FIG. 4 ). Then delivery catheter 106 is advanced over guidewire 103 until the distal end of the delivery catheter is in coronary sinus 30 ( FIG. 5 ). Next, guidewire 103 is withdrawn ( FIG. 6 ). Then push rod 109 , with elongated body 157 in a deflated condition, is advanced along the interior of delivery catheter 106 so that balloon B is adjacent to the mitral valve ( FIG. 39 ). Then balloon B is inflated, using inflation lumen L ( FIG. 38 ), so that elongated body 157 assumes its elongated, straightening configuration ( FIG. 40 ). As this occurs, the posterior annulus of the mitral valve is compressed anteriorly, so as to reduce mitral regurgitation.
- inflatable body 157 of push rod 109 may comprise other configurations.
- inflatable body 157 may comprise a distal portion 157 ′ and a proximal portion 157 ′′, with the distal and proximal portions being in a sliding, piston-like relationship.
- fluid may be supplied to the combined interiors of the distal and proximal portions, so as to force the two elements apart relative to one another.
- the push rod 109 of FIGS. 41 and 42 is positioned in its “compressed” state ( FIG. 41 ), passed down the interior of delivery cannula 106 until inflatable elongated body 157 is positioned adjacent to the mitral valve, and then inflated (using inflation lumen L) into its “expanded” state ( FIG. 42 ).
- inflation lumen L inflation lumen L
- the flexible body 148 may comprise an electrical lead for an implantable bi-ventricular pacing device and/or an electrical lead for an implantable cardio defibrillator device, etc.
- the distal end of flexible body 148 would be elongated somewhat and would not reside within the coronary sinus; rather, it would be positioned within the tissue which is to receive the electrical stimulus while elongated body 157 is positioned adjacent to the mitral valve.
- Such a construction would allow the bi-ventricular pacing device and/or the implantable cardio defibrillator device to work in conjunction with elongated body 157 to reduce mitral regurgitation.
- hydraulic energy employed to enlarge inflatable body 157 may be substituted by a mechanical energy transformer such as a lead screw mechanism or an electromechanical solenoid.
- the guidewire 103 over which elongated body 184 is deployed may also be in the form of an electrical lead for an implantable bi-ventricular pacing device and/or an electrical lead for an implantable cardio defibrillator device, etc.
- the distal end of the wire will be positioned within the tissue which is to receive the electrical stimulus while elongated body 184 is positioned adjacent to the mitral valve.
- Such a construction would allow the implantable bi-ventricular pacing device and/or the implantable cardio defibrillator device to work in conjunction with elongated body 157 to reduce mitral regurgitation.
- an elongated shape memory alloy body SMA which is configured to be substantially flexible at a temperature T 1 and substantially rigid and in a straight configuration at another temperature T 2 , where temperature T 2 is normal body temperature.
- body SMA is brought to temperature T 1 , so that it may be inserted more easily into the natural curvature of the coronary sinus, e.g., during insertion of body SMA into the coronary sinus ( FIG. 43 ).
- body SMA when body SMA thereafter transitions to temperature T 2 , body SMA will assume its straight configuration ( FIG.
- body SMA may be other than straight (i.e., “w” shape, etc.) to best displace the posterior annulus anteriorly.
- the elongated body may be flexible along at least a portion of its length. Regional flexibility and regional stiffness may allow for straightening of select locations of the coronary sinus and corresponding locations of the posterior mitral annulus. This can cause regions of the mitral annulus to move anteriorly, thus causing regional improvements in leaflet coaptation.
- the elongated body may be formed by two end segments connected together by a filament: by anchoring the two end segments relative to the anatomy and pulling the filament taught, the naturally curved wall of the coronary sinus can be straightened, whereby to move the posterior mitral annulus anteriorly and thereby reduce mitral regurgitation.
- anchoring structures can be used to ensure that the body 157 (or 184 ) and delivery catheter 106 do not migrate over the life of a long-term implant.
- a proximal termination allows the body 157 to be permanently implanted in the vascular system. The proximal termination also allows convenient removal or replacement of the body 157 . The proximal termination may also provide additional anchoring of the entire system.
- a series of antimigration barbs 168 may be fabricated into the outside diameter of the delivery catheter 106 , as shown in FIG. 45 .
- a large load is placed onto the midsection of the body 157 .
- the anti-withdrawal barbs 168 load only into the wall of the coronary sinus 30 where that wall is supported by the underlying heart muscle between the body 157 and the mitral annulus 33 .
- the barbs 168 do not load into the unsupported outer wall of the coronary sinus. There are no barb features at either end of the body 157 that might cause damage to the coronary sinus.
- the delivery catheter 106 can flex as it negotiates corners. This ability allows the delivery catheter to withdraw through the vascular system without causing trauma to the intima of the vessels.
- the straight, substantially rigid elongated body 157 may be provided with barbs 156 to stabilize the portion thereof within the delivery catheter 106 .
- the barbs 156 are arranged such that the catheter 106 may be withdrawn from the body 157 (or 184 ).
- Barb anchoring can be unidirectional or bi-directional.
- the barbs 168 engage the inner wall of the coronary sinus and the underlying heart muscle when the device is used without an indwelling delivery catheter in a drop-off configuration.
- the barbs 168 will engage the internal wall of the delivery catheter 106 when a delivery catheter is used in a non-drop off configuration.
- An alternative anchoring structure is a stent 170 ( FIGS. 48 and 49 ) comprising a generally open metallic or bioabsorbable structure that can be collapsed for insertion and then expanded in place.
- the expansion mechanism may be active (e.g., an inflatable balloon) or passive (e.g., pre-formed shapes in a nickel titanium structure).
- a stent is generally used to expand the vessel in which it is placed, but in this case it is used in its expanded condition as an anchor for the body 157 and/or the delivery catheter 106 .
- Typical locations for an anchoring stent include the anterior interventricular vein, the great cardiac vein 32 , or the coronary sinus 30 .
- FIG. 48 shows a distally located stent 170 in the anterior interventricular vein 32 or coronary sinus 30 .
- FIG. 49 shows a stent 170 that runs the entire length of the coronary sinus 30 .
- Stents may also be used at the proximal termination site (in the internal jugular vein 18 , subclavian vein or femoral vein) to provide improved fixation and/or anchoring at that location, as shown in FIG. 50 .
- Distal hooks 174 ( FIG. 51 ) can be provided for reliable anchoring in the anterior interventricular vein 32 or great cardiac vein. Release of the hooks 174 may require a surgical procedure or a custom release device.
- FIG. 51 shows a set of perforating hooks 174 on an expanding three-legged structure 176 connected to the body 157 .
- FIG. 52 shows a set of non-perforating hooks 174 a on an expanding three-legged structure 176 a.
- Stents 170 and hooks 174 are well suited to be used in combination to allow anchoring and vessel patency, as shown in FIG. 53 .
- Stents 170 may also be used in combination with expansion devices (e.g., balloons) 139 , and further in combination with hooks 174 or barbs 156 ( FIG. 54 ).
- expansion devices e.g., balloons
- hooks 174 or barbs 156 FIG. 54 .
- a hook is designed to be perforating, expanding foam or other blockers may be used in the anterior interventricular (AIV) to provide hemostasis. Since this expanding foam is occlusive to the vessel in which it is placed, it will not be incorporated in perforating designs for anchors in the proximal portion of the coronary sinus.
- AIV anterior interventricular
- Hooks 174 may be self-deploying, released by removing a protective sleeve, or other such method. Alternatively, hooks 174 may be deployed by an active mechanism, such as a balloon, mechanical wedge, etc.
- Expanding anchors for the bodies 157 , 184 , or delivery catheters 106 include expandable devices 139 which may be attached to either the delivery catheter or the body itself.
- FIGS. 55 and 56 show an expandable foam structure 177 attached to the body 157 that is inflated in the AIV or great cardiac vein. By virtue of its shape, it lodges in that vessel and resists any tendency of the body to migrate out of the coronary sinus.
- FIG. 57 shows a balloon 179 attached to the body 157 that provides anchoring of the distal end of the rigid body 157 and the guiding catheter during placement of the body 157 and/or long term anchoring of the body.
- Rigid (PET, urethane) or complaint (silicone, and the like) balloons can be used with and without textured surfaces, inflatable ridges, or other grip enhancing features. Configurations of more than one balloon (fenestration) may be used to allow blood flow by the inflated balloon or to increase anchor force, as shown in FIGS. 58 and 59 .
- Expanding foam such as polyvinylalcohol (PVA) expands significantly from its compressed shape when hydrated.
- PVA polyvinylalcohol
- the foam is compressed and protected from hydration within a capsule or covering tube. Once the foam has been advanced to the desired position, it is exposed to the hydrating effects of the blood by removing the covering. Once expanded, the foam lodges in the vessel by virtue of the deformation imposed on the vessel in which it expands.
- Wire balls 180 behave in a manner similar to the expanding foams 177 .
- the wire balls 180 may be compressed while introduced through the delivery catheter 106 , and then expand when released out of the end of the catheter.
- the wire balls also anchor by virtue of the deformation imposed on the vessel in which it expands, as shown in FIG. 61 .
- FIGS. 62, 63 and 63 A there is shown a cam 182 that anchors the delivery catheter 106 .
- This cam 182 functions by distending the vessel into which it is placed. Due to the eccentic attachment of the anchor release wires 183 a , 183 b and a push wire 181 , withdrawing motion of the delivery catheter causes the cam 182 to lock in place. The cam is released by pulling on the release wires, which causes the cam to align its long axis along the axis of the vessel, thereby allowing the entire device to be removed.
- FIG. 64 shows a similar cam device 182 a attached to the body 157 .
- the aforementioned release wire 183 a is shown in FIG. 64 .
- biocompatible adhesives are suitable for incorporation in the delivery catheter and serve to lock a catheter in place.
- glue may be dispensed through one or more tip orifices 186 a , 186 b ( FIGS. 65-68 ).
- glue may be dispensed through its own lumen 185 or may be contained in a distal sponge-like tip 186 ( FIG. 68 ) that dispenses the glue when squeezed against the vessel wall, or when inflated from within by a balloon.
- Distal and proximal blood flow blockers of balloons may be used to shut off blood flow in the vicinity of the glue bond. This prevents glue being washed away prior to setting up.
- Enhanced in-growth surface treatments or coatings, applied to the outside wall of the delivery catheter 106 and/or the body 157 encourages ingestion of fibrous tissue and adherents that will help provide long-term anchoring of the assembly.
- a mesh structure 189 ( FIG. 69 ) made from Dacron or similar material. Its anchoring properties increase in strength over the first few days in place, and after that time in-growth provides a secure retention of the components.
- External mesh 189 A may also function as a textured surface, providing short or long term anchoring in a manner similar to external barbs 168 , 156 on the catheter or body.
- Other surface treatments include surface texturing, the use of felted or hairy components, or the incorporation of structures resembling fish scales or shark's skin.
- orifices 186 b along the catheter 106 may be positioned such that when a vacuum is pulled on the catheter, tissue is sucked into the orifices, temporarily anchoring the catheter to the wall of the vessel.
- FIG. 74 An assembly for locking the body 157 within the delivery catheter 106 is shown in FIG. 74 .
- the assembly includes a slit tube 214 with variable inner wall diameters and an outer detent feature 216 .
- a ball 218 with integral pull wire 220 rests within the slit tube 214 .
- the pull wire 220 is activated, pulling the ball 218 into the reduced internal diameter section 244 of the slit tube 214 . This forces the barbed midsection 222 into an interference with the internal diameter of the delivery catheter 106 , and thereby locking the tube 214 , and its attached components, into place within the delivery catheter.
- An alternative assembly for locking the body within the catheter comprises a matched set of tapered cams 224 , 226 that passively resist motion in one direction and yet can be slid in either direction.
- the force is transmitted through the bottom-tapered cam 226 .
- This disengages the cam lock and allows the whole assembly to slide forward.
- the tensile force is applied only to the top tapered cam 224 .
- This action also disengages the cam lock.
- the cam lock aggressively engages the internal diameter of the delivery catheter 106 , assisted by a cam spring 228 . This prevents any withdrawing motion until the upper cam 224 is actively disengaged by once again pulling on the release wire 183 .
- This mechanism may be made bi-directional by assembling two devices back-to-back.
- FIGS. 76 and 77 there is illustrated an annulus cinching apparatus 250 which has been guided into the coronary sinus 30 by guidewire and/or catheter means described above.
- the apparatus 250 comprises a flexible cinching tether 252 , distal anchoring means 256 , and/or proximal anchoring means 254 .
- a preferred embodiment of apparatus 250 employs an inflated balloon anchoring means 258 to anchor the distal end of tether 252 .
- Cinching activation means 260 upon operation, exercises a movement force on proximal anchoring means 254 , causing movement of flexible tether 252 so as to cinch the posterior wall of the mitral annulus which, in turn, pushes the posterior mitral valve leaflet anteriorly. Tension may be maintained in apparatus 250 by locking any relative motion of the tether 252 and cinch activation means 260 , both outside the body.
- the distal anchoring means 256 may be a stent, described hereinabove, that anchors to the circumference of the vein, or penetrates through the wall of the vein and into the myocardium.
- distal anchor 256 may be permanently implanted into the patient, and the other components of the apparatus 250 may remain in the body, but the anterior movement of the posterior annulus may be temporary.
- proximal anchor 254 may be a balloon, or simply a flange part of cinch activation means 260 that is too large to enter the ostium of the coronary sinus 30 .
- elongated body 157 (or 184 ) is generally described as being straight and substantially rigid, with or without relatively flexible portions 175 ( FIG. 10 ) and/or elongated relatively flexible portions 178 ( FIG. 11 ) and/or extended strain relief tapers 200 ( FIG. 11B ).
- relatively flexible portions 175 FIG. 10
- elongated relatively flexible portions 178 FIG. 11
- extended strain relief tapers 200 FIG. 11B
- elongated body 157 (or 184 ) is constructed so that (1) its intermediate portion imparts an anteriorly-directed force on the walls of the coronary sinus (e.g., as shown by the arrows A in FIG. 7 ), and (2) its distal and proximal ends impart a posteriorly-directed force on the walls of the coronary sinus (e.g., as shown by the arrows P in FIG. 7 ).
- a high center load 140 ( FIG. 11T ) is imparted to the intermediate portion of elongated body 157 (or 184 ) by the mitral annulus
- smaller loads 141 ( FIG. 11T ) are directed to the distal and proximal ends of elongated body 157 (or 184 ) by the posterior portions of the coronary sinus.
- the distal and proximal ends of elongated body 157 may have relatively flexible portions 175 ( FIG. 10 ) and/or elongated relatively flexible portions 178 ( FIG. 11 ) and/or extended strain relief tapers 200 ( FIG. 11B ). Furthermore, the flexibility of these portions 175 , 178 and/or 200 can vary along their lengths; thus, as shown in FIGS. 11R and 11S , the extended strain relief tapers 200 can become more flexible as they extend toward their outer ends.
- elongated body 157 or 184
- the intermediate portion of elongated body 157 (or 184 ) be absolutely rigid; in fact, it will function satisfactorily so long as it is substantially resistive to the load 140 ( FIG. 11T ) imposed by the mitral annulus.
- the design is further enhanced by having the distal and proximal ends of elongated body 157 (or 184 ) be somewhat less resistive to the smaller loads 141 ( FIG. 11T ) directed by the posterior walls of the coronary sinus.
- a satisfactory design may be implemented with a device which has a flexibility gradient along its length, with a highest rigidity at or near the center and lower rigidity at or near its two ends.
- FIG. 78 shows an elongated body 157 having a degree of curvature throughout its length.
- the present invention may be used to alter the shape of other cardiac tissues, including but not limited to the left ventricle, for other uses, including the treatment of cardiac dysfunction.
Abstract
A method and device for reducing mitral regurgitation. An elongated body is positioned in a coronary sinus of a patient in a vicinity of a heart mitral valve posterior leaflet. The body is adapted to straighten a natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet to move a posterior annulus anteriorly, which in turn moves the posterior leaflet anteriorly, thereby to improve leaflet coaptation.
Description
- This patent application:
- (1) is a continuation-in-part of pending prior U.S. patent application Ser. No. 10/068,264, filed Feb. 5, 2002 by Daniel C. Taylor et al. for METHOD AND APPARATUS FOR IMPROVING MITRAL VALVE FUNCTION (Attorney's Docket No. VIA-29);
- (2) is a continuation-in-part of pending prior U.S. patent application Ser. No. 10/112,354, filed Mar. 29, 2002 by John Liddicoat et al. for METHOD AND APPARATUS FOR IMPROVING MITRAL VALVE FUNCTION (Attorney's Docket No. VIA-19202122);
- (3) is a continuation-in-part of pending prior U.S. patent application Ser. No. 10/218,649, filed Aug. 14, 2002 by Daniel C. Taylor et al. for METHOD AND APPARATUS FOR IMPROVING MITRAL VALVE FUNCTION (Attorney's Docket No. VIA-23);
- (4) claims benefit of pending prior U.S. patent application Ser. No. 10/280,401 filed Oct. 25, 2002 by William E. Cohn et al. for METHOD AND APPARATUS FOR REDUCING MITRAL REGURGITATION (Attorney's Docket No. VIA-30); and
- (5) claims benefit of pending prior U.S. Provisional Patent Application Ser. No. 60/348,424, filed Jan. 14, 2002 by Daniel C. Taylor et al. for METHOD AND APPARATUS TO IMPROVE MITRAL VALVE FUNCTION (Attorney's Docket No. VIA-31 PROV).
- The aforementioned five (5) patent applications are hereby incorporated herein by reference.
- This invention relates to surgical methods and apparatus in general, and more particularly to surgical methods and apparatus for improving mitral valve function.
- Mitral valve repair is the procedure of choice to correct mitral regurgitation of all etiologies. With the use of current surgical techniques, between 70% and 95% of regurgitant mitral valves can be repaired. The advantages of mitral valve repair over mitral valve replacement are well documented. These include better preservation of cardiac function and reduced risk of anticoagulant-related hemorrhage, thromboembolism and endocarditis.
- In current practice, mitral valve surgery requires an extremely invasive approach that includes a chest wall incision, cardiopulmonary bypass, cardiac and pulmonary arrest, and an incision on the heart itself to gain access to the mitral valve. Such a procedure is associated with high morbidity and mortality. Due to the risks associated with this procedure, many of the sickest patients are denied the potential benefits of surgical correction of mitral regurgitation. In addition, patients with moderate, symptomatic mitral regurgitation are denied early intervention and undergo surgical correction only after the development of cardiac dysfunction.
- Mitral regurgitation is a common occurrence in patients with heart failure and a source of important morbidity and mortality in these patients. Mitral regurgitation in patients with heart failure is caused by changes in the geometric configurations of the left ventricle, papillary muscles and mitral annulus. These geometric alterations result in incomplete coaptation of the mitral leaflets during systole. In this situation, mitral regurgitation is corrected by plicating the mitral valve annulus, either by sutures alone or by sutures in combination with a support ring, so as to reduce the circumference of the distended annulus and restore the original geometry of the mitral valve annulus.
- More particularly, current surgical practice for mitral valve repair generally requires that the mitral valve annulus be reduced in radius by surgically opening the left atrium and then fixing sutures, or more commonly sutures in combination with a support ring, to the internal surface of the annulus; this structure is used to pull the annulus back into a smaller radius, thereby reducing mitral regurgitation by improving leaflet coaptation.
- This method of mitral valve repair, generally termed “annuloplasty”, effectively reduces mitral regurgitation in heart failure patients. This, in turn, reduces symptoms of heart failure, improves quality of life and increases longevity. Unfortunately, however, the invasive nature of mitral valve surgery and the attendant risks render most heart failure patients poor surgical candidates. Thus, a less invasive means to increase leaflet coaptation and thereby reduce mitral regurgitation in heart failure patients would make this therapy available to a much greater percentage of patients.
- Mitral regurgitation also occurs in approximately 20% of patients suffering acute myocardial infarction. In addition, mitral regurgitation is the primary cause of cardiogenic shock in approximately 10% of patients who develop severe hemodynamic instability in the setting of acute myocardial infarction. Patients with mitral regurgitation and cardiogenic shock have about a 50% hospital mortality. Elimination of mitral regurgitation in these patients would be of significant benefit. Unfortunately, however, patients with acute mitral regurgitation complicating acute myocardial infarction are particularly high-risk surgical candidates, and are therefore not good candidates for a traditional annuloplasty procedure. Thus, a minimally invasive means to effect a temporary reduction or elimination of mitral regurgitation in these critically ill patients would afford them the time to recover from the myocardial infarction or other acute life-threatening events and make them better candidates for medical, interventional or surgical therapy.
- As a result, one object of the present invention is to provide improved methods and apparatus for reducing mitral regurgitation.
- Another object of the present invention is to provide methods and apparatus for reducing mitral regurgitation which is minimally invasive.
- Another object of the present invention is to provide methods and apparatus for reducing mitral regurgitation which can be deployed either permanently (e.g., for patients suffering from heart failure) or temporarily (e.g., for patients suffering from mitral regurgitation with acute myocardial infarction).
- With the above and other objects in view, a feature of the present invention is the provision of a novel method for reducing mitral regurgitation. The method comprises the steps of inserting a flexible guiding catheter into a coronary sinus of a patient in a vicinity of a posterior leaflet of a mitral valve, anchoring a distal end of the catheter in the coronary sinus, moving an elongated body through the catheter and into a position within the catheter and in the vicinity of the posterior leaflet, the body being adapted to straighten a natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
- In accordance with a further feature of the invention, there is provided a further method for reducing mitral regurgitation. The method comprises the steps of advancing a guidewire into a coronary sinus of a patient, advancing a catheter around the guidewire and into the coronary sinus, providing a push rod having an elongated substantially rigid body fixed to a distal portion thereof, advancing the push rod through the catheter until the body is in a vicinity of a posterior leaflet of a mitral valve of the patient, detaching a proximal portion of the catheter from a distal portion of the catheter, and detaching a proximal portion of the push rod from a distal portion of the push rod, and removing the proximal portions of the catheter and the push rod from the patient.
- In accordance with a further feature of the present invention, there is provided a further method for reducing mitral regurgitation. The method comprises the steps of advancing a flexible strand into a coronary sinus, anchoring at least a distal end of the strand in the coronary sinus proximate an anterior interventricular vein, interconnecting a proximal end of the strand and a cinch activation structure, and operating the cinch activation structure to pull the strand taut, whereby to cause the strand to approach a straight configuration and a mid-portion of the strand to engage a posterior wall of a mitral valve annulus, which pushes a posterior mitral valve leaflet anteriorly to improve coaptation.
- In accordance with a further feature of the present invention, there is provided a novel assembly for reducing mitral regurgitation, the assembly comprising a flexible guiding catheter for insertion into a coronary sinus of a patient in a vicinity of a posterior leaflet of a mitral valve, structure for anchoring a distal end of the catheter in the coronary sinus, an elongated body for moving through the catheter and into a position within the catheter and in the vicinity of the posterior leaflet, the body being adapted to straighten a natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, to move the posterior leaflet anteriorly and thereby improve leaflet coaptation.
- In accordance with a further feature of the present invention, there is provided another assembly for reducing mitral regurgitation. The assembly comprises a flexible catheter having as a part thereof an elongated substantially rigid portion, the catheter being adapted for insertion into a coronary sinus of a patient and adapted to be moved to a position placing the rigid portion in a vicinity of a posterior leaflet of a mitral valve, the rigid portion being adapted to straighten a natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, to move the posterior leaflet anteriorly and thereby improve leaflet coaptation.
- In accordance with a still further feature of the present invention, there is provided another assembly for reducing mitral regurgitation. The assembly comprises a flexible guide wire for insertion into a coronary sinus of a patient, a flexible guiding catheter for disposition around the guide wire and adapted for insertion into the coronary sinus, an elongated substantially rigid body fixed to a distal end of a push rod and adapted to advance in the catheter to a vicinity of a posterior leaflet of a mitral valve of the patient, a detachable joint by which the push rod may be separated, and a break-away joint by which the catheter may be separated into distal and proximal portions, whereby after the body is in the vicinity of the posterior leaflet, the push rod and the catheter proximal portions may be removed from the site and withdrawn from the patient.
- In accordance with a still further feature of the present invention, there is provided another assembly for reducing mitral regurgitation. The assembly comprises a flexible strand adapted to advance into and through a coronary sinus, an anchor at a distal end of the strand for securing the distal end in a fixed position in the coronary sinus, and a cinch activation structure connected to a proximal portion of the strand and operable by an operator to pull the strand taut, whereby to cause the strand to approach a straight configuration with a mid-portion of the strand adapted to engage a posterior wall of a mitral valve annulus to urge a posterior mitral valve leaflet anteriorly to improve coaptation.
- In accordance with a still further feature of the invention, there is provided an elongated body for introduction into a coronary sinus. The body comprises an elastomeric sleeve substantially closed at both ends thereof, the sleeve defining two internal chambers in axial alignment with each other, the chambers being separated by a wall having a aperture therein. A rod is slidably disposed in the aperture and enters into the two chambers, the rod having a distal flexible portion, a middle rigid portion and a proximal flexible portion. A pull wire extends from the proximal end of the rod and through a proximal end of the sleeve. The rod is positionable such that one of the flexible portions of the rod is disposed in the aperture in the chamber wall, rendering the body flexible. The rod is further positionable by manipulation of the pull wire to cause the rod rigid portion to be disposed in the aperture in the chamber wall, rendering the wall rigid. Thus, the body may be rendered flexible so as to be moved to the coronary sinus and may be rendered rigid so as to effect a change in coronary leaflet coaptation.
- In accordance with a still further feature of the invention, there is provided a method for reducing mitral regurgitation comprising inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus having a distal end, a proximal end and an intermediate portion, the apparatus being configured so that when the apparatus is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends will apply a posteriorly-directed force to the walls of the coronary sinus and the intermediate portion will apply an anteriorly-directed force to the walls of the coronary sinus, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
- In accordance with a still further feature of the invention, there is provided an apparatus for reducing mitral regurgitation comprising a body having a distal end, a proximal end and an intermediate portion, the body being configured so that when the body is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends will apply a posteriorly-directed force to the walls of the coronary sinus, and the intermediate portion will apply an anteriorly-directed force to the walls of the coronary sinus, whereby to move the posterior annulus of the mitral valve anteriorly and thereby improve leaflet coaptation.
- Significantly, the present invention may be practiced in a minimally invasive manner, either permanently or temporarily, so as to reduce mitral regurgitation.
- The above and other features of the invention, including various novel details of construction and combinations of parts and method steps, will now be more particularly described with reference to the accompanying drawings and pointed out in the claims. It will be understood that the particular devices and methods embodying the invention are shown by way of illustration only and not as limitations of the invention. The principles and features of this invention may be employed in various and numerous embodiments without departing from the scope of the invention.
- The above and other objects and features of the present invention will be more fully disclosed or rendered obvious by the following detailed description of the preferred embodiments of the invention, which is to be considered together with the accompanying drawings wherein like numbers refer to like parts and further wherein:
-
FIG. 1 is a schematic view of portions of the human vascular system; -
FIG. 2 is a schematic view of portions of the human heart; -
FIG. 3 is a schematic view of a preferred system formed in accordance with the present invention; -
FIGS. 4-7 are a series of views illustrating use of the system ofFIG. 3 to reduce mitral regurgitation; -
FIG. 8 shows an alternative form of delivery catheter; -
FIG. 9 shows an alternative form of flexible push rod; -
FIG. 9A shows an alternative form of the present invention; -
FIG. 9B is a diagrammatic side elevational partly sectioned view of a further flexible push rod; -
FIGS. 9C and 9D are similar toFIG. 9B and showing alternative embodiments of flexible push rod; -
FIG. 9E is a generally side elevational view of a flexible support catheter; -
FIG. 9F is a generally side elevational view of an alternative flexible delivery catheter; -
FIGS. 10 and 11 show alternative constructions for the straight, substantially rigid elongated body; -
FIGS. 11A-11N and 11P-11S illustrate other aspects of the present invention; -
FIG. 11T is a diagrammatic illustration of forces engaging upon an operative portion of the inventive assemblies; -
FIGS. 11U and 11V are graphs illustrating comparative strains and stresses; -
FIG. 12 shows another alternative system formed in accordance with the present invention; -
FIG. 13 shows the components ofFIG. 12 assembled for use; -
FIGS. 14-16 illustrate another aspect of the present invention; -
FIGS. 16A-16D illustrate other aspects of the present invention; -
FIGS. 17-20 illustrate still other aspects of the present invention; -
FIGS. 21-24 illustrate other aspects of the present invention; -
FIG. 24A is a diagrammatic illustration of another feature of the invention; -
FIGS. 24B-24H and 24J-24O illustrate alternative features of the invention; -
FIGS. 25-27 illustrate another form of the present invention; -
FIGS. 28-32 illustrate the embodiment ofFIGS. 25-27 in use; -
FIGS. 32A-32E illustrate other aspects of the present invention; -
FIGS. 33 and 34 illustrate another form of the present invention; -
FIGS. 35-37 illustrate the embodiment ofFIGS. 33 and 34 in use; -
FIGS. 37A-37C illustrate another aspect of the present invention; -
FIGS. 37D and 37E illustrate another aspect of the present invention; -
FIGS. 37F-37I illustrate another aspect of the present invention; -
FIGS. 37J and 37K illustrate yet another aspect of the present invention; -
FIGS. 37L and 37M are sectional views of a further embodiment of the substantially rigid elongated body; illustrate yet another aspect of the present invention; -
FIG. 38 illustrates another form of the present invention; -
FIGS. 39 and 40 illustrate the embodiment ofFIG. 38 in use; -
FIGS. 41 and 42 illustrate yet another form of the present invention; -
FIGS. 43 and 44 illustrate still another aspect of the present invention; -
FIGS. 45-75 are diagrammatic views illustrating alternative methods and apparatus for anchoring components in place; -
FIGS. 76 and 77 illustrate another alternative method and apparatus for reducing mitral regurgitation; and -
FIG. 78 illustrates another form of the present invention. - The coronary sinus is the largest vein in the human heart. During a large portion of its course in the atrioventricular groove, the coronary sinus typically extends adjacent to the left atrium of the heart for a distance of approximately 5 to 10 centimeters. Significantly, for a portion of its length, e.g., typically approximately 7-9 cm, the coronary sinus extends substantially adjacent to the posterior perimeter of the mitral annulus. The present invention takes advantage of this anatomic relationship. More particularly, by deploying novel apparatus in the coronary sinus, adjacent to the posterior leaflet of the mitral valve, the natural curvature of the coronary sinus may be modified in the vicinity of the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly so as to improve leaflet coaptation and, as a result, reduce mitral regurgitation.
- In one preferred embodiment of the invention, the novel apparatus comprises a straight, substantially rigid elongated body, the length of the straight, substantially rigid elongated body being sized so that when the straight, substantially rigid body is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the straight, substantially rigid elongated body causes at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to the posterior leaflet of the mitral valve, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
- And in one preferred embodiment of the invention, access to the coronary sinus is gained percutaneously, e.g., the straight, substantially rigid elongated body is introduced into the patient's vascular system via the jugular vein or via the left subclavian vein, passed down the superior vena cava, passed through the right atrium and then passed into the coronary sinus, where it is deployed. Alternatively, the straight, substantially rigid elongated body may be introduced into the coronary sinus through a small incision in the heart, or through some other incision into the patient's vascular system.
- And in one preferred embodiment of the invention, the straight, substantially rigid elongated body is guided into position by (i) passing it through a pre-positioned catheter, and/or (ii) passing it over a pre-positioned guidewire, and/or (iii) passing it guide-free (e.g., on the end of a steerable delivery tool) to the surgical site.
- Once deployed, the novel apparatus may be left in position permanently (e.g., in the case of patients suffering from mitral regurgitation associated with heart failure) or the novel apparatus may be left in position only temporarily (e.g., in the case of patients suffering from mitral regurgitation associated with acute myocardial infarction).
- Visualization of the procedure may be obtained by fluoroscopy, echocardiography, intravascular ultrasound, angioscopy, real-time magnetic resonance imaging, etc. The efficacy of the procedure may be determined through echocardiography, although other imaging modalities may also be suitable.
- Looking now at
FIGS. 1 and 2 , there are shown aspects of thecardiovascular system 3 of a patient. More particularly,cardiovascular system 3 generally comprises theheart 6, the superior vena cava 9 (FIG. 1 ), the rightsubclavian vein 12, the leftsubclavian vein 15, thejugular vein 18, and theinferior vena cava 21.Superior vena cava 9 andinferior vena cava 21 communicate with the heart's right atrium 24 (FIGS. 1 and 2 ). Acoronary ostium 27 leads to acoronary sinus 30. At a far end 31 (FIG. 2 ) ofcoronary sinus 30, the vascular structure leads to a vertically-descending anterior interventricular vein (“AIV”) 32. For purposes of the present invention, it is convenient to consider the term “coronary sinus” to mean the vascular structure extending betweencoronary ostium 27 andAIV 32. - As seen in
FIG. 2 , betweencoronary ostium 27 andAIV 32,coronary sinus 30 generally extends substantially adjacent to a posterior perimeter of anannulus 33 of amitral valve 36.Mitral valve 36 comprises aposterior leaflet 39 and ananterior leaflet 42. In the case of a regurgitant mitral valve,posterior leaflet 39 andanterior leaflet 42 will generally fail to properly coapt at systole, thereby leaving an interveninggap 45 which will permit regurgitation. - Looking next at
FIG. 3 , there is shown asystem 100 which comprises one preferred embodiment of the present invention. More particularly,system 100 generally comprises aguidewire 103, adelivery catheter 106 and apush rod 109. -
Guidewire 103 comprises aflexible body 112 having adistal end 115 and aproximal end 118. Thedistal end 115 ofguidewire 103 preferably includes aspring tip 121 for allowing the distal end ofguidewire 103 to atraumatically traverse vascular structures, i.e., while theguidewire 103 is being passed through the vascular system of a patient. -
Delivery catheter 106 comprises aflexible body 124 having adistal end 127 and aproximal end 130, preferably with anadjustable valve 133 attached. Acentral lumen 136 extends fromdistal end 127 toproximal end 130. In some circumstances, it is desirable to provide a securing mechanism for securing thedistal end 127 of thedelivery catheter 106 within a vascular structure. By way of example, but not limitation, aballoon 139 may be positioned about the exterior offlexible body 124, just proximal todistal end 127, with aninflation lumen 142 extending betweenballoon 139 and aninflation fitting 145. Alternative means for securing thedelivery catheter 106 within a vascular structure are discussed hereinafter. - Push
rod 109 comprises aflexible body 148 having adistal end 151 and aproximal end 154. A straight, substantially rigidelongated body 157, which may have a variety of different lengths, is formed onflexible body 148, proximal todistal end 151. A removable proximal stiffener, or handle, 160 may be placed between straight, substantially rigidelongated body 157 andproximal end 154 to facilitate grippingflexible body 148, e.g., for advancement or retraction purposes. -
System 100 may be used as follows to reduce mitral regurgitation. - First,
distal end 115 ofguidewire 103 is passed down the jugular vein 18 (or the left subclavian vein 15) of a patient, downsuperior vena cava 9, throughright atrium 24 of theheart 6, and into the coronary sinus 30 (FIG. 4 ). It will be appreciated that asflexible guidewire 103 is passed downcoronary sinus 30, the guidewire will tend to assume the natural curved shape of the coronary sinus, due to the flexible nature of the guidewire. The guidewire'satraumatic spring tip 121 helps ensure minimal damage to vascular structures asguidewire 103 is maneuvered into position. - Next,
distal end 127 ofdelivery catheter 106 is placed overproximal end 118 ofguidewire 103 and passed down the guidewire until thedistal end 127 of thedelivery catheter 106 is positioned in coronary sinus 30 (FIG. 5 ). Again, it will be appreciated that as theflexible delivery catheter 106 passes down the coronary sinus, the delivery catheter will tend to assume the natural curved shape of the coronary sinus, due to the flexible nature of the delivery catheter. - Once
delivery catheter 106 has been positioned within the coronary sinus, guidewire 103 is removed (FIG. 6 ). Either before or afterguidewire 103 is removed,balloon 139 may be inflated so as to securedistal end 127 ofdelivery catheter 106 in position withincoronary sinus 30. Alternatively, a selected one of several anchor structures described hereinbelow may be provided and at this point activated so as to secure the catheterdistal end 127 in place. - Next,
push rod 109 is passed down thecentral lumen 136 ofdelivery catheter 106. As the push rod's straight, substantially rigidelongated body 157 is passed downcentral lumen 136 ofdelivery catheter 106, it forces thedelivery catheter 106 to assume a straight configuration at the point where the straight, substantially rigidelongated body 157 currently resides (FIG. 7 ). Aspush rod 109 is pushed downdelivery catheter 106,balloon 139 holds thedistal end 127 of thedelivery catheter 106 in position withincoronary sinus 30. - Push
rod 109 is pushed downdelivery catheter 106, utilizingproximal handle 160 as needed, until the straight, substantially rigidelongated body 157 is located adjacent to theposterior annulus 33 of mitral valve 36 (FIG. 7 ). As this occurs, the presence of the straight, substantially rigidelongated body 157 indelivery catheter 106 causes at least a portion ofcoronary sinus 30 to assume a substantially straight configuration at this point, so that theposterior annulus 33 ofmitral valve 36 is forced anteriorly. This causes the mitral valve'sposterior leaflet 39 to move anteriorly so as to improve mitral valve leaflet coaptation and thereby reduce (or completely eliminate) mitral valve regurgitation. In this respect, it should be appreciated that theposterior annulus 33 may be shifted anteriorly so as to achieve, or to attempt to achieve to the extent anatomically possible, leaflet-to-leaflet engagement or leaflet-to-annulus engagement (e.g., where a leaflet may be tethered due to left ventricular distortion). Both of these types of engagement, or targeted engagement, are intended to be encompassed by the terms “improved leaflet coaptation” and/or “increased leaflet coaptation” and the like. Using standard visualization means (e.g. echocardiography or fluoroscopy), the exact position of the straight, substantially rigidelongated body 157 is adjusted so as to reduce (or completely eliminate) regurgitation inmitral valve 36. - In this respect, it should be appreciated that the straight, substantially rigid
elongated body 157 is preferably sized to be somewhat less than the length of the coronary sinus betweencoronary ostium 27 andAIV 32. However, in some circumstances it may be desirable to size the straight, substantially rigidelongated body 157 so that it will extend out of thecoronary sinus 30 and into theright atrium 24. - Furthermore, it should also be appreciated that the system provides a degree of tactile feedback to the user during deployment. More particularly, substantial resistance will typically be encountered as the straight, substantially rigid
elongated body 157 is pushed out ofright atrium 24 and intocoronary sinus 30; then resistance will typically drop asbody 157 is moved through the coronary sinus; and then resistance will typically increase significantly again as thedistal end 151 ofpush rod 109, and/or the leading distal tip ofbody 157, comes to thefar end 31 of the coronary sinus. Thus, there is something of a tactile “sweet spot” when the straight, substantially rigidelongated body 157 is located in the coronary sinus betweencoronary ostium 27 andAIV 32, and this tactile “sweet spot” can be helpful to the user in positioning the straight, substantially rigidelongated body 157 incoronary sinus 30. - At this point in the procedure, the straight, substantially rigid
elongated body 157 is locked in position, e.g., by closing adjustable valve 133 (FIG. 3 ), andballoon 139 may be deflated. -
System 100,less guidewire 103, is left in this position until it is no longer needed. In some cases, this may mean thatsystem 100 is left in position for a period of a few hours, days or weeks; inother cases system 100 may be substantially permanent. If and whensystem 100 is to be removed,push rod 109 is removed fromdelivery catheter 106, and thendelivery catheter 106 is removed from the patient. - Thus, it will be seen that with the present invention, the straight, substantially rigid
elongated body 157 is essentially force-fit into the normally curved portion of the coronary sinus adjacent to the mitral valve'sposterior leaflet 39. By properly sizing the length of the straight, substantially rigidelongated body 157 relative to the natural curvature of the patient's anatomy, and by properly positioning the straight, substantially rigidelongated body 157 in the patient's coronary sinus, the straight, substantially rigid elongated body will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to theposterior leaflet 39 of themitral valve 36. This action will, in turn, drive the posterior annulus of the mitral valve anteriorly, so as to improve leaflet coaptation and thereby reduce mitral regurgitation. Thus, by inserting the straight, substantially rigidelongated body 157 into thecoronary sinus 30 adjacent to theposterior leaflet 39 of themitral valve 36, theannulus 33 of the mitral valve is effectively manipulated so that it will assume an increased radius of curvature. - As noted above, by properly sizing the length of the straight, substantially rigid
elongated body 157 relative to the natural curvature of the patient's anatomy, and by properly positioning the straight, substantially rigidelongated body 157 in the patient's coronary sinus, the straight, substantially rigid elongated body will cause at least a portion of the coronary sinus to assume a substantially straight configuration adjacent to theposterior leaflet 39 of themitral valve 36, whereby to drive the posterior annulus of the mitral valve anteriorly, so as to improve leaflet coaptation and thereby reduce mitral regurgitation. To this end, pushrod 109 is preferably provided as part of a kit having a plurality ofdifferent push rods 109, each with a differently-sizedelongated body 157, whereby a physician may select and deploy the appropriately-sizedelongated body 157 for a specific patient's anatomy. Furthermore, if upon deployment it should be discovered (e.g., under echocardiography or fluoroscopy) that a different size ofelongated body 157 is needed, thefirst push rod 109 may be replaced by a second push rod having the desired size ofelongated body 157. - It has also been found that by inserting the straight, substantially rigid
elongated body 157 into the coronary sinus adjacent to the posterior leaflet of the mitral valve, the left ventricle may be remodeled so as to help alleviate congestive heart failure. - It is significant to note that with the present invention, the distal and proximal ends of straight, substantially rigid
elongated body 157 apply a posteriorly-directed force on the walls of coronary sinus 30 (e.g., as shown with arrows P inFIG. 7 ) while the intermediate portion of straight, substantially rigidelongated body 157 applies an anteriorly-directed force on the walls of coronary sinus 30 (e.g., as shown with arrows A inFIG. 7 ). - In some cases, the
proximal end 130 ofdelivery catheter 106 may be fixed to the patient's outer skin, using standard patient care methods such as adhesive tape, pursestring sutures, skin staples, etc. In other cases,proximal end 130 ofdelivery catheter 106 may include a sewing cuff whereby the delivery catheter may be secured to the patient's tissue by suturing. See, for example,FIG. 8 , where asewing cuff 166 is shown attached to theproximal end 130 ofdelivery catheter 106. If desired, anelement 169 may be provided proximal toadjustable valve 133, wherebyflexible push rod 109 may be made fast todelivery catheter 106. By way of example,element 169 may comprise a crimpable element to secureflexible push rod 109 todelivery catheter 106, which is in turn secured to the patient, e.g., withsewing cuff 166. - If desired, the proximal end of the assembly may be embedded under the skin of the patient, e.g., in the case of a permanent implant.
- As noted above, it can be helpful to anchor the distal end of
delivery catheter 106 in position within the coronary sinus prior to pushingpush rod 109 into the delivery catheter. Such an arrangement will keep the delivery catheter in place as the push rod makes the turn within the right atrium and enters the coronary sinus. In the absence of such anchoring, the push rod may drive the delivery catheter down the inferior vena cava 21 (FIG. 1 ). By securing the distal end ofdelivery catheter 106 to the walls ofcoronary sinus 30, the delivery catheter can be stabilized against diversion down theinferior vena cava 21 when the straight, substantially rigidelongate body 157 encounters initial resistance to making the turn into the coronary sinus. - The
balloon 139 is one way of accomplishing such anchoring. However, it is also possible to utilize other types of securing mechanisms to anchor thedistal end 127 ofdelivery catheter 106 in position withincoronary sinus 30, e.g., spring clips, ribs, etc. If desired, thedistal end 151 ofpush rod 109 may itself be provided with a distal anchor, e.g., such as thedistal anchor 172 shown inFIG. 9 . Such a distal anchor onpush rod 109 can help hold the straight, substantially rigidelongated body 157 in proper position withincoronary sinus 30. - It is also possible to prevent diversion of
delivery catheter 106 downinferior vena cava 21 without anchoring the distal end ofdelivery catheter 106 to the walls of the coronary sinus. More particularly, and looking now atFIG. 9A , there is shown asupport catheter 173 which is formed out of a more rigid material thandelivery catheter 106.Support catheter 173 is constructed so that itsdistal end 174 can be positioned incoronary ostium 27 and then itssidewall 174A can supportdelivery catheter 106 adjacent toinferior vena cava 21 whenpush rod 109 is passed downdelivery catheter 106, whereby to preventdelivery catheter 106 from diverting downinferior vena cava 21.FIG. 9A also shows anintroducer catheter 174B at the entrance tojugular vein 18. - Looking next at
FIG. 9B , there is shown apush rod 112A which comprises an alternative form of push rod. Pushrod 112A comprises aflexible body 148A having adistal end 151A and aproximal end 154A. Preferably,flexible body 148A is formed out of a superelastic shape memory alloy, such as Nitinol. A straight, substantiallyrigid member 157A is formed onflexible body 148A, proximal todistal end 151A. Substantiallyrigid member 157A can have a variety of different lengths so as to accommodate different patient anatomies. Atube 158A is positioned concentrically overflexible body 148A and extends for at least part of the distance between substantiallyrigid member 157A and alocking collar 159A secured toproximal end 154A offlexible body 148A.Tube 158A serves as a stiffener or reinforcer forflexible body 148A, wherebyflexible body 148A can have the flexibility required (particularly at itsdistal end 151A) to traverse tortuous vascular passages, yet have the column strength, particularly at itsproximal end 154A, to advanceflexible body 148A by pushing. In addition,tube 158A can be sized so as to have a diameter just slightly smaller than the internal diameter ofdelivery catheter 106, whereby to further supportflexible body 148A. In one preferred form of the invention,tube 158A preferably comprises a PEEK tube. - Looking next at
FIG. 9C ,flexible body 148A can also be necked down, e.g., as shown at 220A, so as to further increase the flexibility offlexible body 148A distal totube 158A. -
Flexible push rod 112A preferably is a device with a series of changes in stiffness and flexibility that allow the device to be bending flexible and have column strength sufficient to pass through a tortuous path, such as the vascular system of a patient, yet have specific areas of stiffness to reduce mitral valve regurgitation by pushing the posterior annulus anteriorly and thus closing the gap between the anterior and posterior leaflets of the mitral valve. One preferred embodiment of this device is a single rod of superelastic material, such as Nitinol, that has a plurality of changes in diameter that allow for appropriate bending flexibility. At the same time, the largest diameter section has a bending stiffness sufficient to push the posterior annulus anteriorly. The longest portions of the rod may have serrations that provide bending flexibility along with column strength. - Alternatively, and looking next at
FIG. 9D , it is also possible to provide additional flexibility toflexible body 148A by severing the flexible body along its length and then connecting the two severed portions with a flexible tube or wire, e.g., such as is shown at 225. - In addition to the foregoing, in an alternative embodiment as shown in
FIG. 9E , it is also possible to use asupport catheter 162, preferably with apre-formed tip 164, which could be advanced overguidewire 103, wherebypre-formed tip 164 ofsupport catheter 162 would engage the opening of thecoronary sinus 30. The distalmost portion of thepre-formed tip 164 is sufficiently flexible to execute extreme bends, and may be of reduced diameter, so as to facilitate deployment into the coronary sinus. At the same time, the region proximal to the distalmost portion is preferably substantially more rigid, e.g., with a rigidity similar to thesidewall 174A ofsupport catheter 173, so as to prevent diversion downinferior vena cava 21. Upon successful engagement and advancement of the support catheter tip 164 a short distance into the coronary sinus, guidewire 103 is removed. Thendelivery catheter 106 is advanced toward and into the coronary sinus through thecentral lumen 165 ofsupport catheter 162. Then, pushrod 109 would be advanced withincentral lumen 136 of thedelivery catheter 106 into the coronary sinus and into position as described herein. - It is also envisioned that the structure of the
delivery catheter 106 may be modified so as to add a region 163 (FIG. 9F ) of increased stiffness proximal to thedistal tip 127 ofdelivery catheter 106. In this way the distal tip ofdelivery catheter 106 will be sufficiently flexible for placement into the coronary sinus, yet the body of delivery catheter will be rigid enough to prevent diversion down the inferior vena cava during the delivery ofpush rod 109. Wheredelivery catheter 106 includes an intermediate region of increased stiffness, it should not be necessary to utilize asupport catheter 173 or asupport catheter 162 to prevent diversion down the inferior vena cava. - As noted above, as push rod 109 (or 112A) is advanced to the region adjacent to the posterior annulus of the mitral valve, the straight, substantially rigid elongated body 157 (or 157A) distorts the natural configuration of the coronary sinus so that it assumes a substantially straight configuration. While this action induces the desired valve remodeling, it can also induce a significant stress on the walls of the coronary sinus, particularly at the distal and proximal ends of the straight, substantially rigid elongated body 157 (or 157A), where stress will be concentrated. To this end, the construction of the straight, substantially rigid elongated body 157 (or 157A) may be modified somewhat so as to better distribute this stress.
- More particularly, and looking next at
FIG. 10 , the distal and proximal ends of straight, substantially rigidelongated body 157 may include relativelyflexible portions 175 to help better distribute the stress exerted on the walls of the coronary sinus. Additionally, and/or alternatively, any taper applied to the distal and proximal ends of straight, substantially rigidelongated body 157 may be elongated, e.g., such as shown at 178 inFIG. 11 , so as to better distribute the stress imposed on the walls of the coronary sinus. - In the preceding discussion of
system 100,push rod 109 is described as being inserted to the surgical site through thedelivery catheter 106 and remaining withindelivery catheter 106 while at the surgical site and, whenpush rod 109 is to be removed, removingpush rod 109 and thendelivery catheter 106. However, if desired, oncepush rod 109 has been deployed at the surgical site,delivery catheter 106 may then be removed, leaving just pushrod 109 at the surgical site. See, for example,FIG. 11A . - It is also possible to advance
push rod 109 directly to the surgical site without passing it through a delivery catheter; in this case pushrod 109 would be advanced on its own through the intervening vascular structure until it is deployed incoronary sinus 30. - Referring to
FIG. 11B , it will be seen that thebody 157 may be provided with extended strain relief tapers 200 and a non-traumaticdistal tip 202 in a body having a cross-section of a circular configuration (FIG. 11C ), which provides the advantage of rotational symmetry. - In
FIGS. 11D and 11E , there is shown asimilar body 157 with extended strain relief tapers 200 andnon-traumatic tip 202, but of a generally “square” configuration with rounded corners, in cross-section, which provides four stable orientations. - In
FIGS. 11F and 11G , there is shown asimilar body 157 which is generally rectangular in cross-section. The rectangular configuration offers increased flexibility in two stable orientations. - As illustrated in
FIGS. 11H, 11I , 11J and 11K, thebody 157, whether circular (FIGS. 11H and 11I ) or generally rectangular (FIGS. 11J and 11K ), may be hollow and of a metal construction. Tubular hollow cross-sections can provide additional flexure. - In
FIGS. 11L-11N and lip, there are shown embodiments in which an elastomericouter body 204 is molded over a metal tube 206 (FIGS. 11L and 11P ) or over a metal rod 208 (FIG. 11N ). Thetubes 206 may be empty (FIG. 11P ) or filled with an appropriate metal or other material 207 (FIG. 11L ). - All of the embodiments of
FIGS. 11L-11N and 11P may be molded with barbs 210 (shown inFIG. 11P ) which are engageable with the interior of thedelivery catheter 106 and/or the walls of thecoronary sinus 30 so as to help stabilize the longitudinal position ofbody 157. - In
FIGS. 11R and 11S , there are illustrated steppedstrain relief segments 212, and inFIG. 11Q there is shown an embodiment in which there are provided a series of metal and/or plasticstrain relief segments 213. - During introduction, the
body 157 must negotiate two difficult turns and several less tortuous ones. The two difficult ones are (1) asmall radius 80 to 120 degree turn as the device begins to enter the coronary ostium, and (2) the 160 to 200 degree turn around the coronary sinus. Two problems must be overcome in order to successfully place thebody 157 in the coronary sinus. First, there is a tendency for thedelivery catheter 106 to withdraw from the coronary sinus as thebody 157 is advancing into the coronary sinus. Second, once thebody 157 has entered the coronary sinus, the forces required to advance it into its correct position can cause thedelivery catheter 106 to prolapse down the inferior vena cava (in the case of a jugular or subclavian approach) or up into the right atrium or superior vena cava (in the case of a femoral vein approach). Once the delivery catheter has prolapsed, further advancement of thebody 157 is generally very difficult. Several features of thebody 157 and introducer systems disclosed above and hereinbelow may be incorporated to solve these introduction problems. - The difficulties associated with introduction of the
body 157 illustrate the benefit of an articulating (i.e. active) body over a non-articulating (passive) body. An articulating body requires significantly smaller forces during introduction, mitigating the anchoring features required to eliminate catheter withdrawal and prolapse. The liability of the articulating (i.e., active body), however, is that it requires a more complex mechanism. - The
body 157 must be able to resist bending moments in order to appropriately deform the mitral annulus. Note that, for the body described above, this requirement directly conflicts with the ability to negotiate the sharp turn into the coronary ostium. For a non-articulating (i.e., passive) body, a balance must generally be struck between flexibility (for introduction) and stiffness (for in-situ functionality). - The force loading and strain reliefs for the
body 157 are shown inFIG. 11T . A high, distributedcenter load 140 is imparted by the mitral annulus and smaller (approximately half) loads 141 on eitherstrain relief 200 are imparted by the coronary sinus. - The stress-strain curves for stainless steel and nickel titanium are shown in
FIG. 11U . Stress is defined as force per unit area, and strain is defined as elongation per unit length. For simplicity, a pure tensile case will be described first. The slightly more complicated condition of bending will be described next. - In pure tension, the stress is uniformly distributed across the area of the body. As a result, the force-deflection and stress-strain curves are similar to each other, as seen in
FIG. 11V . - In bending, the stress distribution in not uniform throughout the body, but is distributed. The outer fibers of the
body 157 are at higher strain levels than those close to the neutral axis. This outer fiber strain limits the amount of bend that the body can tolerate. Sharper bends mean higher strains. - After a
body 157 has been loaded beyond its proportional limit, it will retain some residual strain when it is unloaded. This residual strain will manifest itself as a permanent elongation in the case of a tensile strain, or as a residual bend in the case of a bending strain. A residual bend in the body will have a very specific detrimental effect on the performance of the body. Due to the lubricity of the vessels, a round body with a residual bend will self-align to the minimum energy condition where the bend of the body coincides with the bend of the coronary sinus. As a result, the amount of bend in the body directly subtracts from the deflection of the mitral annulus. Larger residual strains will result in larger residual bends, and larger “lost” deflection. - In can be seen in
FIG. 11V that stainless steel can be stretched to approximately 1% and return with a residual strain of 0.5%, while nickel titanium can be stretched to approximately 6% and return with the same residual strain. This means that nickel titanium can bend around much sharper bends, and return with an equivalent residual strain. - In the inventive method, the
body 157 preferably is placed with a percutaneous procedure. When introducing the body, it must negotiate some relatively sharp turns on its way to the coronary sinus. A body fabricated from non-superelastic material (such as stainless steel) will retain the residual curvature imparted upon the body by the flexure required to negotiate the sharp curves. This residual curvature will detrimentally affect the performance of the body, subtracting from the resultant deflection of the mitral annulus. The use of a body fabricated from a superelastic material will negotiate these sharp curves without acquiring this detrimental residual curvature. - As shown in the stress-strain curves presented in
FIG. 11V , the stress in the stainless steel continues to rise between 0 and 1% (although at a slower rate above 0.4%). With the nickel titanium, however, the stress reaches a plateau level at a strain of about 2%. Between 2% and 6% strain, the stress remains almost constant at about 80 ksi. - Since stress correlates to bending forces in the body, it can be seen that the stress plateau has the very desirable effect of putting an upper limit on the forces that are required to bend the device and strain reliefs. The plateau feature of the nickel titanium allows placing an upper limit on the amount of stress put on the tissue that is causing the body or strain reliefs to bend. With careful design, this intrinsic feature of nickel titanium results in two specific benefits:
- (1) During insertion of the
body 157, the body exerts high side loads on the tissues adjacent to the body. These tissues are deflected out of the way of the body, and the body itself bends in response to these side loads. The most severe side load is placed on the tissue immediately superior to the coronary ostium in the right atrium. The plateau in the stress-strain also allows the selection of an upper limit to the forces exerted on the heart tissue as the device negotiates this curve. Once the maximum side load has been reached (corresponding to the plateau stress), it will require little extra side load to cause the body to bend into a much sharper curve. - (2) In a similar fashion to the situation described above, the plateau in the stress-strain curve allows the selection of an upper limit on the forces (i.e., stresses) that will be exerted on the coronary sinus by the strain reliefs.
- Accordingly, it is preferable that the straight, substantially rigid,
elongated body 157 be of nickel titanium, or an alloy thereof. Inbodies 157 featuring a combination of elastomeric material and metal (e.g., such as those shown inFIGS. 11L-11N and 11P), a preferred metal is, similarly, nickel titanium or an alloy thereof. - Looking next at
FIG. 12 , there is shown asystem 181 which comprises another preferred embodiment of the present invention. More particularly,system 181 generally comprises theguidewire 103, a straight, substantially rigidelongated body 184 and apush cannula 187. -
Guidewire 103 is as previously described. - Straight, substantially rigid
elongated body 184, which may have a variety of different lengths, comprises adistal end 188 and aproximal end 190. Acentral lumen 193 extends betweendistal end 188 andproximal end 190.Central lumen 193 accommodatesguidewire 103. - Push
cannula 187 comprises adistal end 194 and aproximal end 196. Acentral lumen 199 extends betweendistal end 194 andproximal end 196.Central lumen 199 accommodatesguidewire 103. - As a result of this construction,
elongated body 184 and pushcannula 187 may be mounted onguidewire 103, and pushcannula 187 may be used to pushelongated body 184 down guidewire 103 (FIG. 13 ). -
System 181 may be used as follows to reduce mitral regurgitation. - First,
distal end 115 ofguidewire 103 is passed down jugular vein 18 (or the left subclavian vein 15) of a patient, downsuperior vena cava 9, throughright atrium 24 of the heart, and into coronary sinus 30 (FIG. 14 ). It will be appreciated that asflexible guidewire 103 is passed downcoronary sinus 30, the guidewire tends to assume the natural curved shape of the coronary sinus, due to the flexible nature of the guidewire. The guidewire'satraumatic spring tip 121 helps minimize damage to vascular structures as the guidewire is advanced into position. - Next,
distal end 188 of straight, substantially rigidelongated body 184 is placed overproximal end 118 ofguidewire 103 and passed a short distance down the guidewire. Then thedistal end 194 ofpush cannula 187 is placed overproximal end 118 ofguidewire 103, and then pushcannula 187 is advanced down the guidewire. Aspush cannula 187 is advanced down the guidewire, itsdistal end 194 pushes the straight, substantially rigidelongated body 184 ahead of it (FIG. 15 ). - As the straight, substantially rigid
elongated body 184 is passed down thecoronary sinus 30, it forces the coronary sinus to assume a straight configuration at the point where the straight, substantially rigidelongated body 184 currently resides. Pushcannula 187 is pushed downguidewire 103 as needed, until the straight, substantially rigidelongated body 184 is located adjacent to the posterior annulus of the mitral valve (FIG. 16 ). As this occurs, the presence of the straight, substantially rigidelongated body 184 in thecoronary sinus 30 causes the coronary sinus to assume a substantially straight configuration at this point, so that the posterior annulus of the mitral valve is forced anteriorly. This causes the posterior mitral valve leaflet to also move anteriorly so as to improve leaflet coaptation and thereby reduce, or eliminate, mitral valve regurgitation. Using standard visualization means (e.g. echocardiography or fluoroscopy), the exact position of the straight, substantially rigidelongated body 184 may be adjusted so as to reduce, or eliminate regurgitation in the mitral valve. - If desired, the
push cannula 187 may be provided with a releasably attachable interface (e.g., a grasper) so that it may releasably secure theproximal end 190 of the straight, substantially rigidelongated body 184. Such a feature will permit the straight, substantially rigidelongated body 184 to be pulled backward within the coronary sinus, either for positioning or removal purposes. - Where
elongated body 184 is to be left within the body for a substantial period of time, it is possible to leave the apparatus in the position shown in FIG. 16, i.e., withelongated body 184 fit overguidewire 103 and at the end ofpush cannula 187. Alternatively, guidewire 103 and/or pushcannula 187 may be removed, leaving justelongated body 184 deployed at the surgical site (FIG. 16A ). To the extent that elongatedbody 184 may be left by itself at the surgical site, it may be desirable to provideelongated body 184 with an eyelet or hook or other graspable feature G (FIG. 16B ) such that a retriever R may thereafter be used to easily grapple and extract theelongated body 184 from the surgical site. - If desired, the straight, substantially rigid
elongated body 184 may include relativelyflexible portions 175 and/or elongated relativelyflexible portions 178 at its distal and proximal ends so as to better distribute the loads on the coronary sinus. - In a further alternative embodiment, straight
inflexible body 184 is an integral part of flexible delivery catheter 106 (FIG. 16C ). Thecatheter 106 remains in place after the positioning of thebody 184, as shown inFIG. 16D ). - When the
combination delivery catheter 106 andbody 184 is deployed withincoronary sinus 30, theflexible delivery catheter 106 serves as a strain relief means. This strain relief means minimizes trauma to the walls of the coronary sinus by spreading the loads at the proximal and distal ends of thebody 184 over a greater length of the coronary sinus walls. -
Elongated body 157 and/orelongated body 184 may have any of a variety of non-straight shapes along its length. For example, the elongated body may be wavy, spiraled, or curved along all or a portion of its length. By way of example,elongated body 157 and/or 184 may have a curved configuration so as to invert the natural curvature of the coronary sinus, i.e., so that it is bowed towards the anterior annulus. Or the elongated body may have a compound shape along its length, e.g., it may have a sort of “w” shape, with the center of the “w” being directed towards the anterior annulus. See, for example,FIG. 17 , which shows apush rod 109 having anelongated body 157 with a “w” type of shape; and seeFIG. 18 , which shows anelongated body 184 with a “w” type of shape. See also FIGS. 19 and 20, which show a “w” shapedelongated body 184 being advanced down guidewire 103 (FIG. 19 ) to a position adjacent to mitral valve 36 (FIG. 20 ), whereby to reduce mitral regurgitation. Any of the aforementioned elongated body shapes, or other alternative shapes, may effect the anterior displacement of the posterior annulus that results in reduction of the mitral valve regurgitation. - It is preferable that use of the present invention not result in occlusion of
coronary sinus 30. Thus, withsystem 100 shown inFIG. 3 ,delivery catheter 106 is preferably sized so as to have a diameter less than the diameter ofcoronary sinus 30, so that blood may flow about the perimeter ofdelivery catheter 106 whendelivery catheter 106 is disposed incoronary sinus 30. Alternatively, and/or additionally, and looking now atFIGS. 21 and 22 ,delivery catheter 106 may be provided with one or more longitudinally-extending surface grooves SG so as to facilitate blood flow past the perimeter ofdelivery catheter 106. Similarly, withsystem 181 shown inFIG. 12 ,elongated body 184 is preferably sized so as to have a diameter less that the diameter ofcoronary sinus 30, so that blood may flow about the perimeter ofelongated body 184 whenelongated body 184 is disposed incoronary sinus 30. Alternatively, and/or additionally, and looking now atFIGS. 23 and 24 ,elongated body 184 may be provided with one or more longitudinally-extending surface grooves SG so as to facilitate blood flow past the perimeter ofelongated body 184. - There are at least three possible configurations for the mitral regurgitation reduction assembly, namely, (i) a non-drop-off body, (ii) a drop-off body with a detachable short length of a delivery catheter and, (iii) a drop-off body without the short delivery catheter segment.
- The drop-
off body 184 without a short section of delivery catheter is easily appreciated. In one form of the invention, it may comprise the system shown inFIG. 12 . In another form of the invention, thepush rod 109 is provided with a detachable joint 230 (FIG. 24A ) near the proximal end of thebody 184. Thedelivery catheter 106 is introduced into place in the coronary sinus, as described above, the body is advanced into place, and thedelivery catheter 106 and pushrod 187 are withdrawn, leaving only thebody 184 in place, as shown inFIG. 16A . - The drop-off design that leaves a short section of the
delivery catheter 106 in place is shown inFIGS. 24A-24D . This design requires an annular locking mechanism between the body and thedelivery catheter 106. Embodiments of annular locking mechanism are described hereinbelow. The drop-off embodiment requires a break-away joint 232 in thedelivery catheter 106, as well as the breakaway joint 230 in the push rod 12A. - In the non-drop-off design (
FIGS. 24E, 24F and 24G) thedelivery catheter 106 remains indwelling and extends from the body 157 (or 184) all the way to thepuncture site 234. The non-drop-off prosthetic bodies (active or passive) are identical to their diagnostic counterparts, with the additional needs for a long term, reliable anchor and proximal termination of thedelivery catheter 106 and pushrod 109. - Once the
body rod 109 in the case of body 157) are snipped and terminated near theperforation site 234. This site will be the neck, chest or thigh in the case of a jugular, subclavian or femoral vein approach, respectively. Crimping and/or adhesive bonding in the annular space between the push rod and the delivery catheter provides reliable fixation of these two components. Once these components have been secured, the proximal end of the assembly is capped and terminated in a manner similar to the techniques used to implant subcutaneous pacing leads. The fixation of thedelivery catheter 106 to the push rod/body assembly assures that there can be no relative motion between these components, and therefore thebody delivery catheter 106. - An additional feature of prosthetic designs that leave an indwelling delivery catheter is the ability to close the proximal end of the catheter. It is desirable to close off this relatively large lumen to avoid clot formation within the lumen, and the concomitant risk of embolus. A
cap 236 designed to permit this closure is shown inFIG. 24H . Thecap 236 can close thedelivery catheter 106 at any point along its length, from the proximal end of a non-drop-off prosthetic device to the proximal end of the drop-off prosthetic device. - A second embodiment of a delivery catheter cap is shown in
FIGS. 24J-24O . This device is constructed of a short length ofmalleable metal 238 surrounded by a wovenmesh collar 240 fixed to amesh tab 242. When terminating the system with this cap, thedelivery catheter 106 and push rod are sectioned as before. The cap is then slid over the end of thedelivery catheter 106, thecollar 240 of the crimp is crushed onto the delivery catheter (FIG. 24M ), securely locking the delivery catheter and push rod together. The wovenmesh tab 242 is then folded over themesh collar 240 and delivery catheter 106 (FIG. 24N ) and pressed against themesh collar 240 andcatheter 162. - In system 100 (
FIG. 3 ) and in system 181 (FIG. 12 ), theelongated bodies elongated body 157 and/orelongated body 184 in situ from a plurality of smaller elements. - Thus, for example, in
FIGS. 25-27 there is shown an alternative form ofpush rod 109 for use withguidewire 103 anddelivery catheter 106. More particularly, pushrod 109 comprisesflexible body 148 and a plurality of substantially rigidelongated elements elongated body 157. Preferably, the distalmost elongatedelement 157A is fixed toflexible body 148 while the remainingelongated elements flexible body 148. In addition,elongated elements FIG. 25 comprise male and female screw type connectors; however, other types of connectors may also be used. - By assembling the
elongated body 157 in situ using a plurality ofelongated elements elongated body 157 which is perfectly sized to the needs of the patient. - The
push rod 109 shown inFIGS. 25-27 may be used as follows. First, guidewire 103 is passed down to the coronary sinus 30 (FIG. 28 ). Thendelivery catheter 106 is passed downguidewire 103 and into the coronary sinus (FIGS. 28 and 29 ). Then theguidewire 103 is withdrawn from the surgical site and replaced by the push rod'sflexible body 148 withelongated element 157A attached (FIG. 30 ). Next, a plurality ofelongated elements FIG. 31 ) and secured toelongated element 157A (and any preceding elongated element). As manyelongated elements FIG. 32 ). - In
FIGS. 32A-32C , there is shown another form ofpush rod 109. More particularly, with this form of the push rod,elongated body 157 is formed by a plurality ofelongated elements elongated body 157. Preferably the distalmostelongated element 157A is fixed toflexible body 148 while the remainingelongated elements flexible body 148. With this version of the invention,elongated body 157 may be formed in situ by movingelongated elements elongated element 157A acting as a distal stop, and then keepingelongated elements - In
FIGS. 25-32 , and inFIGS. 32A-32C ,elongated elements elongated body 157. However, if desired,elongated elements FIG. 32D elongatedelements elongated body 157, and inFIG. 32E elongatedelements elongated body 157. It will be appreciated that still other shapes may be formed byelongated elements elongated body 157 may be established either by (1) formingelongated elements elongated elements elongated body 157 is by individually rotating various ones ofelongated elements FIGS. 32D and 32E . - As noted above, it is also possible to form the
elongated body 184 of system 181 (FIG. 12 ) in situ from a plurality of smaller elements. - Thus, for example, in
FIGS. 33 and 34 there is shown an alternative form ofelongated body 184 which comprises a plurality of substantially rigidelongated elements elongated body 184. In addition,elongated elements FIGS. 25 and 33 comprise male and female screw type connectors; however, other types of connectors may also be used. - By assembling the
elongated body 184 in situ using a plurality ofelongated elements elongated body 184 which is perfectly sized to the needs of the patient. - The
elongated body 184 shown inFIGS. 33 and 34 may be used as follows. First, guidewire 103 is passed down coronary sinus 30 (FIG. 35 ). Then pushcannula 187 is used to push a plurality ofelongated elements guidewire 103 and into the coronary sinus (FIGS. 36 and 37 ). As manyelongated elements FIG. 37 ). - In
FIGS. 37A-37C , there is shown another form ofelongated body 184. More particularly, with this form of elongated body, theelongated body 184 is formed by a plurality ofelongated elements elongated body 184. Preferably, all of theelongated elements guidewire 103. With this version of the invention,elongated body 184 may be formed in situ by movingelongated elements FIG. 37C and comprising a distal member DM and a crimp CR. - Again, in
FIGS. 33-37 , and inFIGS. 37A-37C ,elongated elements elongated body 184. However, if desired,elongated elements FIG. 37D elongatedelements elongated body 184, and inFIG. 37E elongatedelements elongated body 184. It will be appreciated that still other shapes may be formed byelongated elements elongated body 184 may be established either by (1) formingelongated elements elongated elements elongated body 184 is by individually rotating various ones ofelongated elements FIGS. 37D and 37E . - Looking next at
FIGS. 37F-37I , there is shown another form ofpush rod 109 having anelongated body 157 formed by a plurality ofelongated elements elongated elements flexible body 148 and is separated from adjacent elongated elements by a gap G. By orienting gaps G radially away from mitral valve 36 (FIG. 37H ),push rod 109 will be able to curve as required so as to follow the natural curvature of the coronary sinus, e.g., during insertion ofpush rod 109 intocoronary sinus 30. However, by rotatingflexible body 148 about its axis so that gaps G are oriented 180 degrees opposite to that shown inFIG. 37H (i.e., as shown inFIG. 37I ), gaps G will be closed and pushrod 109 will be straightened, whereby to apply an anteriorly-directed force to the posterior annulus ofmitral valve 36 and reduce mitral regurgitation. - Looking next at
FIGS. 37J and 37K , there is shown another form of the invention. In this construction, an internal member IM has a plurality of slots SI and an external member EM has a plurality of slots SE. Internal member IM is concentrically received within external member EM. By orienting internal member IM and external member EM so that slots SI are aligned with slots SE (FIG. 37J ), internal member IM and external member EM may be curved as required so as to follow the natural curvature of the coronary sinus, e.g. during insertion of the members into the coronary sinus. However, by orienting internal member IM and external member EM so that slots SI are oriented away from slots SE (FIG. 37K ), internal member IM and external member EM will be straightened, whereby to apply an anteriorly-directed force to the posterior annulus of the mitral valve and reduce mitral regurgitation. - In
FIGS. 37L and 37M , there is shown a body assembly comprising tworigid tubes internal rod 266 comprised of three sections. The first andthird sections internal rod 266 are made from a generally flexible material, while themiddle section 272 is made from inflexible material. When theflexible sections rigid tubes FIG. 37L ). Once the assembly is in place, therigid rod portion 272 is pulled into place to span the gap between the outer tubes, generating a rigid, straight assembly (FIG. 37M ). When removal of the assembly is desired, the rod is pulled by apull wire 274 until theflexible segment 268 spans the gap, and thebody 157 can once again flex in the middle. - It is also possible to form
elongated body 157 of push rod 109 (FIG. 3 ) with an inflatable construction. More particularly, and looking next atFIG. 38 , there is shown apush rod 109 having an inflatableelongated body 157 in the form of a balloon B. The push rod'sflexible body 148 includes an inflation lumen L which communicates with the interior of balloon B, whereby fluid may be supplied to the interior of the balloon so as to inflate the balloon. The balloon B is constructed so that it has a flexible configuration when it is in a deflated condition and an elongated, straight configuration when it is in an inflated condition. - The
push rod 109 ofFIG. 38 may be used as follows. First, guidewire 103 is advanced into the coronary sinus 30 (FIG. 4 ). Thendelivery catheter 106 is advanced overguidewire 103 until the distal end of the delivery catheter is in coronary sinus 30 (FIG. 5 ). Next, guidewire 103 is withdrawn (FIG. 6 ). Then pushrod 109, withelongated body 157 in a deflated condition, is advanced along the interior ofdelivery catheter 106 so that balloon B is adjacent to the mitral valve (FIG. 39 ). Then balloon B is inflated, using inflation lumen L (FIG. 38 ), so thatelongated body 157 assumes its elongated, straightening configuration (FIG. 40 ). As this occurs, the posterior annulus of the mitral valve is compressed anteriorly, so as to reduce mitral regurgitation. - It is also possible to form an inflatable
elongated body 157 ofpush rod 109 with other configurations. By way of example, it is possible to form aninflatable body 157 with a piston-type configuration, whereby the body may be elongated or shortened as desired. More particularly, and looking now atFIGS. 41 and 42 ,inflatable body 157 may comprise adistal portion 157′ and aproximal portion 157″, with the distal and proximal portions being in a sliding, piston-like relationship. As a result, fluid may be supplied to the combined interiors of the distal and proximal portions, so as to force the two elements apart relative to one another. - In use, the
push rod 109 ofFIGS. 41 and 42 is positioned in its “compressed” state (FIG. 41 ), passed down the interior ofdelivery cannula 106 until inflatableelongated body 157 is positioned adjacent to the mitral valve, and then inflated (using inflation lumen L) into its “expanded” state (FIG. 42 ). As this occurs, the naturally curved coronary sinus is straightened, thereby pushing the posterior annulus of the mitral valve anteriorly, whereby to reduce mitral regurgitation. - In addition to the foregoing, it should also be appreciated that with respect to push
rod 109, theflexible body 148 may comprise an electrical lead for an implantable bi-ventricular pacing device and/or an electrical lead for an implantable cardio defibrillator device, etc. In this case, the distal end offlexible body 148 would be elongated somewhat and would not reside within the coronary sinus; rather, it would be positioned within the tissue which is to receive the electrical stimulus whileelongated body 157 is positioned adjacent to the mitral valve. Such a construction would allow the bi-ventricular pacing device and/or the implantable cardio defibrillator device to work in conjunction withelongated body 157 to reduce mitral regurgitation. - It should also be appreciated that the function of hydraulic energy employed to enlarge
inflatable body 157 may be substituted by a mechanical energy transformer such as a lead screw mechanism or an electromechanical solenoid. - In a corresponding fashion, the
guidewire 103 over which elongatedbody 184 is deployed may also be in the form of an electrical lead for an implantable bi-ventricular pacing device and/or an electrical lead for an implantable cardio defibrillator device, etc. Again, in this case the distal end of the wire will be positioned within the tissue which is to receive the electrical stimulus whileelongated body 184 is positioned adjacent to the mitral valve. Such a construction would allow the implantable bi-ventricular pacing device and/or the implantable cardio defibrillator device to work in conjunction withelongated body 157 to reduce mitral regurgitation. - Looking next at
FIGS. 43 and 44 , there is shown yet another form of the present invention. In this form of the invention, there is provided an elongated shape memory alloy body SMA which is configured to be substantially flexible at a temperature T1 and substantially rigid and in a straight configuration at another temperature T2, where temperature T2 is normal body temperature. In this situation, body SMA is brought to temperature T1, so that it may be inserted more easily into the natural curvature of the coronary sinus, e.g., during insertion of body SMA into the coronary sinus (FIG. 43 ). However, when body SMA thereafter transitions to temperature T2, body SMA will assume its straight configuration (FIG. 44 ), whereby to apply an anteriorly-directed force to the posterior annulus of the mitral valve and reduce mitral regurgitation. It will be appreciated that the configuration of body SMA may be other than straight (i.e., “w” shape, etc.) to best displace the posterior annulus anteriorly. - In other alternative embodiments, the elongated body may be flexible along at least a portion of its length. Regional flexibility and regional stiffness may allow for straightening of select locations of the coronary sinus and corresponding locations of the posterior mitral annulus. This can cause regions of the mitral annulus to move anteriorly, thus causing regional improvements in leaflet coaptation. In addition, the elongated body may be formed by two end segments connected together by a filament: by anchoring the two end segments relative to the anatomy and pulling the filament taught, the naturally curved wall of the coronary sinus can be straightened, whereby to move the posterior mitral annulus anteriorly and thereby reduce mitral regurgitation.
- As noted above, anchoring structures can be used to ensure that the body 157 (or 184) and
delivery catheter 106 do not migrate over the life of a long-term implant. A proximal termination allows thebody 157 to be permanently implanted in the vascular system. The proximal termination also allows convenient removal or replacement of thebody 157. The proximal termination may also provide additional anchoring of the entire system. - It is desirable to provide an anchor to retain the body and/or delivery catheter securely in place without causing trauma or dissection to the coronary sinus. A series of
antimigration barbs 168 may be fabricated into the outside diameter of thedelivery catheter 106, as shown inFIG. 45 . When the body is in place, a large load is placed onto the midsection of thebody 157. As can be seen inFIG. 46 , theanti-withdrawal barbs 168 load only into the wall of thecoronary sinus 30 where that wall is supported by the underlying heart muscle between thebody 157 and themitral annulus 33. Thebarbs 168 do not load into the unsupported outer wall of the coronary sinus. There are no barb features at either end of thebody 157 that might cause damage to the coronary sinus. Without therod 109 in place, thedelivery catheter 106 can flex as it negotiates corners. This ability allows the delivery catheter to withdraw through the vascular system without causing trauma to the intima of the vessels. - The straight, substantially rigid elongated body 157 (or 184) may be provided with
barbs 156 to stabilize the portion thereof within thedelivery catheter 106. Thebarbs 156 are arranged such that thecatheter 106 may be withdrawn from the body 157 (or 184). Barb anchoring can be unidirectional or bi-directional. Thebarbs 168 engage the inner wall of the coronary sinus and the underlying heart muscle when the device is used without an indwelling delivery catheter in a drop-off configuration. Thebarbs 168 will engage the internal wall of thedelivery catheter 106 when a delivery catheter is used in a non-drop off configuration. - An alternative anchoring structure is a stent 170 (
FIGS. 48 and 49 ) comprising a generally open metallic or bioabsorbable structure that can be collapsed for insertion and then expanded in place. The expansion mechanism may be active (e.g., an inflatable balloon) or passive (e.g., pre-formed shapes in a nickel titanium structure). A stent is generally used to expand the vessel in which it is placed, but in this case it is used in its expanded condition as an anchor for thebody 157 and/or thedelivery catheter 106. Typical locations for an anchoring stent include the anterior interventricular vein, the greatcardiac vein 32, or thecoronary sinus 30.FIG. 48 shows a distally locatedstent 170 in the anteriorinterventricular vein 32 orcoronary sinus 30.FIG. 49 shows astent 170 that runs the entire length of thecoronary sinus 30. - Stents may also be used at the proximal termination site (in the internal
jugular vein 18, subclavian vein or femoral vein) to provide improved fixation and/or anchoring at that location, as shown inFIG. 50 . - Distal hooks 174 (
FIG. 51 ) can be provided for reliable anchoring in the anteriorinterventricular vein 32 or great cardiac vein. Release of thehooks 174 may require a surgical procedure or a custom release device. -
FIG. 51 shows a set of perforatinghooks 174 on an expanding three-legged structure 176 connected to thebody 157.FIG. 52 shows a set ofnon-perforating hooks 174 a on an expanding three-legged structure 176 a. -
Stents 170 and hooks 174 are well suited to be used in combination to allow anchoring and vessel patency, as shown inFIG. 53 .Stents 170 may also be used in combination with expansion devices (e.g., balloons) 139, and further in combination withhooks 174 or barbs 156 (FIG. 54 ). If a hook is designed to be perforating, expanding foam or other blockers may be used in the anterior interventricular (AIV) to provide hemostasis. Since this expanding foam is occlusive to the vessel in which it is placed, it will not be incorporated in perforating designs for anchors in the proximal portion of the coronary sinus. -
Hooks 174 may be self-deploying, released by removing a protective sleeve, or other such method. Alternatively, hooks 174 may be deployed by an active mechanism, such as a balloon, mechanical wedge, etc. - Expanding anchors for the
bodies delivery catheters 106, includeexpandable devices 139 which may be attached to either the delivery catheter or the body itself.FIGS. 55 and 56 show anexpandable foam structure 177 attached to thebody 157 that is inflated in the AIV or great cardiac vein. By virtue of its shape, it lodges in that vessel and resists any tendency of the body to migrate out of the coronary sinus.FIG. 57 shows aballoon 179 attached to thebody 157 that provides anchoring of the distal end of therigid body 157 and the guiding catheter during placement of thebody 157 and/or long term anchoring of the body. - Rigid (PET, urethane) or complaint (silicone, and the like) balloons can be used with and without textured surfaces, inflatable ridges, or other grip enhancing features. Configurations of more than one balloon (fenestration) may be used to allow blood flow by the inflated balloon or to increase anchor force, as shown in
FIGS. 58 and 59 . - Expanding foam, such as polyvinylalcohol (PVA), expands significantly from its compressed shape when hydrated. During introduction, the foam is compressed and protected from hydration within a capsule or covering tube. Once the foam has been advanced to the desired position, it is exposed to the hydrating effects of the blood by removing the covering. Once expanded, the foam lodges in the vessel by virtue of the deformation imposed on the vessel in which it expands.
- Wire balls 180 (
FIGS. 60 and 61 ) behave in a manner similar to the expandingfoams 177. Thewire balls 180 may be compressed while introduced through thedelivery catheter 106, and then expand when released out of the end of the catheter. The wire balls also anchor by virtue of the deformation imposed on the vessel in which it expands, as shown inFIG. 61 . - In
FIGS. 62, 63 and 63A, there is shown acam 182 that anchors thedelivery catheter 106. Thiscam 182 functions by distending the vessel into which it is placed. Due to the eccentic attachment of theanchor release wires push wire 181, withdrawing motion of the delivery catheter causes thecam 182 to lock in place. The cam is released by pulling on the release wires, which causes the cam to align its long axis along the axis of the vessel, thereby allowing the entire device to be removed. -
FIG. 64 shows a similar cam device 182 a attached to thebody 157. Theaforementioned release wire 183 a is shown inFIG. 64 . - Several biocompatible adhesives are suitable for incorporation in the delivery catheter and serve to lock a catheter in place. Once the catheter tip is wedged into the desired position within the vessel, glue may be dispensed through one or
more tip orifices FIGS. 65-68 ). Alternatively, glue may be dispensed through itsown lumen 185 or may be contained in a distal sponge-like tip 186 (FIG. 68 ) that dispenses the glue when squeezed against the vessel wall, or when inflated from within by a balloon. - Distal and proximal blood flow blockers of balloons may be used to shut off blood flow in the vicinity of the glue bond. This prevents glue being washed away prior to setting up.
- Enhanced in-growth surface treatments or coatings, applied to the outside wall of the
delivery catheter 106 and/or thebody 157 encourages ingestion of fibrous tissue and adherents that will help provide long-term anchoring of the assembly. One example is a mesh structure 189 (FIG. 69 ) made from Dacron or similar material. Its anchoring properties increase in strength over the first few days in place, and after that time in-growth provides a secure retention of the components. - External mesh 189A (
FIGS. 70 and 71 ) may also function as a textured surface, providing short or long term anchoring in a manner similar toexternal barbs - Referring to
FIGS. 72 and 73 , it will be seen thatorifices 186 b along thecatheter 106 may be positioned such that when a vacuum is pulled on the catheter, tissue is sucked into the orifices, temporarily anchoring the catheter to the wall of the vessel. - An assembly for locking the
body 157 within thedelivery catheter 106 is shown inFIG. 74 . The assembly includes aslit tube 214 with variable inner wall diameters and anouter detent feature 216. Aball 218 withintegral pull wire 220 rests within theslit tube 214. Once thebody 157 is placed appropriately, thepull wire 220 is activated, pulling theball 218 into the reducedinternal diameter section 244 of theslit tube 214. This forces thebarbed midsection 222 into an interference with the internal diameter of thedelivery catheter 106, and thereby locking thetube 214, and its attached components, into place within the delivery catheter. When it is time to release thetube 214, andbody 157, theball 218 is pulled once again into the enlargedinternal diameter section 244 of theslit tube 214, releasing thetube 214 andbody 157 to slide once again within thedelivery catheter 106. - An alternative assembly for locking the body within the catheter comprises a matched set of
tapered cams push rod 109, the force is transmitted through the bottom-taperedcam 226. This disengages the cam lock and allows the whole assembly to slide forward. When withdrawing the body by pulling on thepull wire 183, the tensile force is applied only to the toptapered cam 224. This action also disengages the cam lock. However, if local motions and forces attempt to push the body in the withdrawing direction, the cam lock aggressively engages the internal diameter of thedelivery catheter 106, assisted by acam spring 228. This prevents any withdrawing motion until theupper cam 224 is actively disengaged by once again pulling on therelease wire 183. This mechanism may be made bi-directional by assembling two devices back-to-back. - In
FIGS. 76 and 77 , there is illustrated anannulus cinching apparatus 250 which has been guided into thecoronary sinus 30 by guidewire and/or catheter means described above. Theapparatus 250 comprises aflexible cinching tether 252, distal anchoring means 256, and/or proximal anchoring means 254. InFIG. 77 , a preferred embodiment ofapparatus 250 employs an inflated balloon anchoring means 258 to anchor the distal end oftether 252. Cinching activation means 260, upon operation, exercises a movement force on proximal anchoring means 254, causing movement offlexible tether 252 so as to cinch the posterior wall of the mitral annulus which, in turn, pushes the posterior mitral valve leaflet anteriorly. Tension may be maintained inapparatus 250 by locking any relative motion of thetether 252 and cinch activation means 260, both outside the body. - In another preferred embodiment, the distal anchoring means 256 may be a stent, described hereinabove, that anchors to the circumference of the vein, or penetrates through the wall of the vein and into the myocardium. For this latter embodiment,
distal anchor 256 may be permanently implanted into the patient, and the other components of theapparatus 250 may remain in the body, but the anterior movement of the posterior annulus may be temporary. - In yet another preferred embodiment,
proximal anchor 254 may be a balloon, or simply a flange part of cinch activation means 260 that is too large to enter the ostium of thecoronary sinus 30. - In the preceding discussion, elongated body 157 (or 184) is generally described as being straight and substantially rigid, with or without relatively flexible portions 175 (
FIG. 10 ) and/or elongated relatively flexible portions 178 (FIG. 11 ) and/or extended strain relief tapers 200 (FIG. 11B ). However, it should be appreciated that the terms “substantially rigid”, “relatively flexible” and the like are meant to be interpreted in the context of the anatomical tissue involved and should not be interpreted in an absolute sense. - Fundamentally, elongated body 157 (or 184) is constructed so that (1) its intermediate portion imparts an anteriorly-directed force on the walls of the coronary sinus (e.g., as shown by the arrows A in
FIG. 7 ), and (2) its distal and proximal ends impart a posteriorly-directed force on the walls of the coronary sinus (e.g., as shown by the arrows P inFIG. 7 ). Conversely, a high center load 140 (FIG. 11T ) is imparted to the intermediate portion of elongated body 157 (or 184) by the mitral annulus, and smaller loads 141 (FIG. 11T ) are directed to the distal and proximal ends of elongated body 157 (or 184) by the posterior portions of the coronary sinus. - In order to better distribute the loads on the proximal portions of the coronary sinus, the distal and proximal ends of elongated body 157 (or 184) may have relatively flexible portions 175 (
FIG. 10 ) and/or elongated relatively flexible portions 178 (FIG. 11 ) and/or extended strain relief tapers 200 (FIG. 11B ). Furthermore, the flexibility of theseportions FIGS. 11R and 11S , the extended strain relief tapers 200 can become more flexible as they extend toward their outer ends. - Indeed, there is nothing in the present invention which requires that the intermediate portion of elongated body 157 (or 184) be absolutely rigid; in fact, it will function satisfactorily so long as it is substantially resistive to the load 140 (
FIG. 11T ) imposed by the mitral annulus. The design is further enhanced by having the distal and proximal ends of elongated body 157 (or 184) be somewhat less resistive to the smaller loads 141 (FIG. 11T ) directed by the posterior walls of the coronary sinus. Thus, a satisfactory design may be implemented with a device which has a flexibility gradient along its length, with a highest rigidity at or near the center and lower rigidity at or near its two ends. This may be accomplished by tapering the elongated body; and/or by varying its material properties; and/or by other techniques. Or a satisfactory design may be implemented with a device which has some degree of flexibility along its entire length; and this flexibility may vary with length or may be constant along the entire length of the body. See, for example,FIG. 78 , which shows anelongated body 157 having a degree of curvature throughout its length. - It should be appreciated that the present invention may be used to alter the shape of other cardiac tissues, including but not limited to the left ventricle, for other uses, including the treatment of cardiac dysfunction.
- It is to be understood that the present invention is by no means limited to the particular constructions herein disclosed and/or shown in the drawings, but also comprises any modifications or equivalents within the scope of the claims.
Claims (77)
1. A method for reducing mitral regurgitation, the method comprising the steps of:
inserting a flexible delivery catheter into a coronary sinus of a patient in a vicinity of a posterior leaflet of a mitral valve;
anchoring a distal end of the catheter in the coronary sinus;
moving an elongated body through the catheter and into a position within the catheter and in the vicinity of the posterior leaflet, the body being adapted to straighten a natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, to move the posterior annulus anteriorly and thereby improve leaflet coaption.
2. The method in accordance with claim 1 wherein the anchoring of the distal end of the catheter comprises engaging barbs on the catheter with internal wall portions of the coronary sinus.
3. The method in accordance with claim 1 wherein the anchoring of the distal end of the catheter comprises inflating a balloon attached to the catheter, the balloon engaging internal wall portions of the coronary sinus.
4. The method in accordance with claim 1 wherein the anchoring of the distal end of the catheter comprises expanding a stent adjacent the catheter, the stent engaging internal wall portions of the coronary sinus.
5. The method in accordance with claim 1 wherein the anchoring of the distal end of the catheter comprises engaging hooks attached to the catheter with internal wall portions of the coronary sinus.
6. The method in accordance with claim 5 wherein the hooks are fixed on a stent and are caused to engage the wall portions of the coronary sinus by expansion of the stent.
7. The method in accordance with claim 5 wherein engaging the hooks with the internal wall comprises perforating the wall with the hooks.
8. The method in accordance with claim 1 wherein the anchoring of the distal end of the catheter comprises expanding an expandable foam body attached to the catheter, the foam body engaging internal wall portions of the coronary sinus.
9. The method in accordance with claim 1 wherein the anchoring of the distal end of the catheter comprises expanding a plurality of selected ones of balloons and foam bodies disposed around the catheter and having gaps therebetween to facilitate blood flow therethrough.
10. The method in accordance with claim 1 wherein the anchoring of the distal end of the catheter comprises expanding a compressed wire ball fixed to the catheter, the expanded wire ball engaging internal wall portions of the catheter.
11. The method in accordance with claim 1 wherein the anchoring of the distal end of the catheter comprises moving a cam member mounted in the catheter into a position for engaging internal wall portions of the catheter and expanding a diameter of the catheter to engage the coronary sinus.
12. The method in accordance with claim 1 wherein the anchoring of the distal end of the catheter comprises flowing adhesive through lumens in the catheter and extending lengthwise thereof, and into side ports in communication with the lumens, to bond the catheter distal end to wall portions of the coronary sinus.
13. The method in accordance with claim 1 wherein anchoring the catheter comprises providing a mesh fixed to the exterior wall of the catheter for encouraging in-growth of patient body materials.
14. The method in accordance with claim 1 wherein the anchoring of the distal end of the catheter comprises applying a vacuum to a lumen in the catheter and extending lengthwise thereof, and to side ports in communication with the lumen, to draw wall portions of the coronary sinus to wall portions of the catheter.
15. The method in accordance with claim 1 and comprising the further step of anchoring a proximal end of the catheter by suturing a sewing cuff fixed to the proximal end of the catheter to a patient's outer skin.
16. The method in accordance with claim 1 and comprising the further step of sealing closed a proximal end of the catheter by using a cap which plugs into the catheter proximal end.
17. The method in accordance with claim 1 comprising the further step of sealing closed a proximal end of the catheter by crimping a wire mesh upon the catheter proximal end.
18. The method in accordance with claim 1 and including the further step of releasably locking the elongated body in the delivery catheter.
19. The method in accordance with claim 18 wherein the locking of the elongated body in the delivery catheter comprises moving at least one cam member connected to the elongated body and disposed in the catheter, by manipulation of a wire connected to the cam member and extending to a proximal end of the catheter.
20. A method for reducing mitral regurgitation, the method comprising the steps of:
advancing a flexible strand into a coronary sinus;
anchoring at least a distal end of the strand in the coronary sinus proximate an anterior interventricular vein;
interconnecting a proximal end of the strand and a cinch actuation structure; and
operating the cinch activation structure to pull the strand taut;
whereby to cause the strand to approach a straight configuration and a mid-portion of the strand to engage a posterior wall of the mitral valve annulus, which pushes a posterior mitral valve leaflet anteriorly and thereby improve coaptation.
21. The method in accordance with claim 20 wherein anchoring the distal end of the strand comprises inflating a balloon attached to the distal end of the strand.
22. The method in accordance with claim 20 wherein anchoring of the distal end of the strand is effected by a stent which anchors to walls of the coronary sinus.
23. The method in accordance with claim 20 wherein anchoring of the distal end of the stent comprises fixing at least one of barbs and hooks on the distal end of the stent for engaging walls of the coronary sinus.
24. The method in accordance with claim 20 wherein anchoring of the distal end of the strand comprises fixing at least one of a wireball, a cam, adhesive outlets, and vacuum openings on the distal end of the strand for engaging walls of the coronary sinus.
25. The method in accordance with claim 20 and including the further step of anchoring the strand at a proximal portion thereof.
26. The method in accordance with claim 25 wherein the anchoring of the strand at the proximal portion thereof is effected by use of a selected one of an expandable body and a flange.
27. An assembly for reducing mitral regurgitation, the assembly comprising:
a flexible delivery catheter for insertion into a coronary sinus of a patient in a vicinity of a posterior leaflet of a mitral valve;
structure for anchoring a distal end of said catheter in said coronary sinus;
an elongated body for moving through said catheter and into a position within the catheter and in the vicinity of the posterior leaflet, the body being adapted to straighten a natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
28. The assembly in accordance with claim 27 wherein said anchoring structure comprises barbs on said catheter for engaging with internal wall portions of the coronary sinus.
29. The assembly in accordance with claim 27 wherein said anchoring structure comprises a balloon attached to said catheter, the balloon engaging internal wall portions of the coronary sinus.
30. The assembly in accordance with claim 27 wherein said anchoring structure comprises a stent adjacent said catheter, said stent being adapted upon expansion thereof for engaging internal wall portions of the coronary sinus.
31. The assembly in accordance with claim 27 wherein said anchoring structure comprises hooks attached to said catheter and adapted to engage internal wall portions of the coronary sinus.
32. The assembly in accordance with claim 31 wherein said hooks are fixed on a stent and are adapted to engage the wall portions of the coronary sinus by expansion of the stent.
33. The assembly in accordance with claim 31 wherein said hooks are adapted for engaging with the internal wall and perforating the wall.
34. The assembly in accordance with claim 27 wherein said anchoring structure comprises an expandable foam body attached to said catheter, said foam body being adapted upon expansion for engaging internal wall portions of the coronary sinus.
35. The assembly in accordance with claim 27 wherein said anchoring structure comprises a plurality of selected ones of balloons and foam bodies disposed around the catheter and having gaps therebetween to facilitate blood flow therethrough.
36. The assembly in accordance with claim 27 wherein said anchoring structure comprises a compressed wire ball fixed to said catheter, said wire ball being expandable to engage internal wall portions of the catheter.
37. The assembly in accordance with claim 27 wherein said anchoring structure comprises a cam member mounted in said catheter and moveable into a position for engaging internal wall portions of said catheter and expanding a diameter of said catheter to engage the coronary sinus.
38. The assembly in accordance with claim 27 wherein said anchoring structure comprises lumens in said catheter and extending lengthwise thereof, and side ports in communication with the lumens, the lumens and ports being adapted to flow adhesive therethrough, to bond the catheter distal end to wall portions of the coronary sinus.
39. The assembly in accordance with claim 27 wherein said anchoring structure comprises a mesh fixed to the exterior wall of said catheter for encouraging in-growth of patient body materials.
40. The assembly in accordance with claim 27 wherein said anchoring structure comprises lumens in said catheter and extending lengthwise thereof, and side ports in communication with the lumens, the lumens and the ports being adapted to convey a vacuum therethrough to draw wall portions of the coronary sinus into engagement with catheter wall portions.
41. The assembly in accordance with claim 27 and comprising second anchor structure for anchoring a proximal end of said catheter, said second anchor structure comprising a sewing cuff fixed to the proximal end of said catheter, for suturing to a patient's outer skin.
42. The assembly in accordance with claim 27 and further comprising a cap for sealing closed a proximal end of said catheter, said cap being adapted to plug into the catheter proximal end.
43. The assembly in accordance with claim 27 and further comprising a cap for sealing closed a proximal end of said catheter, the cap comprising a wire mesh crimpable upon the catheter proximal end to seal the proximal end.
44. (canceled)
45. The assembly in accordance with claim 27 , wherein said elongated body is provided at one end thereof with a rounded non-traumatic tip, and strain relief taper, and in width-wise cross-section, a selected one of round and generally rectangular cross-section.
46. The assembly in accordance with claim 27 wherein said elongated body comprises an elastomeric outer portion disposed upon a core member.
47. The assembly in accordance with claim 46 wherein the core member comprises a selected one of a substantially rigid rod and a substantially rigid tube.
48. The assembly in accordance with claim 47 wherein the core member is a tube comprising a selected one of (i) empty and (ii) filled with a substantially rigid material.
49. The assembly in accordance with claim 46 wherein said outer portion is formed with barbs thereon.
50. The assembly in accordance with claim 27 wherein said elongated body is provided with strain relief steps at either end thereof.
51. The assembly in accordance with claim 27 wherein said elongated body is provided with strain relief segments mounted on a central rod.
52. (canceled)
53. The assembly is accordance with claim 27 wherein said body is anchored in said catheter by a selected one of barbs on said body, stents adjacent said body, and hooks attached to said body.
54. The assembly in accordance with claim 27 wherein said body is anchored in said catheter by an expansion member.
55. The assembly in accordance with claim 54 wherein the expansion member comprises a selected one of a balloon and an expandable foam.
56. The assembly in accordance with claim 27 wherein said body is anchored in said catheter by a selected one of an adhesive, a vacuum, an annular lock, a wedge lock, and a cam.
57. The assembly in accordance with claim 27 wherein said elongated body comprises:
an inner tubular member having a plurality of slots extending width-wise of said inner tubular member; and
an outer tubular member rotatably disposed on said inner tubular member, said outer tubular member having a plurality of slots extending width-wise of said outer tubular member;
the slots of said inner and outer tubular members being alignable with each other to permit bending of said elongated body; and
the slots of said inner and outer tubular members being movable to unaligned positions such that said elongated body resists bending.
58. An assembly for reducing mitral regurgitation, the assembly comprising a flexible catheter having as a part thereof an elongated substantially rigid portion, said catheter being adapted for insertion into a coronary sinus of a patient and adapted to be moved to a position placing the rigid portion in a vicinity of a posterior leaflet of a mitral valve, the rigid portion being adapted to straighten a natural curvature of at least a portion of the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, to move the posterior leaflet anteriorly and thereby improve leaflet coaptation.
59. An assembly for reducing mitral regurgitation, the assembly comprising:
a flexible guide wire for insertion into a coronary sinus of a patient;
a flexible delivery catheter for disposition around said guide wire and adapted for insertion into the coronary sinus;
an elongated substantially rigid body fixed to a distal end of a push rod and adapted to advance in said catheter to a vicinity of a posterior leaflet of a mitral valve of the patient;
a detachable joint by which said push rod may be separated into distal and proximal portions; and
a break-away joint by which said catheter may be separated into distal and proximal portions;
whereby after said body is in the vicinity of the posterior leaflet, said push rod and said catheter proximal portions may be removed form the site and withdrawn from the patient.
60. An assembly for reducing mitral regurgitation, the assembly comprising:
a flexible strand adapted to advance into and through a coronary sinus;
an anchor at a distal end of said strand for securing the distal end in a fixed position in the coronary sinus;
a cinch activation structure connected to a proximal portion of said strand and operable by an operator to pull said strand taut;
whereby to cause said strand to approach a straight configuration, with a mid-portion of said strand adapted to engage a posterior wall of a mitral valve annulus, to urge a posterior mitral valve leaflet anteriorly to improve coaptation.
61. The assembly in accordance with claim 60 wherein said anchor comprises a balloon.
62. The assembly in accordance with claim 60 wherein said anchor comprise a stent.
63. The assembly in accordance with claim 60 wherein said anchor comprises a body having at least one of barbs and hooks thereon for engaging walls of the coronary sinus.
64. The assembly in accordance with claim 60 and further comprising an anchor at a proximal portion of said strand for securing the proximal portion in a selected location.
65. The assembly in accordance with claim 64 wherein said proximal portion anchor comprises a balloon.
66. The assembly in accordance with claim 64 wherein said proximal portion anchor comprises a flange portion of said cinch activation structure.
67. A method for reducing mitral regurgitation, the method comprising the steps of:
advancing a guidewire into a coronary sinus of a patient;
advancing a catheter around the guidewire and into the coronary sinus;
providing a push rod having an elongated substantially rigid body fixed to a distal portion thereof;
advancing the push rod through the catheter until the body is in a vicinity of a posterior leaflet of a mitral valve of the patient;
detaching a proximal portion of the catheter from a distal portion of the catheter;
detaching a proximal portion of the push rod from a distal portion of the push rod; and
removing the proximal portions of the catheter and the push rod from the patient.
68. The method in accordance with claim 1 including the further steps of:
before inserting the flexible delivery catheter, inserting a guidewire into the coronary sinus;
inserting the flexible catheter into the coronary sinus over the guidewire; and
moving the elongated body by means of a push rod.
69. The assembly in accordance with claim 27 , the assembly further comprising:
a guidewire for insertion into the coronary sinus;
said delivery catheter being adapted for insertion into the coronary sinus overriding said guidewire; and
a push rod for moving the elongated body within said catheter to the position in the vicinity of the posterior leaflet.
70. An assembly for reducing mitral regurgitation, the assembly comprising:
a guidewire for insertion into a coronary sinus of a patient;
an elongated body adapted to override said guidewire and move into the coronary sinus; and
a push rod adapted to override said guidewire and push said elongated body into the coronary sinus and to a vicinity of a posterior leaflet;
the body being adapted to straighten a natural curvature of at lest a portion of the coronary sinus in the vicinity of the posterior leaflet, to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
71. A method for reducing mitral regurgitation, the method comprising the steps of:
advancing a guidewire into a coronary sinus of a patient;
mounting a substantially rigid elongated body having an axial central lumen therein on a proximal end of the guidewire and passing the body distally from the guidewire proximal end;
mounting a push rod having an axial central lumen therein on the proximal end of the guidewire and moving the push rod along the guidewire to push the body distally in the coronary sinus to a vicinity of a posterior leaflet, to move a posterior annulus anteriorly to improve leaflet coaptation.
72. The method in accordance with claim 71 and comprising the further step of removing the guidewire and the push rod, and leaving the body in the coronary sinus.
73. (canceled)
74. The assembly in accordance with claim 27 wherein said elongated body is of a superelastic material.
75. An elongated body for introduction into a coronary sinus, the body comprising:
an elastomeric sleeve substantially closed at both ends thereof, said sleeve defining two internal chambers in axial alignment with each other, the chambers being separated by a wall having an aperture therein;
a rod slidably disposed in the aperture and entering into the two chambers, said rod having a distal flexible portion, a middle rigid portion, and a proximal flexible portion; and
a pull wire extending from the proximal end of said rod and through a proximal end of said sleeve;
said rod being positionable such that one of the flexible portions of said rod is disposed in the aperture in the chamber wall, rendering the body flexible; and
said rod being positionable by manipulation of said pull wire to cause the rod rigid portion to be disposed in the aperture in the chamber wall, rendering the wall rigid;
whereby the body may be rendered flexible so as to be moved to the coronary sinus and may be rendered rigid so as to effect a change in coronary leaflet coaptation.
76. A method for reducing mitral regurgitation comprising:
inserting apparatus into the coronary sinus of a patient in the vicinity of the posterior leaflet of the mitral valve, the apparatus having a distal end, a proximal end and an intermediate portion, the apparatus being configured so that when the apparatus is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends will apply a posteriorly-directed force to the walls of the coronary sinus and the intermediate portion will apply an anteriorly-directed force to the walls of the coronary sinus, whereby to move the posterior annulus anteriorly and thereby improve leaflet coaptation.
77. Apparatus for reducing mitral regurgitation comprising:
a body having a distal end, a proximal end and an intermediate portion, the body being configured so that when the body is positioned in the coronary sinus in the vicinity of the posterior leaflet of the mitral valve, the distal and proximal ends will apply a posteriorly-directed force to the walls of the coronary sinus, and the intermediate portion will apply an anteriorly-directed force to the walls of the coronary sinus, whereby to move the posterior annulus of the mitral valve anteriorly and thereby improve leaflet coaptation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/818,991 US20080103590A1 (en) | 2002-01-14 | 2007-06-15 | Method and apparatus for reducing mitral regurgitation |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34842402P | 2002-01-14 | 2002-01-14 | |
US10/068,264 US6656221B2 (en) | 2001-02-05 | 2002-02-05 | Method and apparatus for improving mitral valve function |
US10/112,354 US7186264B2 (en) | 2001-03-29 | 2002-03-29 | Method and apparatus for improving mitral valve function |
US10/218,649 US20030078654A1 (en) | 2001-08-14 | 2002-08-14 | Method and apparatus for improving mitral valve function |
US10/280,401 US7052487B2 (en) | 2001-10-26 | 2002-10-25 | Method and apparatus for reducing mitral regurgitation |
US10/342,034 US7241310B2 (en) | 2002-01-14 | 2003-01-14 | Method and apparatus for reducing mitral regurgitation |
US11/818,991 US20080103590A1 (en) | 2002-01-14 | 2007-06-15 | Method and apparatus for reducing mitral regurgitation |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/342,034 Continuation US7241310B2 (en) | 2002-01-14 | 2003-01-14 | Method and apparatus for reducing mitral regurgitation |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080103590A1 true US20080103590A1 (en) | 2008-05-01 |
Family
ID=27535791
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/280,401 Expired - Lifetime US7052487B2 (en) | 2001-10-26 | 2002-10-25 | Method and apparatus for reducing mitral regurgitation |
US10/342,034 Expired - Lifetime US7241310B2 (en) | 2002-01-14 | 2003-01-14 | Method and apparatus for reducing mitral regurgitation |
US11/371,642 Abandoned US20060229717A1 (en) | 2001-10-26 | 2006-03-09 | Method and apparatus for reducing mitral regurgitation |
US11/818,991 Abandoned US20080103590A1 (en) | 2002-01-14 | 2007-06-15 | Method and apparatus for reducing mitral regurgitation |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/280,401 Expired - Lifetime US7052487B2 (en) | 2001-10-26 | 2002-10-25 | Method and apparatus for reducing mitral regurgitation |
US10/342,034 Expired - Lifetime US7241310B2 (en) | 2002-01-14 | 2003-01-14 | Method and apparatus for reducing mitral regurgitation |
US11/371,642 Abandoned US20060229717A1 (en) | 2001-10-26 | 2006-03-09 | Method and apparatus for reducing mitral regurgitation |
Country Status (5)
Country | Link |
---|---|
US (4) | US7052487B2 (en) |
EP (1) | EP1471858A4 (en) |
AU (1) | AU2003209219A1 (en) |
CA (1) | CA2472482A1 (en) |
WO (1) | WO2003059198A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060136053A1 (en) * | 2003-05-27 | 2006-06-22 | Rourke Jonathan M | Method and apparatus for improving mitral valve function |
US20070156235A1 (en) * | 2002-02-05 | 2007-07-05 | Jonathan Rourke | Method and apparatus for improving mitral valve function |
WO2010051029A1 (en) * | 2008-10-29 | 2010-05-06 | Viacor, Inc. | Method and apparatus for improving mitral valve function |
WO2014187855A1 (en) * | 2013-05-21 | 2014-11-27 | Medtentia International Ltd Oy | Medical system for annuloplasty |
Families Citing this family (311)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6050936A (en) | 1997-01-02 | 2000-04-18 | Myocor, Inc. | Heart wall tension reduction apparatus |
US6406420B1 (en) * | 1997-01-02 | 2002-06-18 | Myocor, Inc. | Methods and devices for improving cardiac function in hearts |
US7883539B2 (en) | 1997-01-02 | 2011-02-08 | Edwards Lifesciences Llc | Heart wall tension reduction apparatus and method |
WO1999000059A1 (en) * | 1997-06-27 | 1999-01-07 | The Trustees Of Columbia University In The City Of New York | Method and apparatus for circulatory valve repair |
FR2768324B1 (en) | 1997-09-12 | 1999-12-10 | Jacques Seguin | SURGICAL INSTRUMENT FOR PERCUTANEOUSLY FIXING TWO AREAS OF SOFT TISSUE, NORMALLY MUTUALLY REMOTE, TO ONE ANOTHER |
US6332893B1 (en) * | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
US6260552B1 (en) | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
US10327743B2 (en) | 1999-04-09 | 2019-06-25 | Evalve, Inc. | Device and methods for endoscopic annuloplasty |
US7604646B2 (en) | 1999-04-09 | 2009-10-20 | Evalve, Inc. | Locking mechanisms for fixation devices and methods of engaging tissue |
CA2620783C (en) * | 1999-04-09 | 2011-04-05 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US7811296B2 (en) | 1999-04-09 | 2010-10-12 | Evalve, Inc. | Fixation devices for variation in engagement of tissue |
US20040044350A1 (en) | 1999-04-09 | 2004-03-04 | Evalve, Inc. | Steerable access sheath and methods of use |
US7226467B2 (en) | 1999-04-09 | 2007-06-05 | Evalve, Inc. | Fixation device delivery catheter, systems and methods of use |
US6752813B2 (en) | 1999-04-09 | 2004-06-22 | Evalve, Inc. | Methods and devices for capturing and fixing leaflets in valve repair |
US8216256B2 (en) | 1999-04-09 | 2012-07-10 | Evalve, Inc. | Detachment mechanism for implantable fixation devices |
US6997951B2 (en) | 1999-06-30 | 2006-02-14 | Edwards Lifesciences Ag | Method and device for treatment of mitral insufficiency |
US6440164B1 (en) * | 1999-10-21 | 2002-08-27 | Scimed Life Systems, Inc. | Implantable prosthetic valve |
EP1113497A3 (en) * | 1999-12-29 | 2006-01-25 | Texas Instruments Incorporated | Semiconductor package with conductor impedance selected during assembly |
US7507252B2 (en) * | 2000-01-31 | 2009-03-24 | Edwards Lifesciences Ag | Adjustable transluminal annuloplasty system |
US6989028B2 (en) * | 2000-01-31 | 2006-01-24 | Edwards Lifesciences Ag | Medical system and method for remodeling an extravascular tissue structure |
US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
US6537198B1 (en) * | 2000-03-21 | 2003-03-25 | Myocor, Inc. | Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly |
US6616684B1 (en) * | 2000-10-06 | 2003-09-09 | Myocor, Inc. | Endovascular splinting devices and methods |
US6723038B1 (en) * | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
US6602286B1 (en) | 2000-10-26 | 2003-08-05 | Ernst Peter Strecker | Implantable valve system |
US7510576B2 (en) * | 2001-01-30 | 2009-03-31 | Edwards Lifesciences Ag | Transluminal mitral annuloplasty |
CA2668308A1 (en) * | 2001-03-05 | 2002-12-05 | Viacor, Incorporated | Apparatus and method for reducing mitral regurgitation |
US7186264B2 (en) * | 2001-03-29 | 2007-03-06 | Viacor, Inc. | Method and apparatus for improving mitral valve function |
US8202315B2 (en) | 2001-04-24 | 2012-06-19 | Mitralign, Inc. | Catheter-based annuloplasty using ventricularly positioned catheter |
US7037334B1 (en) | 2001-04-24 | 2006-05-02 | Mitralign, Inc. | Method and apparatus for catheter-based annuloplasty using local plications |
US6676702B2 (en) * | 2001-05-14 | 2004-01-13 | Cardiac Dimensions, Inc. | Mitral valve therapy assembly and method |
US6800090B2 (en) * | 2001-05-14 | 2004-10-05 | Cardiac Dimensions, Inc. | Mitral valve therapy device, system and method |
US7311729B2 (en) * | 2002-01-30 | 2007-12-25 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
US7635387B2 (en) * | 2001-11-01 | 2009-12-22 | Cardiac Dimensions, Inc. | Adjustable height focal tissue deflector |
US6949122B2 (en) * | 2001-11-01 | 2005-09-27 | Cardiac Dimensions, Inc. | Focused compression mitral valve device and method |
US6824562B2 (en) * | 2002-05-08 | 2004-11-30 | Cardiac Dimensions, Inc. | Body lumen device anchor, device and assembly |
US6575971B2 (en) | 2001-11-15 | 2003-06-10 | Quantum Cor, Inc. | Cardiac valve leaflet stapler device and methods thereof |
US6793673B2 (en) | 2002-12-26 | 2004-09-21 | Cardiac Dimensions, Inc. | System and method to effect mitral valve annulus of a heart |
US6908478B2 (en) * | 2001-12-05 | 2005-06-21 | Cardiac Dimensions, Inc. | Anchor and pull mitral valve device and method |
US6976995B2 (en) | 2002-01-30 | 2005-12-20 | Cardiac Dimensions, Inc. | Fixed length anchor and pull mitral valve device and method |
US7179282B2 (en) | 2001-12-05 | 2007-02-20 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
ATE462378T1 (en) * | 2001-12-28 | 2010-04-15 | Edwards Lifesciences Ag | DELAYED MEMORY DEVICE |
US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
US6960229B2 (en) * | 2002-01-30 | 2005-11-01 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
US20050209690A1 (en) * | 2002-01-30 | 2005-09-22 | Mathis Mark L | Body lumen shaping device with cardiac leads |
US7004958B2 (en) * | 2002-03-06 | 2006-02-28 | Cardiac Dimensions, Inc. | Transvenous staples, assembly and method for mitral valve repair |
US6797001B2 (en) * | 2002-03-11 | 2004-09-28 | Cardiac Dimensions, Inc. | Device, assembly and method for mitral valve repair |
US7007698B2 (en) * | 2002-04-03 | 2006-03-07 | Boston Scientific Corporation | Body lumen closure |
US6752828B2 (en) * | 2002-04-03 | 2004-06-22 | Scimed Life Systems, Inc. | Artificial valve |
EP2289467A1 (en) * | 2002-05-08 | 2011-03-02 | Cardiac Dimensions, Inc. | Device for modifying the shape of a body organ |
US20030233022A1 (en) * | 2002-06-12 | 2003-12-18 | Vidlund Robert M. | Devices and methods for heart valve treatment |
US7883538B2 (en) | 2002-06-13 | 2011-02-08 | Guided Delivery Systems Inc. | Methods and devices for termination |
EP1530441B1 (en) | 2002-06-13 | 2017-08-02 | Ancora Heart, Inc. | Devices and methods for heart valve repair |
US8641727B2 (en) | 2002-06-13 | 2014-02-04 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US9949829B2 (en) | 2002-06-13 | 2018-04-24 | Ancora Heart, Inc. | Delivery devices and methods for heart valve repair |
US7666193B2 (en) | 2002-06-13 | 2010-02-23 | Guided Delivery Sytems, Inc. | Delivery devices and methods for heart valve repair |
US9226825B2 (en) | 2002-06-13 | 2016-01-05 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US7753858B2 (en) | 2002-06-13 | 2010-07-13 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US7758637B2 (en) | 2003-02-06 | 2010-07-20 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US20060122633A1 (en) | 2002-06-13 | 2006-06-08 | John To | Methods and devices for termination |
US8287555B2 (en) | 2003-02-06 | 2012-10-16 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US20050216078A1 (en) * | 2002-06-13 | 2005-09-29 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US7753922B2 (en) | 2003-09-04 | 2010-07-13 | Guided Delivery Systems, Inc. | Devices and methods for cardiac annulus stabilization and treatment |
US8758372B2 (en) * | 2002-08-29 | 2014-06-24 | St. Jude Medical, Cardiology Division, Inc. | Implantable devices for controlling the size and shape of an anatomical structure or lumen |
US7297150B2 (en) * | 2002-08-29 | 2007-11-20 | Mitralsolutions, Inc. | Implantable devices for controlling the internal circumference of an anatomic orifice or lumen |
NZ539136A (en) | 2002-10-21 | 2008-04-30 | Mitralign Inc | Method and apparatus for performing catheter-based annuloplasty using local plications |
US20050119735A1 (en) | 2002-10-21 | 2005-06-02 | Spence Paul A. | Tissue fastening systems and methods utilizing magnetic guidance |
EP1553897A1 (en) * | 2002-10-24 | 2005-07-20 | Boston Scientific Limited | Venous valve apparatus and method |
US7247134B2 (en) * | 2002-11-12 | 2007-07-24 | Myocor, Inc. | Devices and methods for heart valve treatment |
US7112219B2 (en) * | 2002-11-12 | 2006-09-26 | Myocor, Inc. | Devices and methods for heart valve treatment |
US7485143B2 (en) * | 2002-11-15 | 2009-02-03 | Abbott Cardiovascular Systems Inc. | Apparatuses and methods for heart valve repair |
US7837729B2 (en) * | 2002-12-05 | 2010-11-23 | Cardiac Dimensions, Inc. | Percutaneous mitral valve annuloplasty delivery system |
US7316708B2 (en) | 2002-12-05 | 2008-01-08 | Cardiac Dimensions, Inc. | Medical device delivery system |
US6945957B2 (en) * | 2002-12-30 | 2005-09-20 | Scimed Life Systems, Inc. | Valve treatment catheter and methods |
US7314485B2 (en) | 2003-02-03 | 2008-01-01 | Cardiac Dimensions, Inc. | Mitral valve device using conditioned shape memory alloy |
US20040158321A1 (en) * | 2003-02-12 | 2004-08-12 | Cardiac Dimensions, Inc. | Method of implanting a mitral valve therapy device |
US8021359B2 (en) | 2003-02-13 | 2011-09-20 | Coaptus Medical Corporation | Transseptal closure of a patent foramen ovale and other cardiac defects |
US20040254600A1 (en) * | 2003-02-26 | 2004-12-16 | David Zarbatany | Methods and devices for endovascular mitral valve correction from the left coronary sinus |
WO2004082538A2 (en) * | 2003-03-18 | 2004-09-30 | St. Jude Medical, Inc. | Body tissue remodeling apparatus |
US7334064B2 (en) * | 2003-04-23 | 2008-02-19 | Dot Hill Systems Corporation | Application server blade for embedded storage appliance |
US20060161169A1 (en) * | 2003-05-02 | 2006-07-20 | Cardiac Dimensions, Inc., A Delaware Corporation | Device and method for modifying the shape of a body organ |
US20040220654A1 (en) * | 2003-05-02 | 2004-11-04 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
US10646229B2 (en) | 2003-05-19 | 2020-05-12 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US7887582B2 (en) | 2003-06-05 | 2011-02-15 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
US7351259B2 (en) * | 2003-06-05 | 2008-04-01 | Cardiac Dimensions, Inc. | Device, system and method to affect the mitral valve annulus of a heart |
EP1646332B1 (en) | 2003-07-18 | 2015-06-17 | Edwards Lifesciences AG | Remotely activated mitral annuloplasty system |
CA2533556A1 (en) * | 2003-07-23 | 2005-02-03 | Viacor, Inc. | Method and apparatus for improving mitral valve function |
US7004176B2 (en) * | 2003-10-17 | 2006-02-28 | Edwards Lifesciences Ag | Heart valve leaflet locator |
US20060184242A1 (en) * | 2003-10-20 | 2006-08-17 | Samuel Lichtenstein | Method and apparatus for percutaneous reduction of anterior-posterior diameter of mitral valve |
US7056286B2 (en) | 2003-11-12 | 2006-06-06 | Adrian Ravenscroft | Medical device anchor and delivery system |
US20050177228A1 (en) * | 2003-12-16 | 2005-08-11 | Solem Jan O. | Device for changing the shape of the mitral annulus |
US7854761B2 (en) | 2003-12-19 | 2010-12-21 | Boston Scientific Scimed, Inc. | Methods for venous valve replacement with a catheter |
US7794496B2 (en) | 2003-12-19 | 2010-09-14 | Cardiac Dimensions, Inc. | Tissue shaping device with integral connector and crimp |
US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US20050137450A1 (en) * | 2003-12-19 | 2005-06-23 | Cardiac Dimensions, Inc., A Washington Corporation | Tapered connector for tissue shaping device |
US9526616B2 (en) | 2003-12-19 | 2016-12-27 | Cardiac Dimensions Pty. Ltd. | Mitral valve annuloplasty device with twisted anchor |
US20050137449A1 (en) * | 2003-12-19 | 2005-06-23 | Cardiac Dimensions, Inc. | Tissue shaping device with self-expanding anchors |
US7837728B2 (en) * | 2003-12-19 | 2010-11-23 | Cardiac Dimensions, Inc. | Reduced length tissue shaping device |
US8864822B2 (en) | 2003-12-23 | 2014-10-21 | Mitralign, Inc. | Devices and methods for introducing elements into tissue |
US7166127B2 (en) * | 2003-12-23 | 2007-01-23 | Mitralign, Inc. | Tissue fastening systems and methods utilizing magnetic guidance |
US7993397B2 (en) * | 2004-04-05 | 2011-08-09 | Edwards Lifesciences Ag | Remotely adjustable coronary sinus implant |
US7641686B2 (en) * | 2004-04-23 | 2010-01-05 | Direct Flow Medical, Inc. | Percutaneous heart valve with stentless support |
US8377118B2 (en) * | 2004-05-05 | 2013-02-19 | Direct Flow Medical, Inc. | Unstented heart valve with formed in place support structure |
US7566343B2 (en) | 2004-09-02 | 2009-07-28 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US8052592B2 (en) | 2005-09-27 | 2011-11-08 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
CA2748617C (en) | 2004-09-27 | 2014-09-23 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
CA2588653A1 (en) * | 2004-11-24 | 2006-06-01 | Viacor, Inc. | Method and apparatus for improving mitral valve function |
US7433739B1 (en) * | 2004-11-30 | 2008-10-07 | Pacesetter, Inc. | Passive fixation mechanism for epicardial sensing and stimulation lead placed through pericardial access |
US7211110B2 (en) * | 2004-12-09 | 2007-05-01 | Edwards Lifesciences Corporation | Diagnostic kit to assist with heart valve annulus adjustment |
CA2595580A1 (en) * | 2005-01-20 | 2006-07-27 | Cardiac Dimensions, Inc. | Tissue shaping device |
US7854755B2 (en) | 2005-02-01 | 2010-12-21 | Boston Scientific Scimed, Inc. | Vascular catheter, system, and method |
US20060173490A1 (en) * | 2005-02-01 | 2006-08-03 | Boston Scientific Scimed, Inc. | Filter system and method |
US7878966B2 (en) * | 2005-02-04 | 2011-02-01 | Boston Scientific Scimed, Inc. | Ventricular assist and support device |
US7780722B2 (en) | 2005-02-07 | 2010-08-24 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
EP3967269A3 (en) | 2005-02-07 | 2022-07-13 | Evalve, Inc. | Systems and devices for cardiac valve repair |
US7670368B2 (en) | 2005-02-07 | 2010-03-02 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US8470028B2 (en) | 2005-02-07 | 2013-06-25 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
US7867274B2 (en) | 2005-02-23 | 2011-01-11 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US8608797B2 (en) | 2005-03-17 | 2013-12-17 | Valtech Cardio Ltd. | Mitral valve treatment techniques |
EP1861045B1 (en) * | 2005-03-25 | 2015-03-04 | St. Jude Medical, Cardiology Division, Inc. | Apparatus for controlling the internal circumference of an anatomic orifice or lumen |
US8864823B2 (en) * | 2005-03-25 | 2014-10-21 | StJude Medical, Cardiology Division, Inc. | Methods and apparatus for controlling the internal circumference of an anatomic orifice or lumen |
US7722666B2 (en) | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US7357815B2 (en) * | 2005-04-21 | 2008-04-15 | Micardia Corporation | Dynamically adjustable implants and methods for reshaping tissue |
US20060247672A1 (en) * | 2005-04-27 | 2006-11-02 | Vidlund Robert M | Devices and methods for pericardial access |
US20060247491A1 (en) * | 2005-04-27 | 2006-11-02 | Vidlund Robert M | Devices and methods for heart valve treatment |
EP1895941A1 (en) * | 2005-05-20 | 2008-03-12 | The Cleveland Clinic Foundation | Apparatus and methods for repairing the function of a diseased valve and method for making same |
JP5119148B2 (en) | 2005-06-07 | 2013-01-16 | ダイレクト フロウ メディカル、 インク. | Stentless aortic valve replacement with high radial strength |
US8012198B2 (en) | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
US8951285B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
US9492277B2 (en) | 2005-08-30 | 2016-11-15 | Mayo Foundation For Medical Education And Research | Soft body tissue remodeling methods and apparatus |
US7569071B2 (en) | 2005-09-21 | 2009-08-04 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US20070093804A1 (en) * | 2005-10-17 | 2007-04-26 | Coaptus Medical Corporation | Control systems for patient devices, including devices for securing cardiovascular tissue, and associated methods |
US7799038B2 (en) | 2006-01-20 | 2010-09-21 | Boston Scientific Scimed, Inc. | Translumenal apparatus, system, and method |
US7749249B2 (en) | 2006-02-21 | 2010-07-06 | Kardium Inc. | Method and device for closing holes in tissue |
US7503932B2 (en) * | 2006-04-11 | 2009-03-17 | Cardiac Dimensions, Inc. | Mitral valve annuloplasty device with vena cava anchor |
WO2007136532A2 (en) * | 2006-05-03 | 2007-11-29 | St. Jude Medical, Inc. | Soft body tissue remodeling methods and apparatus |
US20070270688A1 (en) | 2006-05-19 | 2007-11-22 | Daniel Gelbart | Automatic atherectomy system |
US9149173B2 (en) * | 2006-06-20 | 2015-10-06 | Boston Scientific Scimed, Inc. | Medical device for use in endoscopic procedure |
US11389232B2 (en) | 2006-06-28 | 2022-07-19 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
US8449605B2 (en) | 2006-06-28 | 2013-05-28 | Kardium Inc. | Method for anchoring a mitral valve |
US9119633B2 (en) | 2006-06-28 | 2015-09-01 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
US10028783B2 (en) | 2006-06-28 | 2018-07-24 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
US8920411B2 (en) | 2006-06-28 | 2014-12-30 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
US11285005B2 (en) | 2006-07-17 | 2022-03-29 | Cardiac Dimensions Pty. Ltd. | Mitral valve annuloplasty device with twisted anchor |
US7837610B2 (en) | 2006-08-02 | 2010-11-23 | Kardium Inc. | System for improving diastolic dysfunction |
US7854849B2 (en) * | 2006-10-10 | 2010-12-21 | Multiphase Systems Integration | Compact multiphase inline bulk water separation method and system for hydrocarbon production |
US8388680B2 (en) | 2006-10-18 | 2013-03-05 | Guided Delivery Systems, Inc. | Methods and devices for catheter advancement and delivery of substances therethrough |
US7935144B2 (en) | 2006-10-19 | 2011-05-03 | Direct Flow Medical, Inc. | Profile reduction of valve implant |
US8133213B2 (en) | 2006-10-19 | 2012-03-13 | Direct Flow Medical, Inc. | Catheter guidance through a calcified aortic valve |
US9974653B2 (en) | 2006-12-05 | 2018-05-22 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US11259924B2 (en) | 2006-12-05 | 2022-03-01 | Valtech Cardio Ltd. | Implantation of repair devices in the heart |
WO2010004546A1 (en) | 2008-06-16 | 2010-01-14 | Valtech Cardio, Ltd. | Annuloplasty devices and methods of delivery therefor |
MX2009007289A (en) | 2007-01-03 | 2009-09-09 | Mitralsolutions Inc | Implantable devices for controlling the size and shape of an anatomical structure or lumen. |
US8133270B2 (en) | 2007-01-08 | 2012-03-13 | California Institute Of Technology | In-situ formation of a valve |
US20080183264A1 (en) * | 2007-01-30 | 2008-07-31 | Cardiac Pacemakers, Inc. | Electrode configurations for transvascular nerve stimulation |
US20080183187A1 (en) * | 2007-01-30 | 2008-07-31 | Cardiac Pacemakers, Inc. | Direct delivery system for transvascular lead |
US8244378B2 (en) * | 2007-01-30 | 2012-08-14 | Cardiac Pacemakers, Inc. | Spiral configurations for intravascular lead stability |
US7949409B2 (en) | 2007-01-30 | 2011-05-24 | Cardiac Pacemakers, Inc. | Dual spiral lead configurations |
US7917230B2 (en) * | 2007-01-30 | 2011-03-29 | Cardiac Pacemakers, Inc. | Neurostimulating lead having a stent-like anchor |
US20080183265A1 (en) * | 2007-01-30 | 2008-07-31 | Cardiac Pacemakers, Inc. | Transvascular lead with proximal force relief |
US20080183255A1 (en) * | 2007-01-30 | 2008-07-31 | Cardiac Pacemakers, Inc. | Side port lead delivery system |
US7967853B2 (en) | 2007-02-05 | 2011-06-28 | Boston Scientific Scimed, Inc. | Percutaneous valve, system and method |
JP5604110B2 (en) * | 2007-02-05 | 2014-10-08 | ボストン サイエンティフィック リミテッド | System for delivering a valve |
US8911461B2 (en) | 2007-03-13 | 2014-12-16 | Mitralign, Inc. | Suture cutter and method of cutting suture |
US8845723B2 (en) | 2007-03-13 | 2014-09-30 | Mitralign, Inc. | Systems and methods for introducing elements into tissue |
US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
US20080249618A1 (en) * | 2007-04-09 | 2008-10-09 | Medtronic Vascular, Inc. | Repair of Incompetent Heart Valves by Interstitial Implantation of Space Occupying Materials or Devices |
US8828079B2 (en) | 2007-07-26 | 2014-09-09 | Boston Scientific Scimed, Inc. | Circulatory valve, system and method |
AU2008288796B2 (en) | 2007-08-23 | 2014-03-20 | Dfm, Llc | Cardiovascular prosthetic valve |
CA2702615C (en) * | 2007-10-19 | 2017-06-06 | Guided Delivery Systems, Inc. | Systems and methods for cardiac remodeling |
US8906011B2 (en) | 2007-11-16 | 2014-12-09 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
EP2227193B8 (en) * | 2007-12-11 | 2022-09-07 | Cornell University | Apparatus for sealing an opening in the side wall of a body lumen |
US8956475B2 (en) | 2007-12-11 | 2015-02-17 | Howard Riina | Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen |
US7892276B2 (en) | 2007-12-21 | 2011-02-22 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
EP2072027B1 (en) | 2007-12-21 | 2020-06-17 | Medtentia International Ltd Oy | pre-annuloplasty device and method |
US20090171456A1 (en) * | 2007-12-28 | 2009-07-02 | Kveen Graig L | Percutaneous heart valve, system, and method |
US20090222081A1 (en) * | 2008-01-24 | 2009-09-03 | Coherex Medical, Inc. | Methods and apparatus for reducing valve prolapse |
US8489172B2 (en) | 2008-01-25 | 2013-07-16 | Kardium Inc. | Liposuction system |
WO2009100242A2 (en) | 2008-02-06 | 2009-08-13 | Guided Delivery Systems, Inc. | Multi-window guide tunnel |
US8382829B1 (en) | 2008-03-10 | 2013-02-26 | Mitralign, Inc. | Method to reduce mitral regurgitation by cinching the commissure of the mitral valve |
CA2723810C (en) | 2008-05-07 | 2015-06-30 | Guided Delivery Systems, Inc. | Deflectable guide |
US20090287304A1 (en) | 2008-05-13 | 2009-11-19 | Kardium Inc. | Medical Device for Constricting Tissue or a Bodily Orifice, for example a mitral valve |
US8006594B2 (en) | 2008-08-11 | 2011-08-30 | Cardiac Dimensions, Inc. | Catheter cutting tool |
US20100121349A1 (en) | 2008-10-10 | 2010-05-13 | Meier Stephen C | Termination devices and related methods |
EP2349020B1 (en) | 2008-10-10 | 2020-06-03 | Ancora Heart, Inc. | Tether tensioning device |
US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US8241351B2 (en) | 2008-12-22 | 2012-08-14 | Valtech Cardio, Ltd. | Adjustable partial annuloplasty ring and mechanism therefor |
US8715342B2 (en) | 2009-05-07 | 2014-05-06 | Valtech Cardio, Ltd. | Annuloplasty ring with intra-ring anchoring |
US8545553B2 (en) | 2009-05-04 | 2013-10-01 | Valtech Cardio, Ltd. | Over-wire rotation tool |
US9011530B2 (en) | 2008-12-22 | 2015-04-21 | Valtech Cardio, Ltd. | Partially-adjustable annuloplasty structure |
US8940044B2 (en) * | 2011-06-23 | 2015-01-27 | Valtech Cardio, Ltd. | Closure element for use with an annuloplasty structure |
CN102341063B (en) | 2008-12-22 | 2015-11-25 | 瓦尔泰克卡迪欧有限公司 | Adjustable annuloplasty device and governor motion thereof |
WO2010085456A1 (en) | 2009-01-20 | 2010-07-29 | Guided Delivery Systems Inc. | Anchor deployment devices and related methods |
WO2010085344A1 (en) | 2009-01-22 | 2010-07-29 | Cornell University | Method and apparatus for restricting flow through the wall of a lumen |
EP2389121B1 (en) * | 2009-01-22 | 2020-10-07 | St. Jude Medical, Cardiology Division, Inc. | Post-operative adjustment tool, minimally invasive attachment apparatus, and adjustable tricuspid ring |
US8353956B2 (en) | 2009-02-17 | 2013-01-15 | Valtech Cardio, Ltd. | Actively-engageable movement-restriction mechanism for use with an annuloplasty structure |
US9968452B2 (en) | 2009-05-04 | 2018-05-15 | Valtech Cardio, Ltd. | Annuloplasty ring delivery cathethers |
EP3042615A1 (en) | 2009-09-15 | 2016-07-13 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
EP2482749B1 (en) | 2009-10-01 | 2017-08-30 | Kardium Inc. | Kit for constricting tissue or a bodily orifice, for example, a mitral valve |
US9180007B2 (en) | 2009-10-29 | 2015-11-10 | Valtech Cardio, Ltd. | Apparatus and method for guide-wire based advancement of an adjustable implant |
US10098737B2 (en) | 2009-10-29 | 2018-10-16 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US9011520B2 (en) | 2009-10-29 | 2015-04-21 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US9649211B2 (en) | 2009-11-04 | 2017-05-16 | Confluent Medical Technologies, Inc. | Alternating circumferential bridge stent design and methods for use thereof |
EP2496189A4 (en) | 2009-11-04 | 2016-05-11 | Nitinol Devices And Components Inc | Alternating circumferential bridge stent design and methods for use thereof |
EP2506777B1 (en) | 2009-12-02 | 2020-11-25 | Valtech Cardio, Ltd. | Combination of spool assembly coupled to a helical anchor and delivery tool for implantation thereof |
US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
US9107749B2 (en) * | 2010-02-03 | 2015-08-18 | Edwards Lifesciences Corporation | Methods for treating a heart |
US9050066B2 (en) | 2010-06-07 | 2015-06-09 | Kardium Inc. | Closing openings in anatomical tissue |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
US9861350B2 (en) | 2010-09-03 | 2018-01-09 | Ancora Heart, Inc. | Devices and methods for anchoring tissue |
US8940002B2 (en) | 2010-09-30 | 2015-01-27 | Kardium Inc. | Tissue anchor system |
CA2822381C (en) | 2010-12-23 | 2019-04-02 | Foundry Newco Xii, Inc. | System for mitral valve repair and replacement |
US9480525B2 (en) | 2011-01-21 | 2016-11-01 | Kardium, Inc. | High-density electrode-based medical device system |
CA2764494A1 (en) | 2011-01-21 | 2012-07-21 | Kardium Inc. | Enhanced medical device for use in bodily cavities, for example an atrium |
US11259867B2 (en) | 2011-01-21 | 2022-03-01 | Kardium Inc. | High-density electrode-based medical device system |
US9452016B2 (en) | 2011-01-21 | 2016-09-27 | Kardium Inc. | Catheter system |
US9072511B2 (en) | 2011-03-25 | 2015-07-07 | Kardium Inc. | Medical kit for constricting tissue or a bodily orifice, for example, a mitral valve |
US9238126B2 (en) * | 2011-04-08 | 2016-01-19 | Sanovas Inc. | Biofeedback controlled deformation of sinus ostia |
CN107496054B (en) | 2011-06-21 | 2020-03-03 | 托尔福公司 | Prosthetic heart valve devices and related systems and methods |
US10792152B2 (en) | 2011-06-23 | 2020-10-06 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
US9918840B2 (en) | 2011-06-23 | 2018-03-20 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
US9668859B2 (en) | 2011-08-05 | 2017-06-06 | California Institute Of Technology | Percutaneous heart valve delivery systems |
US8945177B2 (en) | 2011-09-13 | 2015-02-03 | Abbott Cardiovascular Systems Inc. | Gripper pusher mechanism for tissue apposition systems |
WO2013055703A1 (en) | 2011-10-07 | 2013-04-18 | Cornell University | Method and apparatus for restricting flow through an opening in a body lumen while maintaining normal flow |
CN111000663B (en) | 2011-10-19 | 2022-04-15 | 托尔福公司 | Prosthetic heart valve devices, prosthetic mitral valves, and related systems and methods |
US9039757B2 (en) | 2011-10-19 | 2015-05-26 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
EP3943047B1 (en) | 2011-10-19 | 2023-08-30 | Twelve, Inc. | Device for heart valve replacement |
US9763780B2 (en) | 2011-10-19 | 2017-09-19 | Twelve, Inc. | Devices, systems and methods for heart valve replacement |
US9655722B2 (en) | 2011-10-19 | 2017-05-23 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US11202704B2 (en) | 2011-10-19 | 2021-12-21 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US8858623B2 (en) | 2011-11-04 | 2014-10-14 | Valtech Cardio, Ltd. | Implant having multiple rotational assemblies |
EP3970627B1 (en) | 2011-11-08 | 2023-12-20 | Edwards Lifesciences Innovation (Israel) Ltd. | Controlled steering functionality for implant-delivery tool |
USD777925S1 (en) | 2012-01-20 | 2017-01-31 | Kardium Inc. | Intra-cardiac procedure device |
USD777926S1 (en) | 2012-01-20 | 2017-01-31 | Kardium Inc. | Intra-cardiac procedure device |
US10076414B2 (en) * | 2012-02-13 | 2018-09-18 | Mitraspan, Inc. | Method and apparatus for repairing a mitral valve |
US9579198B2 (en) | 2012-03-01 | 2017-02-28 | Twelve, Inc. | Hydraulic delivery systems for prosthetic heart valve devices and associated methods |
US9198592B2 (en) | 2012-05-21 | 2015-12-01 | Kardium Inc. | Systems and methods for activating transducers |
US9017320B2 (en) | 2012-05-21 | 2015-04-28 | Kardium, Inc. | Systems and methods for activating transducers |
US10827977B2 (en) | 2012-05-21 | 2020-11-10 | Kardium Inc. | Systems and methods for activating transducers |
EP2900150B1 (en) | 2012-09-29 | 2018-04-18 | Mitralign, Inc. | Plication lock delivery system |
US9949828B2 (en) | 2012-10-23 | 2018-04-24 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
WO2014064695A2 (en) | 2012-10-23 | 2014-05-01 | Valtech Cardio, Ltd. | Percutaneous tissue anchor techniques |
US9730793B2 (en) | 2012-12-06 | 2017-08-15 | Valtech Cardio, Ltd. | Techniques for guide-wire based advancement of a tool |
EP2948103B1 (en) | 2013-01-24 | 2022-12-07 | Cardiovalve Ltd | Ventricularly-anchored prosthetic valves |
US9724084B2 (en) | 2013-02-26 | 2017-08-08 | Mitralign, Inc. | Devices and methods for percutaneous tricuspid valve repair |
US10449333B2 (en) | 2013-03-14 | 2019-10-22 | Valtech Cardio, Ltd. | Guidewire feeder |
WO2014144247A1 (en) | 2013-03-15 | 2014-09-18 | Arash Kheradvar | Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves |
EP2968847B1 (en) | 2013-03-15 | 2023-03-08 | Edwards Lifesciences Corporation | Translation catheter systems |
CN108294846A (en) | 2013-05-20 | 2018-07-20 | 托尔福公司 | Implantable cardiac valve device, mitral valve repair device and related system and method |
US10070857B2 (en) | 2013-08-31 | 2018-09-11 | Mitralign, Inc. | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
WO2015059699A2 (en) | 2013-10-23 | 2015-04-30 | Valtech Cardio, Ltd. | Anchor magazine |
US9610162B2 (en) | 2013-12-26 | 2017-04-04 | Valtech Cardio, Ltd. | Implantation of flexible implant |
US9572666B2 (en) | 2014-03-17 | 2017-02-21 | Evalve, Inc. | Mitral valve fixation device removal devices and methods |
US10390943B2 (en) | 2014-03-17 | 2019-08-27 | Evalve, Inc. | Double orifice device for transcatheter mitral valve replacement |
EP3206629B1 (en) | 2014-10-14 | 2021-07-14 | Valtech Cardio, Ltd. | Apparatus for heart valve leaflet restraining |
US10368936B2 (en) | 2014-11-17 | 2019-08-06 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
US10722184B2 (en) | 2014-11-17 | 2020-07-28 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
US10188392B2 (en) | 2014-12-19 | 2019-01-29 | Abbott Cardiovascular Systems, Inc. | Grasping for tissue repair |
EP3253333B1 (en) | 2015-02-05 | 2024-04-03 | Cardiovalve Ltd | Prosthetic valve with axially-sliding frames |
US20160256269A1 (en) | 2015-03-05 | 2016-09-08 | Mitralign, Inc. | Devices for treating paravalvular leakage and methods use thereof |
CA2978599C (en) | 2015-03-05 | 2022-09-06 | Ancora Heart, Inc. | Devices and methods of visualizing and determining depth of penetration in cardiac tissue |
US10524912B2 (en) | 2015-04-02 | 2020-01-07 | Abbott Cardiovascular Systems, Inc. | Tissue fixation devices and methods |
CN114515173A (en) | 2015-04-30 | 2022-05-20 | 瓦尔泰克卡迪欧有限公司 | Valvuloplasty techniques |
US10980973B2 (en) | 2015-05-12 | 2021-04-20 | Ancora Heart, Inc. | Device and method for releasing catheters from cardiac structures |
US10376673B2 (en) | 2015-06-19 | 2019-08-13 | Evalve, Inc. | Catheter guiding system and methods |
US10238494B2 (en) | 2015-06-29 | 2019-03-26 | Evalve, Inc. | Self-aligning radiopaque ring |
US10667815B2 (en) | 2015-07-21 | 2020-06-02 | Evalve, Inc. | Tissue grasping devices and related methods |
US10413408B2 (en) | 2015-08-06 | 2019-09-17 | Evalve, Inc. | Delivery catheter systems, methods, and devices |
EP3337428A1 (en) | 2015-08-21 | 2018-06-27 | Twelve Inc. | Implantable heart valve devices, mitral valve repair devices and associated systems and methods |
US10238495B2 (en) | 2015-10-09 | 2019-03-26 | Evalve, Inc. | Delivery catheter handle and methods of use |
US10751182B2 (en) | 2015-12-30 | 2020-08-25 | Edwards Lifesciences Corporation | System and method for reshaping right heart |
WO2017117370A2 (en) | 2015-12-30 | 2017-07-06 | Mitralign, Inc. | System and method for reducing tricuspid regurgitation |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
WO2017189276A1 (en) | 2016-04-29 | 2017-11-02 | Medtronic Vascular Inc. | Prosthetic heart valve devices with tethered anchors and associated systems and methods |
US10702274B2 (en) | 2016-05-26 | 2020-07-07 | Edwards Lifesciences Corporation | Method and system for closing left atrial appendage |
US10736632B2 (en) | 2016-07-06 | 2020-08-11 | Evalve, Inc. | Methods and devices for valve clip excision |
GB201611910D0 (en) | 2016-07-08 | 2016-08-24 | Valtech Cardio Ltd | Adjustable annuloplasty device with alternating peaks and troughs |
CN114587712A (en) | 2016-08-10 | 2022-06-07 | 卡迪尔维尔福股份有限公司 | Prosthetic valve with coaxial frame |
US11071564B2 (en) | 2016-10-05 | 2021-07-27 | Evalve, Inc. | Cardiac valve cutting device |
US10363138B2 (en) | 2016-11-09 | 2019-07-30 | Evalve, Inc. | Devices for adjusting the curvature of cardiac valve structures |
US10398553B2 (en) | 2016-11-11 | 2019-09-03 | Evalve, Inc. | Opposing disk device for grasping cardiac valve tissue |
US10426616B2 (en) | 2016-11-17 | 2019-10-01 | Evalve, Inc. | Cardiac implant delivery system |
US10667914B2 (en) | 2016-11-18 | 2020-06-02 | Ancora Heart, Inc. | Myocardial implant load sharing device and methods to promote LV function |
US10779837B2 (en) | 2016-12-08 | 2020-09-22 | Evalve, Inc. | Adjustable arm device for grasping tissues |
US10314586B2 (en) | 2016-12-13 | 2019-06-11 | Evalve, Inc. | Rotatable device and method for fixing tricuspid valve tissue |
US10953204B2 (en) | 2017-01-09 | 2021-03-23 | Boston Scientific Scimed, Inc. | Guidewire with tactile feel |
US10390953B2 (en) | 2017-03-08 | 2019-08-27 | Cardiac Dimensions Pty. Ltd. | Methods and devices for reducing paravalvular leakage |
US11045627B2 (en) | 2017-04-18 | 2021-06-29 | Edwards Lifesciences Corporation | Catheter system with linear actuation control mechanism |
US10433961B2 (en) | 2017-04-18 | 2019-10-08 | Twelve, Inc. | Delivery systems with tethers for prosthetic heart valve devices and associated methods |
US10575950B2 (en) | 2017-04-18 | 2020-03-03 | Twelve, Inc. | Hydraulic systems for delivering prosthetic heart valve devices and associated methods |
US10702378B2 (en) | 2017-04-18 | 2020-07-07 | Twelve, Inc. | Prosthetic heart valve device and associated systems and methods |
US10792151B2 (en) | 2017-05-11 | 2020-10-06 | Twelve, Inc. | Delivery systems for delivering prosthetic heart valve devices and associated methods |
WO2018209313A1 (en) | 2017-05-12 | 2018-11-15 | Evalve, Inc. | Long arm valve repair clip |
US10646338B2 (en) | 2017-06-02 | 2020-05-12 | Twelve, Inc. | Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods |
US10709591B2 (en) | 2017-06-06 | 2020-07-14 | Twelve, Inc. | Crimping device and method for loading stents and prosthetic heart valves |
US10729541B2 (en) | 2017-07-06 | 2020-08-04 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US10786352B2 (en) | 2017-07-06 | 2020-09-29 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
EP4309626A3 (en) * | 2017-09-22 | 2024-04-17 | HVR Cardio Oy | Medical system for annuloplasty |
US10835221B2 (en) | 2017-11-02 | 2020-11-17 | Valtech Cardio, Ltd. | Implant-cinching devices and systems |
US11135062B2 (en) | 2017-11-20 | 2021-10-05 | Valtech Cardio Ltd. | Cinching of dilated heart muscle |
US10856985B2 (en) | 2017-11-21 | 2020-12-08 | Abbott Cardiovascular Systems Inc. | System and method for annuloplasty |
WO2019145947A1 (en) | 2018-01-24 | 2019-08-01 | Valtech Cardio, Ltd. | Contraction of an annuloplasty structure |
EP3743014B1 (en) | 2018-01-26 | 2023-07-19 | Edwards Lifesciences Innovation (Israel) Ltd. | Techniques for facilitating heart valve tethering and chord replacement |
US11285003B2 (en) | 2018-03-20 | 2022-03-29 | Medtronic Vascular, Inc. | Prolapse prevention device and methods of use thereof |
US11026791B2 (en) | 2018-03-20 | 2021-06-08 | Medtronic Vascular, Inc. | Flexible canopy valve repair systems and methods of use |
AU2019301967A1 (en) | 2018-07-12 | 2021-01-21 | Edwards Lifesciences Innovation (Israel) Ltd. | Annuloplasty systems and locking tools therefor |
WO2020193807A1 (en) * | 2019-03-28 | 2020-10-01 | Medtentia International Ltd Oy | Medical system for annuloplasty |
WO2021011659A1 (en) | 2019-07-15 | 2021-01-21 | Ancora Heart, Inc. | Devices and methods for tether cutting |
CR20210640A (en) | 2019-10-29 | 2022-05-30 | Valtech Cardio Ltd | Annuloplasty and tissue anchor technologies |
WO2022132571A1 (en) | 2020-12-14 | 2022-06-23 | Cardiac Dimensions Pty. Ltd. | Modular pre-loaded medical implants and delivery systems |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4413989A (en) * | 1980-09-08 | 1983-11-08 | Angiomedics Corporation | Expandable occlusion apparatus |
US5318529A (en) * | 1989-09-06 | 1994-06-07 | Boston Scientific Corporation | Angioplasty balloon catheter and adaptor |
US5334185A (en) * | 1991-06-28 | 1994-08-02 | Giesy Consultants, Inc. | End-to-end instrument placement apparatus |
US5584803A (en) * | 1991-07-16 | 1996-12-17 | Heartport, Inc. | System for cardiac procedures |
US5637091A (en) * | 1995-08-31 | 1997-06-10 | Hakky; Said I. | Collapsible catheter |
US5797951A (en) * | 1995-08-09 | 1998-08-25 | Mueller; Edward Gene | Expandable support member |
US5971983A (en) * | 1997-05-09 | 1999-10-26 | The Regents Of The University Of California | Tissue ablation device and method of use |
US6083259A (en) * | 1998-11-16 | 2000-07-04 | Frantzen; John J. | Axially non-contracting flexible radially expandable stent |
US6206911B1 (en) * | 1996-12-19 | 2001-03-27 | Simcha Milo | Stent combination |
US20020099431A1 (en) * | 2001-01-22 | 2002-07-25 | Armstrong Joseph R. | Deployment system for intraluminal devices |
US20020183835A1 (en) * | 2001-02-05 | 2002-12-05 | Taylor Daniel C. | Method and apparatus for improving mitral valve function |
US20020183838A1 (en) * | 2001-03-29 | 2002-12-05 | Liddicoat John R. | Method and apparatus for improving mitral valve function |
US6821287B1 (en) * | 1991-05-24 | 2004-11-23 | Advanced Cardiovascular Systems, Inc. | Multi-mode vascular catheter system |
US7226477B2 (en) * | 2002-11-15 | 2007-06-05 | Advanced Cardiovascular Systems, Inc. | Apparatuses and methods for heart valve repair |
US20070213758A1 (en) * | 2003-05-27 | 2007-09-13 | Rourke Jonathan M | Method and apparatus for improving mitral valve function |
Family Cites Families (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4535757A (en) * | 1982-03-12 | 1985-08-20 | Webster Wilton W Jr | Autoinflatable catheter |
US4669473A (en) * | 1985-09-06 | 1987-06-02 | Acufex Microsurgical, Inc. | Surgical fastener |
CA1303298C (en) | 1986-08-06 | 1992-06-16 | Alain Carpentier | Flexible cardiac valvular support prosthesis |
US4944745A (en) | 1988-02-29 | 1990-07-31 | Scimed Life Systems, Inc. | Perfusion balloon catheter |
US4917698A (en) * | 1988-12-22 | 1990-04-17 | Baxter International Inc. | Multi-segmented annuloplasty ring prosthesis |
US5032113A (en) | 1989-04-13 | 1991-07-16 | Scimed Life Systems, Inc. | Innerless catheter |
US5092889A (en) * | 1989-04-14 | 1992-03-03 | Campbell Robert M Jr | Expandable vertical prosthetic rib |
US5269809A (en) * | 1990-07-02 | 1993-12-14 | American Cyanamid Company | Locking mechanism for use with a slotted suture anchor |
US5527292A (en) | 1990-10-29 | 1996-06-18 | Scimed Life Systems, Inc. | Intravascular device for coronary heart treatment |
CA2062000A1 (en) | 1991-03-07 | 1992-09-08 | H. Robert Moorehead | Site-selective reinforced catheter and methods of manufacturing and using the reinforced catheter |
FR2683449A1 (en) | 1991-11-08 | 1993-05-14 | Cardon Alain | ENDOPROTHESIS FOR TRANSLUMINAL IMPLANTATION. |
US5509900A (en) * | 1992-03-02 | 1996-04-23 | Kirkman; Thomas R. | Apparatus and method for retaining a catheter in a blood vessel in a fixed position |
US5263932A (en) * | 1992-04-09 | 1993-11-23 | Jang G David | Bailout catheter for fixed wire angioplasty |
US5332402A (en) * | 1992-05-12 | 1994-07-26 | Teitelbaum George P | Percutaneously-inserted cardiac valve |
US5443481A (en) | 1992-07-27 | 1995-08-22 | Lee; Benjamin I. | Methods and device for percutaneous sealing of arterial puncture sites |
US5487730A (en) * | 1992-12-30 | 1996-01-30 | Medtronic, Inc. | Balloon catheter with balloon surface retention means |
US6277107B1 (en) | 1993-08-13 | 2001-08-21 | Daig Corporation | Guiding introducer for introducing medical devices into the coronary sinus and process for using same |
US5545209A (en) * | 1993-09-30 | 1996-08-13 | Texas Petrodet, Inc. | Controlled deployment of a medical device |
US5476506A (en) | 1994-02-08 | 1995-12-19 | Ethicon, Inc. | Bi-directional crimped graft |
US6051020A (en) * | 1994-02-09 | 2000-04-18 | Boston Scientific Technology, Inc. | Bifurcated endoluminal prosthesis |
US5562620A (en) | 1994-04-01 | 1996-10-08 | Localmed, Inc. | Perfusion shunt device having non-distensible pouch for receiving angioplasty balloon |
US6332896B1 (en) * | 1994-07-14 | 2001-12-25 | Ortho Development Corporation | Orthopaedic implant with proximal collar |
US5575779A (en) * | 1994-12-30 | 1996-11-19 | Namic U.S.A. Corporation | Liquid regulator and method of use |
US5569198A (en) * | 1995-01-23 | 1996-10-29 | Cortrak Medical Inc. | Microporous catheter |
US5681345A (en) | 1995-03-01 | 1997-10-28 | Scimed Life Systems, Inc. | Sleeve carrying stent |
CA2171896C (en) * | 1995-03-17 | 2007-05-15 | Scott C. Anderson | Multi-anchor stent |
US5575799A (en) | 1995-03-30 | 1996-11-19 | United States Surgical Corporation | Articulating surgical apparatus |
WO1996039225A1 (en) | 1995-06-06 | 1996-12-12 | The Board Of Regents, The University Of Texas System | Electrode system in iontophoretic treatment devices |
US6132438A (en) * | 1995-06-07 | 2000-10-17 | Ep Technologies, Inc. | Devices for installing stasis reducing means in body tissue |
CA2179083A1 (en) | 1995-08-01 | 1997-02-02 | Michael S. Williams | Composite metal and polymer locking stents for drug delivery |
JPH09322936A (en) | 1996-06-06 | 1997-12-16 | A S A Sangyo Kk | Catheter for peritoneal dialysis and dialytic liquid container |
US6090136A (en) * | 1996-07-29 | 2000-07-18 | Radiance Medical Systems, Inc. | Self expandable tubular support |
US5755781A (en) | 1996-08-06 | 1998-05-26 | Iowa-India Investments Company Limited | Embodiments of multiple interconnected stents |
US5755778A (en) | 1996-10-16 | 1998-05-26 | Nitinol Medical Technologies, Inc. | Anastomosis device |
AU5355598A (en) | 1996-11-07 | 1998-06-10 | Medtronic Instent, Inc. | Variable flexibility stent |
US5855565A (en) * | 1997-02-21 | 1999-01-05 | Bar-Cohen; Yaniv | Cardiovascular mechanically expanding catheter |
US5911732A (en) | 1997-03-10 | 1999-06-15 | Johnson & Johnson Interventional Systems, Co. | Articulated expandable intraluminal stent |
US5800495A (en) * | 1997-03-27 | 1998-09-01 | Sulzer Intermedics Inc. | Endocardial lead assembly |
US5957949A (en) * | 1997-05-01 | 1999-09-28 | World Medical Manufacturing Corp. | Percutaneous placement valve stent |
US6162245A (en) * | 1997-05-07 | 2000-12-19 | Iowa-India Investments Company Limited | Stent valve and stent graft |
US6033436A (en) | 1998-02-17 | 2000-03-07 | Md3, Inc. | Expandable stent |
US5980570A (en) * | 1998-03-27 | 1999-11-09 | Sulzer Carbomedics Inc. | System and method for implanting an expandable medical device into a body |
US6241746B1 (en) * | 1998-06-29 | 2001-06-05 | Cordis Corporation | Vascular filter convertible to a stent and method |
US6165194A (en) | 1998-07-24 | 2000-12-26 | Micrus Corporation | Intravascular flow modifier and reinforcement device |
US6328765B1 (en) | 1998-12-03 | 2001-12-11 | Gore Enterprise Holdings, Inc. | Methods and articles for regenerating living tissue |
US6086599A (en) * | 1999-02-08 | 2000-07-11 | The Regents Of The University Of California | Micro devices using shape memory polymer patches for mated connections |
US6258117B1 (en) * | 1999-04-15 | 2001-07-10 | Mayo Foundation For Medical Education And Research | Multi-section stent |
US6187040B1 (en) * | 1999-05-03 | 2001-02-13 | John T. M. Wright | Mitral and tricuspid annuloplasty rings |
SE514718C2 (en) * | 1999-06-29 | 2001-04-09 | Jan Otto Solem | Apparatus for treating defective closure of the mitral valve apparatus |
US7192442B2 (en) | 1999-06-30 | 2007-03-20 | Edwards Lifesciences Ag | Method and device for treatment of mitral insufficiency |
US6989028B2 (en) | 2000-01-31 | 2006-01-24 | Edwards Lifesciences Ag | Medical system and method for remodeling an extravascular tissue structure |
US6402781B1 (en) | 2000-01-31 | 2002-06-11 | Mitralife | Percutaneous mitral annuloplasty and cardiac reinforcement |
US6648874B2 (en) * | 2000-02-28 | 2003-11-18 | Scimed Life Systems, Inc. | Guide catheter with lubricious inner liner |
US6569198B1 (en) | 2000-03-31 | 2003-05-27 | Richard A. Wilson | Mitral or tricuspid valve annuloplasty prosthetic device |
US6585716B2 (en) * | 2000-04-05 | 2003-07-01 | Biocardia, Inc. | Method of treating the heart |
US6638268B2 (en) | 2000-04-07 | 2003-10-28 | Imran K. Niazi | Catheter to cannulate the coronary sinus |
US6419696B1 (en) * | 2000-07-06 | 2002-07-16 | Paul A. Spence | Annuloplasty devices and related heart valve repair methods |
US6602288B1 (en) | 2000-10-05 | 2003-08-05 | Edwards Lifesciences Corporation | Minimally-invasive annuloplasty repair segment delivery template, system and method of use |
US7591826B2 (en) | 2000-12-28 | 2009-09-22 | Cardiac Dimensions, Inc. | Device implantable in the coronary sinus to provide mitral valve therapy |
US6810882B2 (en) | 2001-01-30 | 2004-11-02 | Ev3 Santa Rosa, Inc. | Transluminal mitral annuloplasty |
JP4195612B2 (en) | 2001-01-30 | 2008-12-10 | エドワーズ ライフサイエンシーズ アーゲー | Medical system and method for improving extracorporeal tissue structure |
US6790231B2 (en) * | 2001-02-05 | 2004-09-14 | Viacor, Inc. | Apparatus and method for reducing mitral regurgitation |
US6890353B2 (en) * | 2001-03-23 | 2005-05-10 | Viacor, Inc. | Method and apparatus for reducing mitral regurgitation |
EP1383448B1 (en) * | 2001-03-29 | 2008-06-04 | Viacor, Inc. | Apparatus for improving mitral valve function |
US6676702B2 (en) | 2001-05-14 | 2004-01-13 | Cardiac Dimensions, Inc. | Mitral valve therapy assembly and method |
US6800090B2 (en) | 2001-05-14 | 2004-10-05 | Cardiac Dimensions, Inc. | Mitral valve therapy device, system and method |
US6949122B2 (en) | 2001-11-01 | 2005-09-27 | Cardiac Dimensions, Inc. | Focused compression mitral valve device and method |
US6805710B2 (en) | 2001-11-13 | 2004-10-19 | Edwards Lifesciences Corporation | Mitral valve annuloplasty ring for molding left ventricle geometry |
US6908478B2 (en) | 2001-12-05 | 2005-06-21 | Cardiac Dimensions, Inc. | Anchor and pull mitral valve device and method |
DE10161543B4 (en) * | 2001-12-11 | 2004-02-19 | REITAN, Öyvind | Implant for the treatment of heart valve insufficiency |
-
2002
- 2002-10-25 US US10/280,401 patent/US7052487B2/en not_active Expired - Lifetime
-
2003
- 2003-01-14 AU AU2003209219A patent/AU2003209219A1/en not_active Abandoned
- 2003-01-14 CA CA002472482A patent/CA2472482A1/en not_active Abandoned
- 2003-01-14 WO PCT/US2003/000971 patent/WO2003059198A2/en not_active Application Discontinuation
- 2003-01-14 US US10/342,034 patent/US7241310B2/en not_active Expired - Lifetime
- 2003-01-14 EP EP03707367A patent/EP1471858A4/en not_active Withdrawn
-
2006
- 2006-03-09 US US11/371,642 patent/US20060229717A1/en not_active Abandoned
-
2007
- 2007-06-15 US US11/818,991 patent/US20080103590A1/en not_active Abandoned
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4413989A (en) * | 1980-09-08 | 1983-11-08 | Angiomedics Corporation | Expandable occlusion apparatus |
US5318529A (en) * | 1989-09-06 | 1994-06-07 | Boston Scientific Corporation | Angioplasty balloon catheter and adaptor |
US6821287B1 (en) * | 1991-05-24 | 2004-11-23 | Advanced Cardiovascular Systems, Inc. | Multi-mode vascular catheter system |
US5334185A (en) * | 1991-06-28 | 1994-08-02 | Giesy Consultants, Inc. | End-to-end instrument placement apparatus |
US5584803A (en) * | 1991-07-16 | 1996-12-17 | Heartport, Inc. | System for cardiac procedures |
US5797951A (en) * | 1995-08-09 | 1998-08-25 | Mueller; Edward Gene | Expandable support member |
US5637091A (en) * | 1995-08-31 | 1997-06-10 | Hakky; Said I. | Collapsible catheter |
US6206911B1 (en) * | 1996-12-19 | 2001-03-27 | Simcha Milo | Stent combination |
US5971983A (en) * | 1997-05-09 | 1999-10-26 | The Regents Of The University Of California | Tissue ablation device and method of use |
US6083259A (en) * | 1998-11-16 | 2000-07-04 | Frantzen; John J. | Axially non-contracting flexible radially expandable stent |
US20020099431A1 (en) * | 2001-01-22 | 2002-07-25 | Armstrong Joseph R. | Deployment system for intraluminal devices |
US20020183835A1 (en) * | 2001-02-05 | 2002-12-05 | Taylor Daniel C. | Method and apparatus for improving mitral valve function |
US20020183838A1 (en) * | 2001-03-29 | 2002-12-05 | Liddicoat John R. | Method and apparatus for improving mitral valve function |
US7226477B2 (en) * | 2002-11-15 | 2007-06-05 | Advanced Cardiovascular Systems, Inc. | Apparatuses and methods for heart valve repair |
US20070213758A1 (en) * | 2003-05-27 | 2007-09-13 | Rourke Jonathan M | Method and apparatus for improving mitral valve function |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070156235A1 (en) * | 2002-02-05 | 2007-07-05 | Jonathan Rourke | Method and apparatus for improving mitral valve function |
US20060136053A1 (en) * | 2003-05-27 | 2006-06-22 | Rourke Jonathan M | Method and apparatus for improving mitral valve function |
WO2010051029A1 (en) * | 2008-10-29 | 2010-05-06 | Viacor, Inc. | Method and apparatus for improving mitral valve function |
WO2014187855A1 (en) * | 2013-05-21 | 2014-11-27 | Medtentia International Ltd Oy | Medical system for annuloplasty |
CN105208972A (en) * | 2013-05-21 | 2015-12-30 | 梅德坦提亚国际有限公司 | Medical system for annuloplasty |
AU2014270431B2 (en) * | 2013-05-21 | 2019-03-07 | Medtentia International Ltd Oy | Medical system for annuloplasty |
US10517724B2 (en) | 2013-05-21 | 2019-12-31 | Medtentia International Ltd. Oy | Medical system for annuloplasty |
Also Published As
Publication number | Publication date |
---|---|
US7052487B2 (en) | 2006-05-30 |
AU2003209219A8 (en) | 2003-07-30 |
US20060229717A1 (en) | 2006-10-12 |
WO2003059198A2 (en) | 2003-07-24 |
CA2472482A1 (en) | 2003-07-24 |
US20040019377A1 (en) | 2004-01-29 |
EP1471858A4 (en) | 2008-10-01 |
EP1471858A2 (en) | 2004-11-03 |
US7241310B2 (en) | 2007-07-10 |
AU2003209219A1 (en) | 2003-07-30 |
WO2003059198A3 (en) | 2004-03-25 |
US20030130730A1 (en) | 2003-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7241310B2 (en) | Method and apparatus for reducing mitral regurgitation | |
US11865001B2 (en) | Cardiac valve downsizing device and method | |
US10166102B2 (en) | Mitral valve annuloplasty device with twisted anchor | |
JP4184794B2 (en) | Method and apparatus for improving mitral valve function | |
US20030078654A1 (en) | Method and apparatus for improving mitral valve function | |
US7186264B2 (en) | Method and apparatus for improving mitral valve function | |
CN106061437B (en) | System and method for transcatheter treatment of valve regurgitation | |
US7316706B2 (en) | Tensioning device, system, and method for treating mitral valve regurgitation | |
EP1383448B1 (en) | Apparatus for improving mitral valve function | |
US7125420B2 (en) | Method and apparatus for improving mitral valve function | |
EP2039325A1 (en) | Device for modifying the shape of a body organ | |
US20070027533A1 (en) | Cardiac valve annulus restraining device | |
JP2004535851A (en) | BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention generally relates to techniques for treating mitral dysfunction, such as mitral valve leakage. More specifically, the present invention relates to systems and methods for treating leaky mitral valves in a minimally invasive manner. | |
JP2006528036A (en) | Method and apparatus for improving mitral valve function | |
JP4456605B2 (en) | Method and apparatus for improving mitral valve function | |
WO2003034947A1 (en) | Method and apparatus for reducing mitral regurgitation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |